128196-01-0 | 5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-

Packsize	Purity	Availability	Price	Discounted Price
5mg	97%	in stock	$58.00	$40.00
10mg	97%	in stock	$103.00	$72.00
25mg	≥98%	in stock	$241.00	$169.00
50mg		in stock	$253.00	$177.00
100mg		in stock	$308.00	$216.00

Description

• Catalog Number: AA43656
• Chemical Name: 5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-
• CAS Number: 128196-01-0
• Molecular Formula: C20H21FN2O
• Molecular Weight: 324.3919
• MDL Number: MFCD09817397
• SMILES: N#Cc1ccc2c(c1)CO[C@@]2(CCCN(C)C)c1ccc(cc1)F

Computed Properties

• Complexity: 466
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 1
• Heavy Atom Count: 24
• Hydrogen Bond Acceptor Count: 4
• Rotatable Bond Count: 5
• XLogP3: 3.2

Literature

• Chronic treatment with caffeine and its withdrawal modify the antidepressant-like activity of selective serotonin reuptake inhibitors in the forced swim and tail suspension tests in mice. Effects on Comt, Slc6a15 and Adora1 gene expression.

  Toxicology and applied pharmacology 20171215

• Depressive-like effect of prenatal exposure to DDT involves global DNA hypomethylation and impairment of GPER1/ESR1 protein levels but not ESR2 and AHR/ARNT signaling.

  The Journal of steroid biochemistry and molecular biology 20170701

• X-ray structures and mechanism of the human serotonin transporter.

  Nature 20160421

• Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity.

  Neurotoxicology 20160101

• Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.

  Toxicology in vitro : an international journal published in association with BIBRA 20151001

• Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling.

  Cancer research 20141015

• A case of akathisia induced by escitalopram: case report & review of literature.

  Current drug safety 20140301

• Profiling of enantiopure drugs towards aryl hydrocarbon (AhR), glucocorticoid (GR) and pregnane X (PXR) receptors in human reporter cell lines.

  Chemico-biological interactions 20140205

• A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram.

  The Journal of clinical psychiatry 20130801

• Chronic antidepressant treatment impairs the acquisition of fear extinction.

  Biological psychiatry 20130601

• Quetiapine ameliorates stress-induced cognitive inflexibility in rats.

  Neuropharmacology 20130101

• Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users.

  Neuropharmacology 20130101

• A rhodamine-labeled citalopram analogue as a high-affinity fluorescent probe for the serotonin transporter.

  Bioorganic & medicinal chemistry letters 20130101

• Mechanisms of high-dose citalopram-induced death in a rat model.

  Toxicology 20121216

• Cognitive therapy for anxious depression in STAR(*) D: what have we learned?

  Journal of affective disorders 20121215

• Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.

  Psychological medicine 20121201

• Feasibility of ASL-based phMRI with a single dose of oral citalopram for repeated assessment of serotonin function.

  NeuroImage 20121115

• Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels.

  The Biochemical journal 20121115

• Escitalopram improves memory deficits induced by maternal separation in the rat.

  European journal of pharmacology 20121115

• Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report.

  The international journal of neuropsychopharmacology 20121101

• The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning.

  Journal of psychopharmacology (Oxford, England) 20121101

• Safety profile of enantiomers vs. racemic mixtures: it's the same?

  British journal of clinical pharmacology 20121101

• Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-magnetic resonance spectroscopy of N-acetyl-aspartate.

  The international journal of neuropsychopharmacology 20121101

• Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine.

  Journal of psychopharmacology (Oxford, England) 20121101

• Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus.

  Psychopharmacology 20121101

• Functional neuroanatomy of emotion processing in major depressive disorder is altered after successful antidepressant therapy.

  Journal of psychopharmacology (Oxford, England) 20121101

• Establishing a probabilistic reversal learning test in mice: evidence for the processes mediating reward-stay and punishment-shift behaviour and for their modulation by serotonin.

  Neuropharmacology 20121101

• Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas.

  NeuroImage 20121101

• Serotonin modulation of cerebral glucose metabolism: sex and age effects.

  Synapse (New York, N.Y.) 20121101

• Arrays of SnO2 nanorods as novel solid phase microextraction for trace analysis of antidepressant drugs in body fluids.

  Journal of pharmaceutical and biomedical analysis 20121101

• The effect of acute serotonergic modulation on rectal motor function in diarrhea-predominant irritable bowel syndrome and healthy controls.

  European journal of gastroenterology & hepatology 20121101

• Adherence to escitalopram treatment in depression: a study of electronically compiled dosing histories in the 'Depression: the search for phenotypes' study.

  International clinical psychopharmacology 20121101

• A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake.

  Bioorganic & medicinal chemistry 20121101

• Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression.

  Pharmacogenetics and genomics 20121101

• Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study.

  International journal of clinical practice 20121101

• In vivo evaluation of [¹²³I]mZIENT as a SPECT radioligand for the serotonin transporter.

  Nuclear medicine and biology 20121101

• Distance from source of reward as a marker for extinction-induced 'despair': modulation by the antidepressants clomipramine and citalopram.

  Neuroscience 20121025

• Behavioral changes after maternal separation are reversed by chronic constant light treatment.

  Brain research 20121022

• 5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats.

  The international journal of neuropsychopharmacology 20121001

• Study of interaction between croscarmellose and escitalopram during sample preparation.

  Drug development and industrial pharmacy 20121001

• Synergistic antidepressant-like action of gaboxadol and escitalopram.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20121001

• Catechol-O-methyltranferase gene expression is associated with response to citalopram in obsessive-compulsive disorder.

  International journal of psychiatry in clinical practice 20121001

• Analysis of region-specific changes in gene expression upon treatment with citalopram and desipramine reveals temporal dynamics in response to antidepressant drugs at the transcriptome level.

  Psychopharmacology 20121001

• The effects of the co-administration of the α₁-adrenoreceptor antagonist prazosin on the anxiolytic effect of citalopram in conditioned fear stress in the rat.

  Progress in neuro-psychopharmacology & biological psychiatry 20121001

• Patterns of cardiorespiratory coordination in young women with recurrent major depressive disorder treated with escitalopram or venlafaxine.

  Progress in neuro-psychopharmacology & biological psychiatry 20121001

• No change in [¹¹C]CUMI-101 binding to 5-HT(1A) receptors after intravenous citalopram in human.

  Synapse (New York, N.Y.) 20121001

• Microdialysis evaluation of clozapine and N-desmethylclozapine pharmacokinetics in rat brain.

  Drug metabolism and disposition: the biological fate of chemicals 20121001

• Intrahippocampal transplantation of mesenchymal stromal cells promotes neuroplasticity.

  Cytotherapy 20121001

• Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.

  Journal of psychiatric research 20121001

• Cardiovascular safety of one-year escitalopram therapy in clinically nondepressed patients with acute coronary syndrome: results from the DEpression in patients with Coronary ARtery Disease (DECARD) trial.

  Journal of cardiovascular pharmacology 20121001

• Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes.

  Journal of psychopharmacology (Oxford, England) 20121001

• Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP).

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20121001

• Chronic citalopram treatment ameliorates depressive behavior associated with light at night.

  Behavioral neuroscience 20121001

• Drug-drug conditioning between citalopram and haloperidol or olanzapine in a conditioned avoidance response model: implications for polypharmacy in schizophrenia.

  Behavioural pharmacology 20121001

• Restoration of functionality in postpartum depressed mothers: an open-label study with escitalopram.

  Journal of clinical psychopharmacology 20121001

• Spinal cord injury induces serotonin supersensitivity without increasing intrinsic excitability of mouse V2a interneurons.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20120919

• Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice.

  American journal of physiology. Lung cellular and molecular physiology 20120915

• Citalopram (Celexa) and QT interval prolongation.

  The Medical letter on drugs and therapeutics 20120903

• Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review.

  Schizophrenia bulletin 20120901

• Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20120901

• Determination of cyclobenzaprine in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry and its application in a pharmacokinetic study.

  Biomedical chromatography : BMC 20120901

• 5-HT(3) receptor mediates the dose-dependent effects of citalopram on pentylenetetrazole-induced clonic seizure in mice: involvement of nitric oxide.

  Epilepsy research 20120901

• Fate of citalopram during water treatment with O3, ClO2, UV and Fenton oxidation.

  Chemosphere 20120901

• Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?

  The American journal of medicine 20120901

• Comparison of two extraction methods for the determination of selective serotonin reuptake inhibitors in sewage sludge by hollow fiber liquid-phase microextraction.

  Journal of separation science 20120901

• Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats.

  The European journal of neuroscience 20120901

• Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 2003-2009.

  Current medical research and opinion 20120901

• Persistence on a stress-challenge task before initiating buprenorphine treatment was associated with successful transition from opioid use to early abstinence.

  Journal of addiction medicine 20120901

• A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.

  The American journal of psychiatry 20120901

• The use of antidepressants in Belgian nursing homes: focus on indications and dosages in the PHEBE study.

  Drugs & aging 20120901

• How dopamine enhances an optimism bias in humans.

  Current biology : CB 20120821

• Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression.

  Biological psychiatry 20120815

• In with the new: the determinants of prescribing innovation by general practitioners in Ireland.

  The European journal of health economics : HEPAC : health economics in prevention and care 20120801

• Lipase-catalyzed remote kinetic resolution of citalopram intermediate by asymmetric alcoholysis and thermodynamic analysis.

  Bioprocess and biosystems engineering 20120801

• Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial.

  Menopause (New York, N.Y.) 20120801

• A functional Tph2 C1473G polymorphism causes an anxiety phenotype via compensatory changes in the serotonergic system.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120801

• Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120801

• Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.

  The Journal of pharmacology and experimental therapeutics 20120801

• Bioavailability of pharmaceuticals in waters close to wastewater treatment plants: use of fish bile for exposure assessment.

  Environmental toxicology and chemistry 20120801

• Vertical distribution of pharmaceuticals in lake sediments-citalopram as potential chemomarker.

  Environmental toxicology and chemistry 20120801

• Pharmacoproteomic investigation into antidepressant response in two mouse inbred strains.

  Proteomics 20120801

• Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients.

  Psychiatry and clinical neurosciences 20120801

• Increased amygdala responses to sad but not fearful faces in major depression: relation to mood state and pharmacological treatment.

  The American journal of psychiatry 20120801

• Depression in Parkinson's disease: diagnosis and treatment.

  Arquivos de neuro-psiquiatria 20120801

• Citalopram alleviates chronic stress induced depression-like behaviors in rats by activating GSK3β signaling in dorsal hippocampus.

  Brain research 20120727

• Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.

  Annals of internal medicine 20120717

• Summaries for Patients. Prevention of depression in patients treated for chronic hepatitis C virus infection with interferon-alpha.

  Annals of internal medicine 20120717

• Targeting the BH3-interacting domain death agonist to develop mechanistically unique antidepressants.

  Molecular psychiatry 20120701

• Cost-effectiveness comparisons between antidepressant treatments in depression: evidence from database analyses and prospective studies.

  Journal of affective disorders 20120701

• Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder.

  The international journal of neuropsychopharmacology 20120701

• The SSRI citalopram affects fetal thalamic axon responsiveness to netrin-1 in vitro independently of SERT antagonism.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120701

• The effect of citalopram on chronic stress-induced depressive-like behavior in rats through GSK3β/β-catenin activation in the medial prefrontal cortex.

  Brain research bulletin 20120701

• Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study.

  Clinical pharmacology and therapeutics 20120701

• Bioequivalence of two formulations of escitalopram.

  Arzneimittel-Forschung 20120701

• The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.

  The Journal of clinical psychiatry 20120701

• Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.

  Translational psychiatry 20120701

• Anxiolytic effects of a novel herbal treatment in mice models of anxiety.

  Life sciences 20120627

• [Isolated fear of frogs and toads--a case of bufono-ranophobia].

  MMW Fortschritte der Medizin 20120611

• Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression.

  The international journal of neuropsychopharmacology 20120601

• Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.

  Psychological medicine 20120601

• Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.

  Psychological medicine 20120601

• Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice.

  Journal of neural transmission (Vienna, Austria : 1996) 20120601

• Pharmacological treatment of unipolar depression during pregnancy and breast-feeding--a clinical overview.

  Nordic journal of psychiatry 20120601

• Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram.

  Metabolic brain disease 20120601

• Effects of sustained administration of quetiapine alone and in combination with a serotonin reuptake inhibitor on norepinephrine and serotonin transmission.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120601

• An integrative assessment of the psychophysiologic alterations in young women with recurrent major depressive disorder.

  Psychosomatic medicine 20120601

• The effect of citalopram on midbrain CRF receptors 1 and 2 in a primate model of stress-induced amenorrhea.

  Reproductive sciences (Thousand Oaks, Calif.) 20120601

• Functional connectivity in the cognitive control network and the default mode network in late-life depression.

  Journal of affective disorders 20120601

• Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study.

  Journal of thrombosis and haemostasis : JTH 20120601

• Effect of escitalopram on hot flash interference: a randomized, controlled trial.

  Fertility and sterility 20120601

• Synthesis of molecularly imprinted polymer as a sorbent for solid phase extraction of citalopram from human serum and urine.

  Journal of materials science. Materials in medicine 20120601

• Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children.

  Clinical toxicology (Philadelphia, Pa.) 20120601

• Running interference.

  Fertility and sterility 20120601

• Escitalopram for treatment of night eating syndrome: a 12-week, randomized, placebo-controlled trial.

  Journal of clinical psychopharmacology 20120601

• Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.

  Depression and anxiety 20120601

• Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine.

  Clinical drug investigation 20120601

• Delayed, fatal cardiotoxicity associated with bupropion and citalopram overdose.

  Journal of clinical psychopharmacology 20120601

• Reversal of SSRI-associated urinary retention with mirtazapine augmentation.

  Journal of clinical psychopharmacology 20120601

• Cost-effectiveness of escitalopram in major depressive disorder in the Dutch health care setting.

  Clinical therapeutics 20120601

• Psychiatrists' psychotropic drug prescription preferences for themselves or their family members.

  Psychiatria Danubina 20120601

• Development and validation of a capillary electrophoresis method for the determination of escitalopram and sensitive quantification of its enantiomeric impurity in formulations.

  Electrophoresis 20120601

• Antidepressants reduce extinction-induced withdrawal and biting behaviors: a model for depressive-like behavior.

  Neuroscience 20120517

• Increasing escitalopram dose is associated with fewer discontinuations than switch or combination approaches in patients initially on escitalopram 10 mg.

  European psychiatry : the journal of the Association of European Psychiatrists 20120501

• Short-term antidepressant administration reduces negative self-referential processing in the medial prefrontal cortex in subjects at risk for depression.

  Molecular psychiatry 20120501

• Female sexual dysfunction in patients treated with antidepressant-comparison between escitalopram and fluoxetine.

  The journal of sexual medicine 20120501

• Treatment-related alteration of cortisol predicts change in neuropsychological function during acute treatment of late-life anxiety disorder.

  International journal of geriatric psychiatry 20120501

• Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram.

  Journal of psychopharmacology (Oxford, England) 20120501

• Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.

  Psychological medicine 20120501

• Effects of reboxetine and citalopram on appraisal of infant facial expressions and attentional biases.

  Journal of psychopharmacology (Oxford, England) 20120501

• Central glucocorticoid receptor-mediated effects of the antidepressant, citalopram, in humans: a study using EEG and cognitive testing.

  Psychoneuroendocrinology 20120501

• Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.

  Journal of clinical pharmacology 20120501

• Severe and anxious depression: combining definitions of clinical sub-types to identify patients differentially responsive to selective serotonin reuptake inhibitors.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120501

• The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France.

  European journal of clinical pharmacology 20120501

• Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.

  Journal of psychopharmacology (Oxford, England) 20120501

• Serotonin syndrome during treatment with low dose of escitalopram associated with miconazole mucoadhesive tablet: a suspected drug interaction.

  International psychogeriatrics 20120501

• Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.

  International clinical psychopharmacology 20120501

• Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics.

  Contemporary clinical trials 20120501

• Combination of citalopram plus paliperidone is better than citalopram alone in the treatment of somatoform disorder: results of a 6-week randomized study.

  International clinical psychopharmacology 20120501

• Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram.

  Journal of psychiatric research 20120501

• Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?

  International clinical psychopharmacology 20120501

• The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy.

  Epilepsia 20120501

• Changes in the prescription of psychotropic drugs in the palliative care of advanced cancer patients over a seven-year period.

  Journal of pain and symptom management 20120501

• When prevention is a bad idea: problems with the DECARD trial and the premise behind it.

  Journal of psychosomatic research 20120501

• Geriatrics update 2012: what parts of our practice to change, what to 'think about'.

  Cleveland Clinic journal of medicine 20120501

• Italian guidelines for primary headaches: 2012 revised version.

  The journal of headache and pain 20120501

• Statement of the AGNP-Work Group 'Child and Adolescent Pharmacology' on the decision of the Joint Federal Committee (GBA) of the 17/02/2011 to combine escitalopram with citalopram into a fixed amount group.

  Pharmacopsychiatry 20120501

• Voltage-dependent K+ channels as oncotargets in malignant gliomas.

  Oncotarget 20120501

• Escitalopram: torsades de pointes.

  Prescrire international 20120501

• Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120501

• Endogenous ciliary neurotrophic factor modulates anxiety and depressive-like behavior.

  Behavioural brain research 20120415

• Simultaneous evaluation of the harms and benefits of treatments in randomized clinical trials: demonstration of a new approach.

  Psychological medicine 20120401

• First prescription of new elderly patients attending the psychiatry outpatient of a tertiary care institute in North India.

  Geriatrics & gerontology international 20120401

• Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.

  Acta psychiatrica Scandinavica 20120401

• Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence.

  Synapse (New York, N.Y.) 20120401

• Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics.

  Pharmacogenetics and genomics 20120401

• Electrosynthesis of polypyrrole on steel fiber for solid-phase microextraction of citalopram in serum.

  Analytical and bioanalytical chemistry 20120401

• 3D-QSAR study indicates an enhancing effect of membrane ions on psychiatric drugs targeting serotonin receptor 5-HT1A.

  Molecular bioSystems 20120401

• A question about the potential cardiac toxicity of escitalopram.

  Journal of psychosocial nursing and mental health services 20120401

• Does antidepressant treatment improve cognition in older people with schizophrenia or schizoaffective disorder and comorbid subsyndromal depression?

  Neuropsychobiology 20120401

• The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial.

  Danish medical journal 20120401

• Interaction of morphine and selective serotonin receptor inhibitors in rats experiencing inflammatory pain.

  Journal of Korean medical science 20120401

• A population-based study of the use of selective serotonin reuptake inhibitors before and after introduction of generic equivalents.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20120401

• Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder.

  Clinics (Sao Paulo, Brazil) 20120401

• Developmentally informed pharmacotherapy for child and adolescent depressive disorders.

  Child and adolescent psychiatric clinics of North America 20120401

• Dorsal raphe nucleus serotonin neurons in WKY rats demonstrate subresponsivity to an acute application of escitalopram: effect of repeated escitalopram treatment.

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20120401

• Rapid improvement of depression and quality of life with escitalopram treatment in outpatients with breast cancer: a 12-week, open-label prospective trial.

  Progress in neuro-psychopharmacology & biological psychiatry 20120330

• Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial.

  BMJ (Clinical research ed.) 20120309

• Online responsibility: bad samaritanism and the influence of internet mediation.

  Science and engineering ethics 20120301

• Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders.

  Journal of autism and developmental disorders 20120301

• Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal.

  British journal of clinical pharmacology 20120301

• Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120301

• CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP.

  Journal of psychopharmacology (Oxford, England) 20120301

• Chronic restraint stress affects serotonin transporter uptake kinetics but not binding sites in the rat hippocampus.

  Synapse (New York, N.Y.) 20120301

• Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice.

  Drug metabolism and disposition: the biological fate of chemicals 20120301

• Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder.

  Journal of psychiatric research 20120301

• Hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: a comparison between escitalopram and fluoxetine.

  International journal of psychiatry in clinical practice 20120301

• Detection of amitriptyline, citalopram, and metabolites in porcine bones following extended outdoor decomposition.

  Journal of forensic sciences 20120301

• Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder.

  The Journal of pharmacology and experimental therapeutics 20120301

• Aprepitant quetiapine: a clinically significant drug interaction in a patient treated for head and neck cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120301

• Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder.

  Journal of psychopharmacology (Oxford, England) 20120301

• Reversal of SSRI-associated apathy syndrome by discontinuation of therapy.

  The Annals of pharmacotherapy 20120301

• Sexual function in nondepressed women using escitalopram for vasomotor symptoms: a randomized controlled trial.

  Obstetrics and gynecology 20120301

• Evidence-based somatic treatment of depression in adults.

  The Psychiatric clinics of North America 20120301

• Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.

  The Australian and New Zealand journal of psychiatry 20120301

• Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant.

  Pharmacotherapy 20120301

• Comparison of treatment adherence between selective serotonin reuptake inhibitors and moclobemide in patients with social anxiety disorder.

  Psychiatry investigation 20120301

• Usefulness of LDAEP to predict tolerability to SSRIs in major depressive disorder: a case report.

  Psychiatry investigation 20120301

• Citalopram-induced major depression in a patient with panic disorder - a case report.

  Psychiatria Danubina 20120301

• No evidence for an anti-inflammatory effect of escitalopram intervention in healthy individuals with a family history of depression.

  Journal of neuroimmunology 20120227

• Neurochemical enhancement of conscious error awareness.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20120222

• Consideration of allosterism and interacting proteins in the physiological functions of the serotonin transporter.

  Biochemical pharmacology 20120215

• [Treatment research of intermediate severity depression: what is useful for the routine patient?].

  MMW Fortschritte der Medizin 20120209

• Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.

  The pharmacogenomics journal 20120201

• Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration.

  Molecular psychiatry 20120201

• Concomitant blockade of 5-HT(1A) receptor and 5-HT transporter: use of the Hunter Serotonin toxicity criteria in a clinical pharmacology study.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120201

• Prevention of posttraumatic stress disorder by early treatment: results from the Jerusalem Trauma Outreach And Prevention study.

  Archives of general psychiatry 20120201

• Severity of depression and response to antidepressants: GENPOD randomised controlled trial.

  The British journal of psychiatry : the journal of mental science 20120201

• Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.

  Journal of clinical psychopharmacology 20120201

• Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.

  Journal of clinical psychopharmacology 20120201

• Angular cheilitis after paroxetine treatment.

  Journal of clinical psychopharmacology 20120201

• Resumption of food and fluid intake in Alzheimer's disease with severe apathy following intravenous citalopram.

  Psychiatry and clinical neurosciences 20120201

• Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression.

  The Australian and New Zealand journal of psychiatry 20120201

• [Body dysmorphic disorder and psychosis. Case reports and discussion].

  L'Encephale 20120201

• [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].

  L'Encephale 20120201

• Influence of tobacco smoke on the pharmacokinetics of citalopram and its enantiomers.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20120201

• Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.

  Depression and anxiety 20120201

• Shock priming enhances the efficacy of SSRIs in the foot shock-induced ultrasonic vocalization test.

  Progress in neuro-psychopharmacology & biological psychiatry 20120110

• Dose-dependent effects of neonatal SSRI exposure on adult behavior in the rat.

  Brain research 20120106

• Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models.

  Molecular psychiatry 20120101

• Neuroendocrine assessment of serotonergic, dopaminergic, and noradrenergic functions in alcohol-dependent individuals.

  Alcoholism, clinical and experimental research 20120101

• Quantification of ligand PET studies using a reference region with a displaceable fraction: application to occupancy studies with [(11)C]-DASB as an example.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20120101

• Recurrent escitalopram-induced hyponatremia in an elderly woman with dementia with Lewy bodies.

  General hospital psychiatry 20120101

• Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.

  Psychopharmacology 20120101

• Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats.

  Behavioural brain research 20120101

• The antidepressant citalopram inhibits delayed rectifier outward K⁺ current in mouse cortical neurons.

  Journal of neuroscience research 20120101

• Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120101

• Differential effects of escitalopram challenge on disgust processing in obsessive-compulsive disorder.

  Behavioural brain research 20120101

• Correlation of QTc interval prolongation and serum level of citalopram after intoxication--a case report.

  Pharmacopsychiatry 20120101

• Effects of heart disease on depression treatment: results from the COMED study.

  General hospital psychiatry 20120101

• Diminished conditioned responding to the nicotine stimulus by antidepressant drugs with differing specificity for the serotonin and norepinephrine transporter.

  Pharmacology, biochemistry, and behavior 20120101

• Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients.

  Journal of psychiatric research 20120101

• Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study.

  International clinical psychopharmacology 20120101

• Treatment of pseudobulbar affect with citalopram in a patient with progressive multifocal leukoencephalopthy.

  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20120101

• Rapid improvement of a complex migrainous episode with sodium valproate in a patient with CADASIL.

  The journal of headache and pain 20120101

• Risk of adverse events in treatment-resistant depression: propensity-score-matched comparison of antidepressant augment and switch strategies.

  General hospital psychiatry 20120101

• Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987.

  Pharmacology, biochemistry, and behavior 20120101

• Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review.

  General hospital psychiatry 20120101

• Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats.

  Psychopharmacology 20120101

• Clinically significant drug interactions with newer antidepressants.

  CNS drugs 20120101

• Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial.

  American heart journal 20120101

• Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?

  Obstetrics and gynecology international 20120101

• Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD).

  Journal of psychosomatic research 20120101

• Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.

  Psychosomatics 20120101

• Depression treatment in patients with general medical conditions: results from the CO-MED trial.

  Annals of family medicine 20120101

• The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.

  Parkinson's disease 20120101

• Lycanthropy as a culture-bound syndrome: a case report and review of the literature.

  Journal of psychiatric practice 20120101

• When too much is not enough: obsessive-compulsive disorder as a pathology of stopping, rather than starting.

  PloS one 20120101

• Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review.

  Cost effectiveness and resource allocation : C/E 20120101

• Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviors.

  Journal of biomedical science 20120101

• Citalopram for agitation in Alzheimer's disease: design and methods.

  Alzheimer's & dementia : the journal of the Alzheimer's Association 20120101

• Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation.

  Core evidence 20120101

• Antidepressant treatment for acute bipolar depression: an update.

  Depression research and treatment 20120101

• Changes in patients' beliefs about their antidepressant during the acute phase of depression treatment.

  General hospital psychiatry 20120101

• Infusion of a lipid emulsion in healthy men decreases the serotonergic response.

  Neuroendocrinology 20120101

• Treatment persistence & health care costs of adult MDD patients treated with escitalopram vs. citalopram in a medicaid population.

  Managed care (Langhorne, Pa.) 20120101

• Metoprolol-induced visual hallucinations: a case series.

  Journal of medical case reports 20120101

• Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial.

  Clinical pharmacology : advances and applications 20120101

• [Effect of treatment with selective serotonin reuptake inhibitors on lipid profile: state of the art].

  La Clinica terapeutica 20120101

• Selective serotonin reuptake inhibitor use is associated with right ventricular structure and function: the MESA-right ventricle study.

  PloS one 20120101

• Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression.

  Frontiers in psychiatry 20120101

• Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial.

  PloS one 20120101

• Prolonged QTc interval and torsades de pointes induced by citalopram.

  Texas Heart Institute journal 20120101

• Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.

  Current medicinal chemistry 20120101

• Cost-effectiveness evaluation in Sweden of escitalopram compared with venlafaxine extended-release as first-line treatment in major depressive disorder.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101

• Escitalopram-induced subclinical hypothyroidism. A case report.

  Hormones (Athens, Greece) 20120101

• Serotonin toxicity in aripiprazole augmentation.

  The Journal of neuropsychiatry and clinical neurosciences 20120101

• Current and future options for the management of phantom-limb pain.

  Journal of pain research 20120101

• Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants.

  BMJ open 20120101

• Pregabalin effects on neural response to emotional faces.

  Frontiers in human neuroscience 20120101

• Adolescents' perceptions of their consent to psychiatric mental health treatment.

  Nursing research and practice 20120101

• Differentiation of schizophrenia patients from healthy subjects by mismatch negativity and neuropsychological tests.

  PloS one 20120101

• Loop diuretics have anxiolytic effects in rat models of conditioned anxiety.

  PloS one 20120101

• Efficacy and safety of add on low-dose mirtazapine in depression.

  Indian journal of pharmacology 20120101

• Expression of monoamine transporters, nitric oxide synthase 3, and neurotrophin genes in antidepressant-stimulated astrocytes.

  Frontiers in psychiatry 20120101

• Accumulation of an antidepressant in vesiculogenic membranes of yeast cells triggers autophagy.

  PloS one 20120101

• Citalopram-induced subacute cutaneous lupus erythematosus -- first case and review concerning photosensitivity in selective serotonin reuptake inhibitors.

  General hospital psychiatry 20120101

• A survey of patient preferences for a placebo orodispersible tablet.

  Patient preference and adherence 20120101

• Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good.

  Frontiers in psychology 20120101

• Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.

  PloS one 20120101

• New findings in delusions of parasitosis.

  Skinmed 20120101

• Secondary delusional parasitosis treated successfully with a combination of clozapine and citalopram.

  Psychosomatics 20120101

• Treatment-resistant depression: therapeutic trends, challenges, and future directions.

  Patient preference and adherence 20120101

• Pharmacological management of binge eating disorder: current and emerging treatment options.

  Therapeutics and clinical risk management 20120101

• Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants.

  Pharmacological reports : PR 20120101

• Optimal treatment of social phobia: systematic review and meta-analysis.

  Neuropsychiatric disease and treatment 20120101

• The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation.

  International journal of hepatology 20120101

• High-performance liquid chromatographic assay for ziprasidone in plasma samples: application to pharmacokinetic studies in rats.

  Journal of chromatographic science 20120101

• Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder.

  Oxidative medicine and cellular longevity 20120101

• An audit of first prescription of new patients attending a psychiatry walk-in-clinic in north India.

  Indian journal of pharmacology 20120101

• Milnacipran inhibits glutamatergic N-methyl-D-aspartate receptor activity in spinal dorsal horn neurons.

  Molecular pain 20120101

• Quinacrine induced mood disturbance--the unmasking of bipolar affective disorder.

  BMJ case reports 20120101

• Escitalopram increased gray matter and white matter in a first-episode drug-naïve panic disorder patient within 6 weeks.

  The Journal of neuropsychiatry and clinical neurosciences 20120101

• Citalopram and nightmares.

  The Journal of neuropsychiatry and clinical neurosciences 20120101

• Citalopram versus other anti-depressive agents for depression.

  The Cochrane database of systematic reviews 20120101

• [Celexa: an antidepressant with potential cardiac toxicity ].

  Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec 20120101

• Citalopram decreases tryptophan 2,3-dioxygenase activity and brain 5-HT turnover in swim stressed rats.

  Pharmacological reports : PR 20120101

• Regional brain metabolism and treatment response in panic disorder patients: an [18F]FDG-PET study.

  Neuropsychobiology 20120101

• Development and optimization of an HPLC analysis of citalopram and its four nonchiral impurities using experimental design methodology.

  Journal of AOAC International 20120101

• Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model.

  PloS one 20120101

• [Antidepressants in the treatment of alcoholism].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20120101

• State and trait olfactory markers of major depression.

  PloS one 20120101

• Therapeutic monitoring of escitalopram by dexamethasone suppression test.

  Actas espanolas de psiquiatria 20120101

• Duloxetine versus other anti-depressive agents for depression.

  The Cochrane database of systematic reviews 20120101

• In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.

  Pharmacological reports : PR 20120101

• Agomelatine augmentation of escitalopram therapy in treatment-resistant obsessive-compulsive disorder: a case report.

  Case reports in psychiatry 20120101

• Sexual arousal difficulties in women treated with antidepressants: a comparison between escitalopram and fluoxetine.

  International journal of psychiatry in medicine 20120101

• Second-generation antidepressants for seasonal affective disorder.

  The Cochrane database of systematic reviews 20111207

• An eight component decision-making model for problem gambling: a systems approach to stimulate integrative research.

  Journal of gambling studies 20111201

• Sleep and cognition at baseline and the effects of REM sleep diminution after 1 week of antidepressive treatment in patients with depression.

  Journal of sleep research 20111201

• Genetic markers anticipate response to citalopram in a majority of patients.

  Psychiatric genetics 20111201

• Using an experimental medicine model to explore combination effects of pharmacological and cognitive interventions for depression and anxiety.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20111201

• Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20111201

• Estradiol and progesterone modify the effects of the serotonin reuptake transporter polymorphism on serotonergic responsivity to citalopram.

  Experimental and clinical psychopharmacology 20111201

• Increased numbers of orexin/hypocretin neurons in a genetic rat depression model.

  Neuropeptides 20111201

• Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram.

  Biochimica et biophysica acta 20111201

• Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial.

  Progress in neuro-psychopharmacology & biological psychiatry 20111201

• Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C.

  Alimentary pharmacology & therapeutics 20111201

• Antidepressants and the resilience to early-life stress in inbred mouse strains.

  Pharmacogenetics and genomics 20111201

• The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.

  Psychiatria Danubina 20111201

• A critical evaluation of the cardiac toxicity of citalopram: part 2.

  Journal of psychosocial nursing and mental health services 20111201

• No influence of body weight on serum levels of antidepressants.

  Therapeutic drug monitoring 20111201

• Assessing the 'true' effect of active antidepressant therapy v. placebo in major depressive disorder: use of a mixture model.

  The British journal of psychiatry : the journal of mental science 20111201

• Antidepressants in pregnancy: a review of commonly prescribed medications.

  Obstetrical & gynecological survey 20111201

• Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.

  The Journal of clinical psychiatry 20111201

• A lifespan view of anxiety disorders.

  Dialogues in clinical neuroscience 20111201

• Pharmacotherapy of anxiety disorders: a critical review.

  Dialogues in clinical neuroscience 20111201

• Pharmacotherapy for anxiety disorders in children and adolescents.

  Dialogues in clinical neuroscience 20111201

• Experimental panic provocation in healthy man-a translational role in anti-panic drug development?

  Dialogues in clinical neuroscience 20111201

• [Six-month follow-up study of drug treatment for cannabis addiction: comparison study of four drugs].

  Harefuah 20111201

• Neurotrophins role in depression neurobiology: a review of basic and clinical evidence.

  Current neuropharmacology 20111201

• Biomarkers of anhedonic-like behavior, antidepressant drug refraction, and stress resilience in a rat model of depression.

  Neuroscience 20111124

• Escitalopram reduces circulating pro-inflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post-cardiac infarct depression.

  Behavioural brain research 20111120

• Perinatal citalopram exposure selectively increases locus ceruleus circuit function in male rats.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20111116

• Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20111108

• Antidepressants elevate GDNF expression and release from C₆ glioma cells in a β-arrestin1-dependent, CREB interactive pathway.

  The international journal of neuropsychopharmacology 20111101

• PharmGKB summary: citalopram pharmacokinetics pathway.

  Pharmacogenetics and genomics 20111101

• Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra.

  Synapse (New York, N.Y.) 20111101

• A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C).

  European journal of clinical pharmacology 20111101

• Differential pattern of response in mood symptoms and suicide risk measures in severely ill depressed patients assigned to citalopram with placebo or citalopram combined with lithium: role of lithium levels.

  Journal of psychiatric research 20111101

• Increased frequency of first-episode poststroke depression after discontinuation of escitalopram.

  Stroke 20111101

• Incidence and predictors of relapse during continuation treatment of major depression with SSRI, interpersonal psychotherapy, or their combination.

  Depression and anxiety 20111101

• Escitalopram is associated with reductions in pain severity and pain interference in opioid dependent patients with depressive symptoms.

  Pain 20111101

• A critical evaluation of the cardiac toxicity of citalopram: part 1.

  Journal of psychosocial nursing and mental health services 20111101

• Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder.

  Advances in therapy 20111101

• Treatment of depression associated with age-related macular degeneration: a double-blind, randomized, controlled study.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20111101

• Restless legs syndrome in subjects with a knee prosthesis: evidence that symptoms are generated in the periphery.

  Clinics (Sao Paulo, Brazil) 20111101

• A review of escitalopram and citalopram in child and adolescent depression.

  Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 20111101

• Medication for borderline personality disorder: a survey at a secure hospital.

  International journal of psychiatry in clinical practice 20111101

• Comparison of eye movement desensitization and reprocessing with citalopram in treatment of obsessive-compulsive disorder.

  International journal of psychiatry in clinical practice 20111101

• Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.

  The Journal of clinical psychiatry 20111101

• Can pindolol really enhance antidepressant effect?

  The Journal of clinical psychiatry 20111101

• Citalopram-mediated anxiolysis and differing neurobiological responses in both sexes of a genetic model of depression.

  Neuroscience 20111027

• Depression in children and adolescents.

  BMJ clinical evidence 20111021

• Chiral imprinted polymers as enantiospecific coatings of stir bar sorptive extraction devices.

  Biosensors & bioelectronics 20111015

• Premenstrual syndrome and premenstrual dysphoric disorder.

  American family physician 20111015

• [Therapy of moderately severe depressions in daily practice: first patient care research study reinforces clinical data].

  MMW Fortschritte der Medizin 20111013

• Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.

  Journal of psychopharmacology (Oxford, England) 20111001

• Association between CYP2C19*17 and metabolism of amitriptyline, citalopram and clomipramine in Dutch hospitalized patients.

  The pharmacogenomics journal 20111001

• Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression.

  Human brain mapping 20111001

• Daily emotional dynamics in depressed youth: a cell phone ecological momentary assessment study.

  Journal of experimental child psychology 20111001

• Dissociation of antidepressant-like activity of escitalopram and nortriptyline on behaviour and hippocampal BDNF expression in female rats.

  Journal of psychopharmacology (Oxford, England) 20111001

• Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.

  Psychological medicine 20111001

• Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20111001

• Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20111001

• [Tolvaptan in antidiuretic hormone secretion syndrome secondary to treatment with citalopram].

  Revista clinica espanola 20111001

• Treatment of a major depression episode suppresses markers of bone turnover in premenopausal women.

  Journal of psychiatric research 20111001

• Escitalopram reduced hot flashes in non-depressed perimenopausal and postmenopausal women.

  Evidence-based medicine 20111001

• A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20111001

• Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.

  Journal of affective disorders 20111001

• Antidepressants encounter autophagy in neural cells.

  Autophagy 20111001

• Association between tryptophan hydroxylase-2 genotype and the antidepressant effect of citalopram and paroxetine on immobility time in the forced swim test in mice.

  Pharmacology, biochemistry, and behavior 20111001

• Neutralization of haemorrhagic activity of viper venoms by 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-3-oxo-1,3-dihydroisobenzofuran-5-carbonitrile.

  Basic & clinical pharmacology & toxicology 20111001

• Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk.

  The Journal of pharmacology and experimental therapeutics 20111001

• Development and characterization of molecularly imprinted polymers for controlled release of citalopram.

  Journal of materials science. Materials in medicine 20111001

• Drug monitoring of a case of citalopram overdosage.

  Drug and chemical toxicology 20111001

• Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study.

  Journal of clinical psychopharmacology 20111001

• Escitalopram for the treatment of major depressive disorder in youth.

  Expert opinion on pharmacotherapy 20111001

• Altered expression of tyrosine hydroxylase in the locus coeruleus noradrenergic system in citalopram neonatally exposed rats and monoamine oxidase a knock out mice.

  Anatomical record (Hoboken, N.J. : 2007) 20111001

• Gas chromatography-tandem mass spectrometry assay for the quantification of four benzodiazepines and citalopram in eleven postmortem rabbit fluids and tissues, with application to animal and human samples.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111001

• Treating post-CABG depression with telephone-delivered collaborative care: does patient age affect treatment and outcome?

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20111001

• Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study.

  The Journal of nervous and mental disease 20111001

• Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial.

  Psychiatric services (Washington, D.C.) 20111001

• The perception and pharmacokinetics of a 20-mg dose of escitalopram orodispersible tablets in a relative bioavailability study in healthy men.

  Clinical therapeutics 20111001

• Treatment of pulmonary hypertension: bench to bedside.

  Respiratory medicine 20111001

• Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.

  The Journal of clinical psychiatry 20111001

• [Unilateral cystoid macular edema induced by citalopram--a case report].

  Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20111001

• Effect of serotonin reuptake inhibitors on pulmonary hemodynamics in humans.

  Journal of clinical medicine research 20111001

• [Interactions between metoprolol and antidepressants].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20110920

• Discovery of Lu AA33810: a highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder.

  Bioorganic & medicinal chemistry letters 20110915

• Combined therapy versus usual care for the treatment of depression in oncologic patients: a randomized controlled trial.

  Psycho-oncology 20110901

• 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.

  Neuropharmacology 20110901

• Repeated citalopram administration counteracts kainic acid-induced spreading of PSA-NCAM-immunoreactive cells and loss of reelin in the adult mouse hippocampus.

  European journal of pharmacology 20110901

• Changes in neuropsychological functioning following treatment for late-life generalised anxiety disorder.

  The British journal of psychiatry : the journal of mental science 20110901

• A case of pseudomembranous colitis after voriconazole therapy.

  Yonsei medical journal 20110901

• Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients.

  International clinical psychopharmacology 20110901

• What is the optimal dose of escitalopram for the treatment of obsessive-compulsive disorder? A naturalistic open-label study.

  International clinical psychopharmacology 20110901

• A fatal case of simultaneous ingestion of mirtazapine, escitalopram, and valproic acid.

  Journal of analytical toxicology 20110901

• A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

  The Australian and New Zealand journal of psychiatry 20110901

• Citalopram may reduce sympathoadrenal hyperactivity in elderly depressed patients: an open multicenter study in Belgium and Luxembourg.

  Psychiatria Danubina 20110901

• Pharmacotherapy in depressed children and adolescents.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20110901

• Antidepressant prescribing patterns in Korea: results from the clinical research center for depression study.

  Psychiatry investigation 20110901

• Duloxetine-induced liver injury in patients with major depressive disorder.

  Psychiatry investigation 20110901

• Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure.

  Current neuropharmacology 20110901

• Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers.

  NeuroImage 20110815

• Serum BDNF levels before treatment predict SSRI response in depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20110815

• Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: a pilot study.

  International journal of geriatric psychiatry 20110801

• Citalopram improves metabolic risk factors among high hostile adults: results of a placebo-controlled intervention.

  Psychoneuroendocrinology 20110801

• Escitalopram treatment of menopausal hot flashes.

  Menopause (New York, N.Y.) 20110801

• Propriospinal myoclonus associated with fragile-X-premutation and response to selective serotonin reuptake inhibitor.

  Parkinsonism & related disorders 20110801

• Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies: a randomized open study.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20110801

• Effects of venlafaxine and escitalopram treatments on NMDA receptors in the rat depression model.

  The Journal of membrane biology 20110801

• Pyromania associated with escitalopram in a child.

  Journal of child and adolescent psychopharmacology 20110801

• Variation in GNB3 predicts response and adverse reactions to antidepressants.

  Journal of psychopharmacology (Oxford, England) 20110701

• Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.

  The Journal of clinical psychiatry 20110701

• Escitalopram affects cytoskeleton and synaptic plasticity pathways in a rat gene-environment interaction model of depression as revealed by proteomics. Part II: environmental challenge.

  The international journal of neuropsychopharmacology 20110701

• Escitalopram modulates neuron-remodelling proteins in a rat gene-environment interaction model of depression as revealed by proteomics. Part I: genetic background.

  The international journal of neuropsychopharmacology 20110701

• Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.

  The Journal of clinical psychiatry 20110701

• Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression.

  Psychopharmacology 20110701

• Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract.

  Current drug metabolism 20110701

• Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.

  Journal of affective disorders 20110701

• Serotonin syndrome secondary to tramadol and citalopram.

  Age and ageing 20110701

• CB-1 receptors modulate the effect of the selective serotonin reuptake inhibitor, citalopram on extracellular serotonin levels in the rat prefrontal cortex.

  Neuroscience research 20110701

• Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

  The American journal of psychiatry 20110701

• Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.

  Current medical research and opinion 20110701

• The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo.

  Journal of psychiatric research 20110701

• Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity.

  Journal of chemical neuroanatomy 20110701

• The antidepressant fluoxetine but not citalopram suppresses synapse formation and synaptic transmission between Lymnaea neurons by perturbing presynaptic and postsynaptic machinery.

  The European journal of neuroscience 20110701

• Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder.

  International journal of clinical pharmacology and therapeutics 20110701

• Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20110615

• Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.

  The British journal of psychiatry : the journal of mental science 20110601

• SSRI administration reduces resting state functional connectivity in dorso-medial prefrontal cortex.

  Molecular psychiatry 20110601

• Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.

  Progress in neuro-psychopharmacology & biological psychiatry 20110601

• Torsade de pointes induced by citalopram and amiodarone.

  Annales de cardiologie et d'angeiologie 20110601

• Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice.

  Pharmacology, biochemistry, and behavior 20110601

• Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors.

  Current medical research and opinion 20110601

• Pre- and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress.

  Experimental neurology 20110601

• Serotonin toxicity: a short review of the literature and two case reports involving citalopram.

  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110601

• Association between citalopram serum levels and clinical improvement of patients with major depression.

  Journal of clinical psychopharmacology 20110601

• The role of 5-HT(3) receptors in the additive anticonvulsant effects of citalopram and morphine on pentylenetetrazole-induced clonic seizures in mice.

  Epilepsy & behavior : E&B 20110601

• Generalized action myoclonus associated with escitalopram in a patient with mixed dementia.

  Journal of clinical psychopharmacology 20110601

• Biomarkers in development of psychotropic drugs.

  Dialogues in clinical neuroscience 20110601

• Hyponatremia associated with bupropion.

  Electrolyte & blood pressure : E & BP 20110601

• Anesthesia in multiple sclerosis and obstructive sleep apnea: case report and literature review.

  Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20110601

• Correlations between Pre-morbid Personality and Depression Scales in Stroke Patients.

  Annals of rehabilitation medicine 20110601

• Gene expression biomarkers of response to citalopram treatment in major depressive disorder.

  Translational psychiatry 20110601

• Defense style in panic disorder before and after pharmacological treatment.

  Psychiatry research 20110530

• Antidepressant use during pregnancy. FPIN’s clinical inquiries.

  American family physician 20110515

• Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.

  Journal of medicinal chemistry 20110512

• Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat.

  Synapse (New York, N.Y.) 20110501

• Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20110501

• Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability.

  Biological psychiatry 20110501

• Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.

  Psychopharmacology 20110501

• Androgenic influence on serotonergic activation of the HPA stress axis.

  Endocrinology 20110501

• A systematic review of medical treatments for children with autism spectrum disorders.

  Pediatrics 20110501

• Formation of solid solutions between racemic and enantiomeric citalopram oxalate.

  Chirality 20110501

• Altered brain activation in ventral frontal-striatal regions following a 16-week pharmacotherapy in unmedicated obsessive-compulsive disorder.

  Journal of Korean medical science 20110501

• Tamoxifen-SSRIs interaction: clinical manifestations of inhibition and lack of inhibition of CYP2D6.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20110501

• [Repetitive transcranial magnetic stimulation combined with antidepressant medication in treatment of first-episode patients with major depression].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20110501

• A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers.

  Psychiatry research 20110430

• Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20110427

• Influence of citalopram and environmental temperature on exercise-induced changes in BDNF.

  Neuroscience letters 20110425

• Increased plasma corticosterone levels after periaqueductal gray stimulation-induced escape reaction or panic attacks in rats.

  Behavioural brain research 20110415

• Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease.

  International journal of cardiology 20110414

• Hippocampal GABAergic dysfunction in a rat chronic mild stress model of depression.

  Hippocampus 20110401

• Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project.

  The pharmacogenomics journal 20110401

• A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.

  Journal of affective disorders 20110401

• Changes in body weight during pharmacological treatment of depression.

  The international journal of neuropsychopharmacology 20110401

• ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment.

  Pharmacogenetics and genomics 20110401

• Testing anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopram.

  European archives of psychiatry and clinical neuroscience 20110401

• Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial.

  The Journal of clinical psychiatry 20110401

• Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.

  Archives of general psychiatry 20110401

• A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.

  The Journal of clinical psychiatry 20110401

• Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone/renin ratio in normotensive depressed male patients.

  The Journal of clinical endocrinology and metabolism 20110401

• Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.

  Depression and anxiety 20110401

• Escitalopram-related rhabdomyolysis.

  Journal of clinical psychopharmacology 20110401

• Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.

  The Annals of pharmacotherapy 20110401

• Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints.

  PLoS medicine 20110401

• Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents.

  Journal of child and adolescent psychopharmacology 20110401

• Antidepressant-mediated gastroesophageal reflux disease.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20110401

• Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.

  The Journal of clinical psychiatry 20110401

• Comparison of the depression-like behavior and serotonergic system between Wistar and Wistar-Kyoto rat strains.

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20110401

• Antidepressant may help ease hot flashes.

  The Harvard mental health letter 20110401

• Serotonin transporter polymorphism as a predictor for escitalopram treatment of major depressive disorder comorbid with alcohol dependence.

  Psychiatry research 20110330

• Does waterborne citalopram affect the aggressive and sexual behaviour of rainbow trout and guppy?

  Journal of hazardous materials 20110315

• [Citalopram hepatotoxicity].

  Medicina clinica 20110312

• Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis.

  BMJ (Clinical research ed.) 20110311

• Efficacy of escitalopram compared to citalopram: a meta-analysis.

  The international journal of neuropsychopharmacology 20110301

• Chronic escitalopram treatment restores spatial learning, monoamine levels, and hippocampal long-term potentiation in an animal model of depression.

  Psychopharmacology 20110301

• Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.

  CNS drugs 20110301

• [Parkinsonism due to clebopride].

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20110301

• Allergic reactions--outcome of sertraline and escitalopram treatments.

  Psychiatria Danubina 20110301

• Inflammation in depression: is adiposity a cause?

  Dialogues in clinical neuroscience 20110301

• New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum.

  Dialogues in clinical neuroscience 20110301

• Depressogenic effects of medications: a review.

  Dialogues in clinical neuroscience 20110301

• Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retropective investigation.

  Psychiatry investigation 20110301

• Which antidepressant would psychiatrists and nurses from a developing country choose for themselves?

  International journal of psychiatry in clinical practice 20110301

• Effects of citalopram on cognitive performance in passive avoidance, elevated plus-maze and three-panel runway tasks in naïve rats.

  The Chinese journal of physiology 20110227

• Antidepressants for agitation and psychosis in dementia.

  The Cochrane database of systematic reviews 20110216

• Y95 and E444 interaction required for high-affinity S-citalopram binding in the human serotonin transporter.

  ACS chemical neuroscience 20110216

• Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants.

  Biological psychiatry 20110215

• Efficacy and safety of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, randomized, double-blind, flexible-dose study.

  Psychopharmacology 20110201

• An approach for serotonin depletion in pigs: effects on serotonin receptor binding.

  Synapse (New York, N.Y.) 20110201

• Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex.

  Journal of psychiatric research 20110201

• Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease.

  Psychopharmacology 20110201

• Executive function and short-term remission of geriatric depression: the role of semantic strategy.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20110201

• Cytochrome P450-dependent disposition of the enantiomers of citalopram and its metabolites: in vivo studies in Sprague-Dawley and Dark Agouti rats.

  Chirality 20110201

• Citalopram reduces endotoxin-induced fatigue.

  Brain, behavior, and immunity 20110201

• The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder.

  Psychopharmacology 20110201

• Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging.

  Psychopharmacology 20110201

• The effects of acute citalopram dosing on gastric motor function and nutrient tolerance in healthy volunteers.

  Alimentary pharmacology & therapeutics 20110201

• Impact of treatment success on health service use and cost in depression: longitudinal database analysis.

  PharmacoEconomics 20110201

• Antidepressant response to chronic citalopram treatment in eight inbred mouse strains.

  Psychopharmacology 20110201

• Quantification of cerebral blood flow as biomarker of drug effect: arterial spin labeling phMRI after a single dose of oral citalopram.

  Clinical pharmacology and therapeutics 20110201

• Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study.

  Journal of clinical psychopharmacology 20110201

• Hepatic glycogen supercompensation activates AMP-activated protein kinase, impairs insulin signaling, and reduces glycogen deposition in the liver.

  Diabetes 20110201

• Part III: cutaneous hypersensitivity during selective serotonin reuptake inhibitor therapy resulting in acquired cutis laxa.

  Journal of drugs in dermatology : JDD 20110201

• NHS drug budget. Flawed assumption in analysis.

  BMJ (Clinical research ed.) 20110201

• [Depression and professional activity: results of the NEXTEP study].

  L'Encephale 20110201

• Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.

  JAMA 20110119

• Antidepressant use and colorectal cancer risk: a Danish population-based case-control study.

  British journal of cancer 20110104

• Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.

  Psychological medicine 20110101

• Chronic treatment with zinc and antidepressants induces enhancement of presynaptic/extracellular zinc concentration in the rat prefrontal cortex.

  Amino acids 20110101

• In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20110101

• Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants.

  Psychoneuroendocrinology 20110101

• The effect of acute citalopram on face emotion processing in remitted depression: a pharmacoMRI study.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110101

• The effects of antidepressants on the results of skin prick tests used in the diagnosis of allergic diseases.

  International archives of allergy and immunology 20110101

• The effect of escitalopram on platelet activity.

  Thrombosis research 20110101

• Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase.

  Basic & clinical pharmacology & toxicology 20110101

• Narrative evolution and assimilation of problematic experiences in a case of pharmacotherapy for schizophrenia.

  Psychotherapy research : journal of the Society for Psychotherapy Research 20110101

• Environmental risk assessment of three selective serotonin reuptake inhibitors in the aquatic environment: a case study including a cocktail scenario.

  Environmental toxicology and chemistry 20110101

• Combination of escitalopram and a 5-HT(₁A) receptor antagonist selectively decreases the extracellular levels of dopamine in the nucleus accumbens relative to striatum through 5-HT(₂C) receptor stimulation; suggestive of antipsychotic potential.

  Pharmacology, biochemistry, and behavior 20110101

• Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites.

  Biomedical chromatography : BMC 20110101

• Excessive novelty-induced c-Fos expression and altered neurogenesis in the hippocampus of GluA1 knockout mice.

  The European journal of neuroscience 20110101

• Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.

  Clinical pharmacology and therapeutics 20110101

• CYP2C19 variation and citalopram response.

  Pharmacogenetics and genomics 20110101

• Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis.

  The British journal of psychiatry : the journal of mental science 20110101

• Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram?

  Neurosciences (Riyadh, Saudi Arabia) 20110101

• A young women who couldn't see or move.

  Neurosciences (Riyadh, Saudi Arabia) 20110101

• International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.

  Trials 20110101

• The relationship between the acute cerebral metabolic response to citalopram and chronic citalopram treatment outcome.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20110101

• Targeting remission by 8 weeks: when should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor?

  Comprehensive psychiatry 20110101

• Are old-old patients with major depression more likely to relapse than young-old patients during continuation treatment with escitalopram?

  BMC geriatrics 20110101

• Escitalopram for psychogenic nausea and vomiting: a report of two cases.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20110101

• Weight gain, obesity, and psychotropic prescribing.

  Journal of obesity 20110101

• Treatment of postpartum depression: clinical, psychological and pharmacological options.

  International journal of women's health 20110101

• Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement?

  Annals of general psychiatry 20110101

• Citalopram-induced parkinsonian syndrome: case report.

  Clinical neuropharmacology 20110101

• Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study.

  BMC psychiatry 20110101

• [Hypertension induced by escitalopram].

  Turk psikiyatri dergisi = Turkish journal of psychiatry 20110101

• Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: a case report and review of the literature.

  Journal of medical case reports 20110101

• Efficacy, safety, and patient preference of monoamine oxidase B inhibitors in the treatment of Parkinson's disease.

  Patient preference and adherence 20110101

• Comparative efficacy of escitalopram in the treatment of major depressive disorder.

  Neuropsychiatric disease and treatment 20110101

• Paliperidone extended-release: does it have a place in antipsychotic therapy?

  Drug design, development and therapy 20110101

• Rehabilitating a brain with Alzheimer's: a proposal.

  Clinical interventions in aging 20110101

• Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients.

  Journal of translational medicine 20110101

• [The use of the antidepressant citalopran for the treatment of chronic pharyngitis and pharyngeal neurosis].

  Vestnik otorinolaringologii 20110101

• Update in the methodology of the chronic stress paradigm: internal control matters.

  Behavioral and brain functions : BBF 20110101

• Methods to quantify pharmacologically induced alterations in motor function in human incomplete SCI.

  Journal of visualized experiments : JoVE 20110101

• Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates.

  PloS one 20110101

• [Antagonism of tamoxifen and antidepressants among women with breast cancer].

  Revista medica de Chile 20110101

• Serotonin transporter gene polymorphisms and brain function during emotional distraction from cognitive processing in posttraumatic stress disorder.

  BMC psychiatry 20110101

• Effects of early life trauma are dependent on genetic predisposition: a rat study.

  Behavioral and brain functions : BBF 20110101

• Performance of Cpred/Cobs concentration ratios as a metric reflecting adherence to antidepressant drug therapy.

  Neuropsychiatric disease and treatment 20110101

• Impulse control disorders: updated review of clinical characteristics and pharmacological management.

  Frontiers in psychiatry 20110101

• Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder.

  Frontiers in psychiatry 20110101

• FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases.

  BMC neurology 20110101

• Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol.

  Trials 20110101

• The effects of massage on pain, stiffness, and fatigue levels associated with ankylosing spondylitis: a case study.

  International journal of therapeutic massage & bodywork 20110101

• Act In case of Depression: the evaluation of a care program to improve the detection and treatment of depression in nursing homes. Study Protocol.

  BMC psychiatry 20110101

• Antidepressant and antipsychotic use in an Italian pediatric population.

  BMC pediatrics 20110101

• Postural control in bipolar disorder: increased sway area and decreased dynamical complexity.

  PloS one 20110101

• Expert opinion on detecting and treating depression in palliative care: A Delphi study.

  BMC palliative care 20110101

• Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study.

  PloS one 20110101

• Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder.

  Neuropsychiatric disease and treatment 20110101

• Escitalopram and ischemic stroke: causal or chance association?

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Intranasal oxytocin as an adjunct to escitalopram in major depression.

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review.

  Journal of pharmacy & bioallied sciences 20110101

• Pharmacogenetics of antidepressants.

  Frontiers in pharmacology 20110101

• Effects of fluoxetine and escitalopram on C-reactive protein in patients of depression.

  Journal of pharmacology & pharmacotherapeutics 20110101

• Painful bruising syndrome presenting as bullous lesions.

  Indian journal of dermatology 20110101

• Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study.

  PloS one 20110101

• Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients--a randomized placebo-controlled trial.

  PloS one 20110101

• The strategy of combining antidepressants in the treatment of major depression: clinical experience in spanish outpatients.

  Depression research and treatment 20110101

• Antidepressant therapy in severe depression may have different effects on ego-dystonic and ego-syntonic suicidal ideation.

  Depression research and treatment 20110101

• Hyperaesthesia following genital herpes: a case report.

  Dermatology research and practice 20110101

• Noradrenergic symptom cluster in depression.

  Neuropsychiatric disease and treatment 20110101

• The noradrenergic symptom cluster: clinical expression and neuropharmacology.

  Neuropsychiatric disease and treatment 20110101

• Antidepressant prescribing and suicides in emilia-romagna region (Italy) from 1999 to 2008: an ecological study.

  Clinical practice and epidemiology in mental health : CP & EMH 20110101

• Successful management of vaginismus: An eclectic approach.

  Indian journal of psychiatry 20110101

• Pharmacotherapy for fibromyalgia.

  Frontiers in pharmacology 20110101

• Escitalopram treatment for premature ejaculation has a negative effect on semen parameters.

  International journal of impotence research 20110101

• Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression.

  Frontiers in psychology 20110101

• A Rare Case of Secondary Bacterial Peritonitis from Clostridium perfringens in an Adult Patient with Noncirrhotic Ascites and a Krukenberg Tumor: Report of a Case.

  Case reports in medicine 20110101

• Pharmacogenetics of escitalopram and mental adaptation to cancer in palliative care: report of 18 cases.

  Tumori 20110101

• Depression in vascular pathologies: the neurologist's point of view.

  Vascular health and risk management 20110101

• Case control polysomnographic studies of sleep disorders in Parkinson's disease.

  PloS one 20110101

• A review on assessment and treatment for depression in malaysia.

  Depression research and treatment 20110101

• Can online consumers contribute to drug knowledge? A mixed-methods comparison of consumer-generated and professionally controlled psychotropic medication information on the internet.

  Journal of medical Internet research 20110101

• Efficacy of chronic antidepressant treatments in a new model of extreme anxiety in rats.

  Depression research and treatment 20110101

• Postdischarge impact of C-L psychiatry treatment in obstetrical inpatients.

  ISRN obstetrics and gynecology 20110101

• Antidepressant use and risk of adverse outcomes in older people: population based cohort study.

  BMJ (Clinical research ed.) 20110101

• Radioelectric asymmetric brain stimulation and lingual apex repositioning in patients with atypical deglutition.

  Journal of multidisciplinary healthcare 20110101

• Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.

  BMJ (Clinical research ed.) 20110101

• Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation.

  Clinical interventions in aging 20110101

• Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor.

  Neuropsychiatric disease and treatment 20110101

• Serotonin receptor expression in human prefrontal cortex: balancing excitation and inhibition across postnatal development.

  PloS one 20110101

• High-dose citalopram for cocaine dependence in veteran population-a pilot project.

  The American journal on addictions 20110101

• Radioelectric brain stimulation in the treatment of generalized anxiety disorder with comorbid major depression in a psychiatric hospital: a pilot study.

  Neuropsychiatric disease and treatment 20110101

• Marked mydriasis and neuritis nervi optici associated with galactorrhea following citalopram treatment: a case report and discussion.

  Case reports in medicine 20110101

• Support and undermining in interpersonal relationships are associated with symptom improvement in a trial of antidepressant medication.

  Psychiatry 20110101

• Effectiveness and safety of citalopram in hospitalized adolescents with major depression: a preliminary, 8-week, fixed-dose, open-label, prospective study.

  Clinical neuropharmacology 20110101

• Psychotherapy and medication management strategies for obsessive-compulsive disorder.

  Neuropsychiatric disease and treatment 20110101

• Radio electric tissue optimization in the treatment of surgical wounds.

  Clinical, cosmetic and investigational dermatology 20110101

• Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder.

  ClinicoEconomics and outcomes research : CEOR 20110101

• Atrioventricular dissociation after electroconvulsive therapy.

  Cardiology research and practice 20110101

• Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice.

  Journal of pharmacy & bioallied sciences 20110101

• Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug.

  Behavioral and brain functions : BBF 20110101

• Current management of obsessive and phobic states.

  Neuropsychiatric disease and treatment 20110101

• Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials.

  BMJ open 20110101

• Drug utilization study of psychotropic drugs in outdoor patients in a teaching hospital.

  Indian journal of psychological medicine 20110101

• Intense suicidal thoughts and self-harm following escitalopram treatment.

  Indian journal of psychological medicine 20110101

• Enteric microbiome metabolites correlate with response to simvastatin treatment.

  PloS one 20110101

• What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association.

  BMC clinical pharmacology 20110101

• Generalised anxiety disorder.

  BMJ clinical evidence 20110101

• Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition.

  Neuropsychiatric disease and treatment 20110101

• Polypharmacy or medication washout: an old tool revisited.

  Neuropsychiatric disease and treatment 20110101

• Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid Study.

  BMC medical research methodology 20110101

• New developments in cognitive behavioral therapy as the first-line treatment of insomnia.

  Psychology research and behavior management 20110101

• Clinical features and efficacy of escitalopram treatment for geriatric depression.

  The Journal of international medical research 20110101

• Drug interaction in psycho-oncology: antidepressants and antineoplastics.

  Pharmacology 20110101

• Satisfaction with medication is correlated with outcome but not persistence in patients treated with placebo, escitalopram, or serotonin-norepinephrine reuptake inhibitors: a post hoc analysis.

  The primary care companion for CNS disorders 20110101

• Hair loss associated with escitalopram but not with venlafaxine: a case report.

  The primary care companion for CNS disorders 20110101

• State of Consultation-Liaison Psychiatry in India: Current status and vision for future.

  Indian journal of psychiatry 20110101

• Anterior capsulotomy for refractory OCD: First case as per the core group guidelines.

  Indian journal of psychiatry 20110101

• Meta-Review of Metanalytic Studies with Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Major Depression.

  Clinical practice and epidemiology in mental health : CP & EMH 20110101

• Zolpidem withdrawal delirium.

  Indian journal of pharmacology 20110101

• Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination.

  Indian journal of pharmacology 20110101

• Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study.

  BMC psychiatry 20110101

• Antidepressant drug exposure during pregnancy. CZTIS small prospective study.

  Neuro endocrinology letters 20110101

• Parasomnias and antidepressant therapy: a review of the literature.

  Frontiers in psychiatry 20110101

• Learning and memory alterations are associated with hippocampal N-acetylaspartate in a rat model of depression as measured by 1H-MRS.

  PloS one 20110101

• Exploring new frontiers in neuropsychopharmacology: SSRIs for stroke.

  Indian journal of psychiatry 20110101

• Serotonin transporter gene polymorphism and psychiatric disorders: is there a link?

  Indian journal of psychiatry 20110101

• Investigations on gastroprotective effect of citalopram, an antidepressant drug against stress and pyloric ligation induced ulcers.

  Pharmacological reports : PR 20110101

• Simultaneous thin-layer chromatography-densitometric analysis of sibutramine and citalopram.

  Folia medica 20110101

• The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring.

  Clinical epigenetics 20110101

• A case of major depressive disorder and symptoms of polycystic ovary syndrome responding to escitalopram.

  The primary care companion for CNS disorders 20110101

• A case of galactorrhea with escitalopram: a biopsychosocial phenomenon.

  The primary care companion for CNS disorders 20110101

• Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression.

  Frontiers in endocrinology 20110101

• Rhabdomyolysis associated with polydipsia induced hyponatraemia.

  BMJ case reports 20110101

• Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram.

  Journal of affective disorders 20101201

• Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.

  Journal of affective disorders 20101201

• Neurofeedback intervention in fibromyalgia syndrome; a randomized, controlled, rater blind clinical trial.

  Applied psychophysiology and biofeedback 20101201

• Structural elucidation of process-related impurities in escitalopram by LC/ESI-MS and NMR.

  Journal of pharmaceutical and biomedical analysis 20101201

• Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.

  British journal of pharmacology 20101201

• Interactions of corticotropin-releasing factor, urocortin and citalopram in a primate model of stress-induced amenorrhea.

  Neuroendocrinology 20101201

• Attenuation of fear-like response by escitalopram treatment after electrical stimulation of the midbrain dorsolateral periaqueductal gray.

  Experimental neurology 20101201

• Role of serotonin transporter inhibition in the regulation of tryptophan hydroxylase in brainstem raphe nuclei: time course and regional specificity.

  Neuroscience 20101201

• Adolescent escitalopram administration modifies neurochemical alterations in the hippocampus of maternally separated rats.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20101201

• Biochemical and behavioral effects of long-term citalopram administration and discontinuation in rats: role of serotonin synthesis.

  Neurochemistry international 20101201

• A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation.

  Thrombosis research 20101201

• Biomarkers to predict antidepressant response.

  Current psychiatry reports 20101201

• Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences.

  Current medical research and opinion 20101201

• Changes in regional brain volumes in social anxiety disorder following 12 weeks of treatment with escitalopram.

  Metabolic brain disease 20101201

• Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20101201

• Citalopram versus other antidepressants for late-life depression: a systematic review and meta-analysis.

  International journal of geriatric psychiatry 20101201

• Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults.

  Journal of clinical psychopharmacology 20101201

• Evaluation of a QT nomogram for risk assessment after antidepressant overdose.

  British journal of clinical pharmacology 20101201

• An interesting case of serotonin syndrome precipitated by escitalopram.

  Indian journal of pharmacology 20101201

• Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.

  The Journal of clinical psychiatry 20101201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20101201

• The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment.

  Psychiatry investigation 20101201

• Prolonged QTc interval due to escitalopram overdose.

  Journal of the Mississippi State Medical Association 20101201

• Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability.

  Current neuropharmacology 20101201

• Escitalopram related erectile dysfunction and spontaneous ejaculation during micturition.

  The West Indian medical journal 20101201

• Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.

  Healthcare informatics research 20101201

• Effects of reboxetine and citalopram pretreatment on changes in cocaine and amphetamine regulated transcript (CART) expression in rat brain induced by the forced swimming test.

  European journal of pharmacology 20101125

• N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor.

  Biochemical pharmacology 20101115

• Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression.

  Neuroscience 20101110

• MRI signal hyperintensities and treatment remission of geriatric depression.

  Journal of affective disorders 20101101

• Involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20101101

• In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by α2-adrenoceptor antagonism.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20101101

• Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: dose-dependent effects.

  Anatomical record (Hoboken, N.J. : 2007) 20101101

• Improving medication compliance in patients with depression: Use of orodispersible tablets.

  Advances in therapy 20101101

• Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication.

  Psychosomatic medicine 20101101

• Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with depression care management.

  International journal of geriatric psychiatry 20101101

• Comment on 'Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease'.

  Journal of immunology (Baltimore, Md. : 1950) 20101101

• Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.

  Psychiatria Danubina 20101101

• Antidepressant pretreatment and symptomatic treatment in interferon treatment.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20101101

• Recursive subsetting to identify patients in the STAR*D: a method to enhance the accuracy of early prediction of treatment outcome and to inform personalized care.

  The Journal of clinical psychiatry 20101101

• Possible role of NO modulators in protective effect of trazodone and citalopram (antidepressants) in acute immobilization stress in mice.

  Indian journal of experimental biology 20101101

• Effects of citalopram on serum deprivation induced PC12 cell apoptosis and BDNF expression.

  Die Pharmazie 20101101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20101101

• Developing thai economic model to study cost-effectiveness of switching to bupropion compared to combination with bupropion after the failure of an SSRI for major depressive disorder.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20101101

• Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20101027

• QEEG Measures in Huntington's Disease: A Pilot Study.

  PLoS currents 20101025

• Effects of selective serotonin reuptake inhibitors on GABAergic inhibition in the hippocampus of normal and pilocarpine induced epileptic rats.

  Brain research 20101021

• A fatal intoxication case involving topiramate.

  Forensic science international 20101010

• Serotonin selectively influences moral judgment and behavior through effects on harm aversion.

  Proceedings of the National Academy of Sciences of the United States of America 20101005

• A study of central serotoninergic activity in healthy subjects and patients with Type 2 diabetes treated by traditional one-to-one care or Group Care.

  Journal of endocrinological investigation 20101001

• A highly sensitive LC-MS/MS method for the determination of S-citalopram in rat plasma: application to a pharmacokinetic study in rats.

  Biomedical chromatography : BMC 20101001

• Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans.

  Journal of endocrinological investigation 20101001

• The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20101001

• Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20101001

• The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine.

  Psychopharmacology 20101001

• Mitotic recombination: a genotoxic effect of the antidepressant citalopram in Aspergillus nidulans.

  Experimental biology and medicine (Maywood, N.J.) 20101001

• Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.

  Neurocase 20101001

• A rare case of tardive dyskinesia and akathisia induced by citalopram.

  PM & R : the journal of injury, function, and rehabilitation 20101001

• [Efficacy of escitalopram vs paroxetine on severe depression with associated anxiety: data from the 'Boulenger' study].

  L'Encephale 20101001

• Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats.

  European journal of pharmacology 20100925

• A role for p11 in the antidepressant action of brain-derived neurotrophic factor.

  Biological psychiatry 20100915

• A genomewide association study of citalopram response in major depressive disorder-a psychometric approach.

  Biological psychiatry 20100915

• The role of proteomics in depression research.

  European archives of psychiatry and clinical neuroscience 20100901

• BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression.

  Journal of affective disorders 20100901

• A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.

  The Journal of clinical psychiatry 20100901

• Association between CYP2C19 polymorphism and depressive symptoms.

  American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20100901

• The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.

  The Journal of pharmacology and experimental therapeutics 20100901

• Strain-dependent serotonin neuron feedback control: role of serotonin 2C receptors.

  Journal of neurochemistry 20100901

• Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons.

  Journal of substance abuse treatment 20100901

• Trends in the consumption of antidepressants in Castilla y León (Spain). Association between suicide rates and antidepressant drug consumption.

  Pharmacoepidemiology and drug safety 20100901

• Escitalopram and ischemic stroke: cause or chance association?

  The Annals of pharmacotherapy 20100901

• Escitalopram: a review of its use in the management of major depressive disorder in adults.

  CNS drugs 20100901

• Treatment of subsyndromal depressive symptoms in middle-age and older patients with schizophrenia: effect of age on response.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20100901

• Shared obsessive-compulsive disorder: broadening the concept of shared psychotic disorder.

  The Australian and New Zealand journal of psychiatry 20100901

• The haunting of medical journals: how ghostwriting sold 'HRT'.

  PLoS medicine 20100901

• Drugs and breastfeeding.

  Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association 20100901

• The antidepressant citalopram cuts hot flash severity and frequency.

  Harvard women's health watch 20100901

• Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: a randomized double-blind placebo-controlled trial.

  Psychiatry research 20100830

• Tryptophan hydroxylase 2 genotype determines brain serotonin synthesis but not tissue content in C57Bl/6 and BALB/c congenic mice.

  Neuroscience letters 20100830

• Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transporters.

  Journal of medicinal chemistry 20100826

• Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20100816

• Nitric oxide is involved in the regulation of marble-burying behavior.

  Neuroscience letters 20100809

• Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).

  The Cochrane database of systematic reviews 20100804

• Augmenting serotonin neurotransmission with citalopram modulates emotional expression decoding but not structural encoding of moderate intensity sad facial emotional stimuli: an event-related potential (ERP) investigation.

  Journal of psychopharmacology (Oxford, England) 20100801

• Housekeeping gene expression is affected by antidepressant treatment in a mouse fibroblast cell line.

  Journal of psychopharmacology (Oxford, England) 20100801

• A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers.

  Journal of psychopharmacology (Oxford, England) 20100801

• Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers.

  Journal of psychopharmacology (Oxford, England) 20100801

• Trajectories of change in depression severity during treatment with antidepressants.

  Psychological medicine 20100801

• Thyroid autoimmunity and treatment response to escitalopram in major depression.

  Nordic journal of psychiatry 20100801

• Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.

  Journal of psychopharmacology (Oxford, England) 20100801

• fMRI tracks reductions in repetitive behaviors in autism: two case studies.

  Neurocase 20100801

• The SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young men.

  European journal of nuclear medicine and molecular imaging 20100801

• Antiplatelet effects of antidepressant treatment: a randomized comparison between escitalopram and nortriptyline.

  Thrombosis research 20100801

• Factors associated with response in depressed elderly outpatients treated with escitalopram in a naturalistic setting in Germany.

  Pharmacopsychiatry 20100801

• First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial.

  Journal of psychosomatic research 20100801

• Comparative bioavailability of two escitalopram formulations in healthy human volunteers.

  International journal of clinical pharmacology and therapeutics 20100801

• Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.

  Drugs & aging 20100801

• Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.

  Expert review of neurotherapeutics 20100801

• What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology.

  Journal of psychopharmacology (Oxford, England) 20100801

• Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20100801

• Neuroticism but not omega-3 fatty acid levels correlate with early responsiveness to escitalopram.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20100801

• Escitalopram may improve some cognitive functions after stroke in non-depressed patients.

  Evidence-based mental health 20100801

• Selective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum.

  The European journal of neuroscience 20100801

• Serotonergic modulation of response inhibition and re-engagement? Results of a study in healthy human volunteers.

  Human psychopharmacology 20100801

• Metabolic acidosis and generalized seizures secondary to citalopram overdose: a case report.

  Journal of clinical pharmacy and therapeutics 20100801

• Do Hospital and Community SSRI Usage Patterns in Children and Adolescents Match the Evidence?

  Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 20100801

• Drug safety monitoring in patients of movement disorders of a tertiary care hospital.

  Indian journal of pharmacology 20100801

• Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100710

• Comparison of toxicity of acute overdoses with citalopram and escitalopram.

  The Journal of emergency medicine 20100701

• The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression.

  Hippocampus 20100701

• Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.

  International clinical psychopharmacology 20100701

• Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial.

  The Journal of clinical psychiatry 20100701

• The influence of citalopram on interdigestive gastrointestinal motility in man.

  Alimentary pharmacology & therapeutics 20100701

• Serum concentrations of citalopram--dose-dependent variation in R- and S-enantiomer ratios.

  Pharmacopsychiatry 20100701

• Antidepressant 'treatment'.

  Menopause (New York, N.Y.) 20100701

• Escitalopram in the treatment of major depressive disorder in adolescent patients. Profile report.

  CNS drugs 20100701

• Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.

  International clinical psychopharmacology 20100701

• Transdermal rotigotine for the perioperative management of Parkinson's disease.

  Journal of neural transmission (Vienna, Austria : 1996) 20100701

• Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder.

  Menopause (New York, N.Y.) 20100701

• The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission.

  Human psychopharmacology 20100701

• Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression.

  Journal of psychiatry & neuroscience : JPN 20100701

• Impact of escitalopram on nocturnal sleep, day-time sleepiness and performance compared to amitriptyline: a randomized, double-blind, placebo-controlled study in healthy male subjects.

  Pharmacopsychiatry 20100701

• Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers.

  British journal of clinical pharmacology 20100701

• Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.

  Postgraduate medicine 20100701

• History of suicide attempts among patients with depression in the GENDEP project.

  Journal of affective disorders 20100601

• Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms.

  Psychopharmacology 20100601

• Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery.

  Journal of affective disorders 20100601

• Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression.

  Journal of psychiatric research 20100601

• Alpha1-adrenoceptors modulate citalopram-induced serotonin release.

  Neuropharmacology 20100601

• DNA sequence variants of the FKBP5 gene are associated with unipolar depression.

  The international journal of neuropsychopharmacology 20100601

• The identification of inhibitors of Schistosoma mansoni miracidial transformation by incorporating a medium-throughput small-molecule screen.

  Experimental parasitology 20100601

• Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.

  Synapse (New York, N.Y.) 20100601

• High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin.

  Journal of substance abuse treatment 20100601

• Prescription patterns of antidepressants: findings from a US claims database.

  Current medical research and opinion 20100601

• Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.

  CNS neuroscience & therapeutics 20100601

• Update on antithrombotic therapy for stroke prevention in atrial fibrillation.

  Current treatment options in cardiovascular medicine 20100601

• Escitalopram: in the treatment of major depressive disorder in adolescent patients.

  Paediatric drugs 20100601

• Affective and anxiety disorders: prevalence, treatment and antidepressant medication use.

  The Australian and New Zealand journal of psychiatry 20100601

• Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.

  The Journal of clinical psychiatry 20100601

• [Serotoninergic antidepressants and opiate analgesics: a sometimes-painful association. A case report].

  L'Encephale 20100601

• Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality.

  Future oncology (London, England) 20100601

• Escitalopram for persistent symptoms of generalized anxiety disorder after CBT: a pilot study.

  The Journal of nervous and mental disease 20100601

• An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.

  Psychiatria Danubina 20100601

• An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.

  Psychiatria Danubina 20100601

• Suicide risk and choice of antidepressant.

  Psychiatria Danubina 20100601

• A report from the 4th biennial conference of the international society of bipolar disorder (March 17-20, 2010 - Sao Paulo, Brazil).

  Drugs of today (Barcelona, Spain : 1998) 20100601

• Pathological gambling and compulsive buying: do they fall within an obsessive-compulsive spectrum?

  Dialogues in clinical neuroscience 20100601

• Drug treatment of obsessive-compulsive disorder.

  Dialogues in clinical neuroscience 20100601

• Body dysmorphic disorder.

  Dialogues in clinical neuroscience 20100601

• Probable epistaxis associated with escitalopram.

  Progress in neuro-psychopharmacology & biological psychiatry 20100530

• Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder.

  Psychiatry research 20100530

• Escitalopram attenuates posterior cingulate activity during self-evaluation in healthy volunteers.

  Psychiatry research 20100530

• Deaths involving serotonergic drugs.

  Forensic science international 20100520

• A common mechanism of action of the selective serotonin reuptake inhibitors citalopram and fluoxetine: reversal of chronic psychosocial stress-induced increase in CRE/CREB-directed gene transcription in transgenic reporter gene mice.

  European journal of pharmacology 20100510

• Aging impairs the antidepressant-like response to citalopram in male rats.

  European journal of pharmacology 20100510

• Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation.

  Journal of psychopharmacology (Oxford, England) 20100501

• Role of the serotonergic system in reduced pulmonary function after exposure to methamphetamine.

  American journal of respiratory cell and molecular biology 20100501

• Antidepressant study design affects patient expectancy: a pilot study.

  Psychological medicine 20100501

• The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents.

  Biological psychiatry 20100501

• The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.

  Behavioural brain research 20100501

• Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats.

  American journal of physiology. Endocrinology and metabolism 20100501

• Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100501

• Anxiety impairs depression remission in partial responders during extended treatment in late-life.

  Depression and anxiety 20100501

• Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder.

  The American journal of psychiatry 20100501

• Urinary flow and urinary symptoms in elderly males exposed to either escitalopram or duloxetine.

  Current medical research and opinion 20100501

• Melatonin inhibits serotonin transporter activity in intestinal epithelial cells.

  Journal of pineal research 20100501

• Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK.

  Current medical research and opinion 20100501

• Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia.

  Bioorganic & medicinal chemistry letters 20100501

• Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

  The American journal of psychiatry 20100501

• Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.

  Pediatrics 20100501

• Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain.

  Expert opinion on pharmacotherapy 20100501

• Medial prefrontal cortex activity during memory encoding of pictures and its relation to symptomatic improvement after citalopram treatment in patients with major depression.

  Journal of psychiatry & neuroscience : JPN 20100501

• Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.

  Archives of general psychiatry 20100501

• Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.

  Depression and anxiety 20100501

• Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats.

  Indian journal of experimental biology 20100501

• Escitalopram versus placebo in the treatment of dysthymic disorder.

  International clinical psychopharmacology 20100501

• Escitalopram induced galactorrhoea: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20100416

• Brain imaging of serotonin 4 receptors in humans with [11C]SB207145-PET.

  NeuroImage 20100415

• The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.

  Journal of psychopharmacology (Oxford, England) 20100401

• Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients.

  Journal of affective disorders 20100401

• Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study.

  Journal of psychiatric research 20100401

• A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depression.

  Journal of psychiatric research 20100401

• The wish to die and 5-year mortality in elderly primary care patients.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20100401

• Differential effects of acute and repeated citalopram in mouse models of anxiety and depression.

  The international journal of neuropsychopharmacology 20100401

• A perfect storm in the emergency department.

  Neurocritical care 20100401

• Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease.

  Neurobiology of disease 20100401

• Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen.

  Acta oncologica (Stockholm, Sweden) 20100401

• Sex differences in the serotonergic influence on the hypothalamic-pituitary-adrenal stress axis.

  Endocrinology 20100401

• Open channel block of Kv1.5 currents by citalopram.

  Acta pharmacologica Sinica 20100401

• Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.

  Pharmacogenomics 20100401

• Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.

  Archives of general psychiatry 20100401

• Chronic thromboembolic pulmonary hypertension.

  Current treatment options in cardiovascular medicine 20100401

• MRP1 polymorphisms associated with citalopram response in patients with major depression.

  Journal of clinical psychopharmacology 20100401

• Suicidal behavior and alcohol abuse.

  International journal of environmental research and public health 20100401

• Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach.

  Forensic science international 20100320

• Excessive daytime somnolence in spinocerebellar ataxia type 1.

  Journal of the neurological sciences 20100315

• Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons.

  European journal of pharmacology 20100310

• Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion.

  Behavioural brain research 20100305

• Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.

  International journal of cardiology 20100304

• [Depression].

  Praxis 20100303

• Intravenous anti-obsessive agents: a review.

  Journal of psychopharmacology (Oxford, England) 20100301

• 5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response.

  European archives of psychiatry and clinical neuroscience 20100301

• Acute citalopram administration may disrupt contextual information processing in healthy males.

  European psychiatry : the journal of the Association of European Psychiatrists 20100301

• Creatine transporter expression after antidepressant therapy in rats bred for learned helplessness.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301

• Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes.

  Drug and alcohol dependence 20100301

• Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound.

  The Journal of pharmacology and experimental therapeutics 20100301

• Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.

  Biological psychiatry 20100301

• Changes in 5-HT4 receptor and 5-HT transporter binding in olfactory bulbectomized and glucocorticoid receptor heterozygous mice.

  Neurochemistry international 20100301

• Relationship of residual mood and panic-agoraphobic spectrum phenomenology to quality of life and functional impairment in patients with major depression.

  International clinical psychopharmacology 20100301

• Quality of sleep in escitalopram-treated female patients with panic disorder.

  Human psychopharmacology 20100301

• Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine.

  Current medical research and opinion 20100301

• Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors.

  Arthritis and rheumatism 20100301

• Estradiol valerate elicits antidepressant-like effects in middle-aged female rats under chronic mild stress.

  Behavioural pharmacology 20100301

• Escitalopram causes fewer seizures in human overdose than citalopram.

  Clinical toxicology (Philadelphia, Pa.) 20100301

• Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study.

  Human psychopharmacology 20100301

• Effect of escitalopram on the processing of emotional faces.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20100301

• Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301

• Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17.

  British journal of clinical pharmacology 20100301

• Psychiatric pharmacogenomic testing in clinical practice.

  Dialogues in clinical neuroscience 20100301

• Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting.

  Psychiatry investigation 20100301

• Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.

  The Cochrane database of systematic reviews 20100217

• Simultaneous determination of citalopram and its metabolite in human plasma by LC-MS/MS applied to pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100215

• [Personality test and prediction of antidepressive treatment effect in mental illness].

  Ugeskrift for laeger 20100215

• Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20100215

• The two enantiomers of citalopram bind to the human serotonin transporter in reversed orientations.

  Journal of the American Chemical Society 20100203

• Do atypical features affect outcome in depressed outpatients treated with citalopram?

  The international journal of neuropsychopharmacology 20100201

• Normalization of GRK2 protein and mRNA measures in patients with depression predict response to antidepressants.

  The international journal of neuropsychopharmacology 20100201

• Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.

  Psychological medicine 20100201

• Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective.

  The European journal of health economics : HEPAC : health economics in prevention and care 20100201

• Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors.

  International psychogeriatrics 20100201

• Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning.

  International journal of geriatric psychiatry 20100201

• In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension.

  Cardiovascular research 20100201

• SSRI antidepressants do not confound single photon emission computed tomography (SPECT) imaging studies using the alpha4beta2 nicotinic acetylcholine receptor [123I]5-I-A85380 ligand: in vivo and in vitro evidence.

  Synapse (New York, N.Y.) 20100201

• Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment.

  The international journal of neuropsychopharmacology 20100201

• Depression masked as paroxysmal hypertension episodes.

  Blood pressure 20100201

• Effects of escitalopram on stress-related relapses in women with multiple sclerosis: an open-label, randomized, controlled, one-year follow-up study.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100201

• Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.

  The Journal of clinical psychiatry 20100201

• A pharmacogenetic study of escitalopram in autism spectrum disorders.

  Autism research : official journal of the International Society for Autism Research 20100201

• Notch1 signaling related hippocampal neurogenesis in adult poststroke depression rats: a valid index for an efficient combined citalopram and WAY100635 pharmacotherapy.

  Behavioural pharmacology 20100201

• Antidepressant medication and executive dysfunction: a deleterious interaction in late-life depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20100201

• Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20100201

• Escitalopram and enhancement of cognitive recovery following stroke.

  Archives of general psychiatry 20100201

• Antidepressants in functional dyspepsia.

  Expert review of gastroenterology & hepatology 20100201

• Serotonin modulates glutamatergic transmission in the rat olfactory tubercle.

  The European journal of neuroscience 20100201

• Prinzmetal-variant angina in a patient using zolmitriptan and citalopram.

  The American journal of emergency medicine 20100201

• Is escitalopram really relevantly superior to citalopram in treatment of major depressive disorder? A meta-analysis of head-to-head randomized trials.

  Croatian medical journal 20100201

• Use of antidepressants in children: is it time for a comparative effectiveness trial?

  Journal of the American Academy of Child and Adolescent Psychiatry 20100201

• Potential role of glutamate neurotransmission in the pathogenesis of ischemic brain damage and of depression. Effects of L-kynurenine on the survival of the hippocampal neurons and on the corticocerebral blood flow in ischemic animal models.

  Ideggyogyaszati szemle 20100130

• Evaluation of the influence of sex and CYP2C19 and CYP2D6 polymorphisms in the disposition of citalopram.

  European journal of pharmacology 20100125

• [Discontinuation of antidepressant serotonergic antidepressant].

  Ugeskrift for laeger 20100125

• Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.

  NeuroImage 20100115

• A genomewide association study of citalopram response in major depressive disorder.

  Biological psychiatry 20100115

• Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.

  The Journal of biological chemistry 20100115

• Development of a stir bar sorptive extraction based HPLC-FLD method for the quantification of serotonin reuptake inhibitors in plasma, urine and brain tissue samples.

  Journal of pharmaceutical and biomedical analysis 20100105

• Aggression--interactions of serotonin and testosterone in healthy men and women.

  Behavioural brain research 20100105

• Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons.

  Journal of psychopharmacology (Oxford, England) 20100101

• A short duration of untreated illness (DUI) improves response outcomes in first-depressive episodes.

  Journal of affective disorders 20100101

• Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.

  Psychological medicine 20100101

• Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20100101

• Effect of age, weight, and CYP2C19 genotype on escitalopram exposure.

  Journal of clinical pharmacology 20100101

• Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100101

• Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study.

  Journal of neural transmission (Vienna, Austria : 1996) 20100101

• Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.

  Journal of hepatology 20100101

• Antidepressant effect of the extracts from Fructus Akebiae.

  Pharmacology, biochemistry, and behavior 20100101

• Ethnic differences in antidepressant response: a prospective multi-site clinical trial.

  Depression and anxiety 20100101

• Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.

  International clinical psychopharmacology 20100101

• Why do some promising brain-stimulation devices fail the next steps of clinical development?

  Expert review of medical devices 20100101

• Clinical presentation and outcome of geriatric depression in subcortical ischemic vascular disease.

  Gerontology 20100101

• Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study.

  BMC surgery 20100101

• The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later life.

  Trials 20100101

• Combining motivational interviewing with compliance enhancement therapy (MI-CET): development and preliminary evaluation of a new, manual-guided psychosocial adjunct to alcohol-dependence pharmacotherapy.

  Journal of studies on alcohol and drugs 20100101

• In response to van Gorp F. et al. Escitalopram overdose.

  Annals of emergency medicine 20100101

• The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse.

  The American journal of drug and alcohol abuse 20100101

• Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.

  BMJ (Clinical research ed.) 20100101

• Anti-inflammatory effects of antidepressant and atypical antipsychotic medication for the treatment of major depression and comorbid arthritis: a case report.

  Journal of medical case reports 20100101

• Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.

  PloS one 20100101

• Depression, extrapyramidal symptoms, dementia and an unexpected outcome: a case report.

  Cases journal 20100101

• Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial.

  Trials 20100101

• Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review.

  BMC infectious diseases 20100101

• Salvage use of citalopram for treatment of fluoxetine-resistant premature ejaculation in recently married men: a prospective clinical trial.

  Urology journal 20100101

• GPs' decision-making when prescribing medicines for breastfeeding women: Content analysis of a survey.

  BMC research notes 20100101

• Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole.

  Neuropsychiatric disease and treatment 20100101

• Continuation treatment of major depressive disorder: is there a case for duloxetine?

  Drug design, development and therapy 20100101

• Citalopram (antidepressant) administration causes sexual dysfunction in male mice through RF-amide related peptide in the dorsomedial hypothalamus.

  Neuropharmacology 20100101

• Adolescent mental health: Challenges with maternal noncompliance.

  Neuropsychiatric disease and treatment 20100101

• Plaque deposition dependent decrease in 5-HT2A serotonin receptor in AbetaPPswe/PS1dE9 amyloid overexpressing mice.

  Journal of Alzheimer's disease : JAD 20100101

• Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorder.

  Trials 20100101

• Euprolactinemic galactorrhea associated with use of imipramine and escitalopram in a postmenopausal woman.

  General hospital psychiatry 20100101

• [Diagnosis of epilepsy complicated by panic disorder and a non-specific reaction to a SSRI].

  Tijdschrift voor psychiatrie 20100101

• Comparison of the consumption of antidepressants in the immigrant and native populations in a Spanish health region: an observational study.

  BMC public health 20100101

• The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report.

  Annals of general psychiatry 20100101

• Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasons.

  Journal of medical economics 20100101

• Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury.

  Brain injury 20100101

• Current trends in drug treatment of obsessive-compulsive disorder.

  Neuropsychiatric disease and treatment 20100101

• Trazodone effects on [H]-paroxetine and alpha(2)-adrenoreceptors in platelets of patients with major depression.

  Neuropsychiatric disease and treatment 20100101

• Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases.

  BMC psychiatry 20100101

• Multifactorial QT interval prolongation.

  Cardiology journal 20100101

• Abnormal macrophage response to microbial stimulus in a 43-year-old man with a severe form of atherosclerosis: a case report.

  Journal of medical case reports 20100101

• Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.

  BMC neurology 20100101

• Depressive symptoms during rehabilitation period predict poor outcome of lumbar spinal stenosis surgery: a two-year perspective.

  BMC musculoskeletal disorders 20100101

• Management of unusual case of self-inflicted penetrating craniocerebral injury by a nail.

  Journal of emergencies, trauma, and shock 20100101

• Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients.

  Brain stimulation 20100101

• The Factors Influencing Depression Endpoints Research (FINDER) study: final results of Italian patients with depression.

  Annals of general psychiatry 20100101

• Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.

  Primary care companion to the Journal of clinical psychiatry 20100101

• Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.

  Journal of medical economics 20100101

• Environmental enrichment induces behavioral recovery and enhanced hippocampal cell proliferation in an antidepressant-resistant animal model for PTSD.

  PloS one 20100101

• The 6-month persistence on SSRIs and associated economic burden.

  Journal of medical economics 20100101

• Past, present and future drugs for the treatment of obsessive-compulsive disorder.

  Current medicinal chemistry 20100101

• Adherence to antidepressant therapy for major depressive patients in a psychiatric hospital in Thailand.

  BMC psychiatry 20100101

• Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report.

  BMC psychiatry 20100101

• Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial.

  Psychosomatics 20100101

• Medical errors - I : The problem.

  Indian journal of psychiatry 20100101

• Colorimetric method for the estimation of escitalopram oxalate in tablet dosage form.

  Indian journal of pharmaceutical sciences 20100101

• Herbal medicine--sets the heart racing!

  Irish medical journal 20100101

• Reversible escitalopram-induced hypothyroidism.

  General hospital psychiatry 20100101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20100101

• Getting the balance right: Established and emerging therapies for major depressive disorders.

  Neuropsychiatric disease and treatment 20100101

• Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters.

  Neuropsychiatric disease and treatment 20100101

• Management of depression in elderly stroke patients.

  Neuropsychiatric disease and treatment 20100101

• Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis.

  Clinical epidemiology 20100101

• Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study.

  Journal of medical economics 20100101

• Citalopram related euprolactinaemic galactorrhoea: a case report.

  The West Indian medical journal 20100101

• Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.

  BMJ (Clinical research ed.) 20100101

• Role of paliperidone extended-release in treatment of schizoaffective disorder.

  Neuropsychiatric disease and treatment 20100101

• [Selective serotonin reuptake inhibitors and mammary pathologies].

  Voprosy onkologii 20100101

• Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

  Human genomics and proteomics : HGP 20100101

• The Nordic health registers - an important source when evaluating the safety of antidepressants during pregnancy.

  Clinical epidemiology 20100101

• Optimal management of perimenopausal depression.

  International journal of women's health 20100101

• Validated HPLC method for quantitative determination of talinolol in rat plasma and application to a preclinical pharmacokinetic study.

  Bioanalysis 20100101

• Indirect comparisons: a review of reporting and methodological quality.

  PloS one 20100101

• Urinary retention with a high dose of escitalopram.

  General hospital psychiatry 20100101

• Citalopram-induced hallucinations and delusions in a young adult.

  General hospital psychiatry 20100101

• A Hybrid Machine Learning Method for Fusing fMRI and Genetic Data: Combining both Improves Classification of Schizophrenia.

  Frontiers in human neuroscience 20100101

• Can depression be a menopause-associated risk?

  BMC medicine 20100101

• A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole.

  Neuropsychiatric disease and treatment 20100101

• A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency.

  BMC medicine 20100101

• 3D-QSAR design of new escitalopram derivatives for the treatment of major depressive disorders.

  Scientia pharmaceutica 20100101

• Prescription drugs associated with reports of violence towards others.

  PloS one 20100101

• Familial vulnerability to an unusual cognitive adverse effect of topiramate: Discussion of mechanisms.

  Indian journal of psychiatry 20100101

• Hot tongue on FDG PET scan in a patient of Hodgkin's lymphoma undergoing antipsychotic treatment.

  Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India 20100101

• Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.

  Neuro endocrinology letters 20100101

• Zero order spectrophotometric method for estimation of escitalopram oxalate in tablet formulations.

  Journal of young pharmacists : JYP 20100101

• The geriatric population and psychiatric medication.

  Mens sana monographs 20100101

• Lactating mother and psychotropic drugs.

  Mens sana monographs 20100101

• Linezolid interaction with serotonin reuptake inhibitors: report of two cases and incidence assessment.

  Drug metabolism and drug interactions 20100101

• Identifying phronotypes in psychiatry.

  Frontiers in psychiatry 20100101

• Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptor.

  International journal of molecular sciences 20100101

• Amino acid-responsive Crohn's disease: a case study.

  Clinical and experimental gastroenterology 20100101

• Antidepressant-associated sexual dysfunction: impact, effects, and treatment.

  Drug, healthcare and patient safety 20100101

• Recognition of the kind of stress coping in patients of multiple sclerosis.

  Indian journal of psychological medicine 20100101

• An Open-label Trial of Risperidone and Fluoxetine in Children with Autistic Disorder.

  Indian journal of psychological medicine 20100101

• Initiatives in biological research in Indian psychiatry.

  Indian journal of psychiatry 20100101

• Molecular biology research in neuropsychiatry: India's contribution.

  Indian journal of psychiatry 20100101

• An overview of Indian research in depression.

  Indian journal of psychiatry 20100101

• Research on antidepressants in India.

  Indian journal of psychiatry 20100101

• [Development of a method for estimation of citalopram and desmethylcitalopram in nails and hair and its usefulness in forensic toxicology].

  Archiwum medycyny sadowej i kryminologii 20100101

• Successful use of stellate ganglion block and pulsed radiofrequency in the treatment of posttraumatic stress disorder: a case report.

  Pain research and treatment 20100101

• Decreased expression of serotonin 1A receptor in the dentate gyrus in association with chronic mild stress: a rat model of post-stroke depression.

  Psychiatry research 20091230

• Depression-like and anxiety-like behavioural aftermaths of impact accelerated traumatic brain injury in rats: a model of comorbid depression and anxiety?

  Behavioural brain research 20091228

• An academic perspective on the APPEs' educational significance.

  American journal of pharmaceutical education 20091217

• [Medication associated long QT syndrome].

  Praxis 20091202

• Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression.

  Journal of affective disorders 20091201

• Electroconvulsive therapy for an urgent social indication.

  The journal of ECT 20091201

• Self-injury behavior in an adolescent with Wilson's disease.

  European child & adolescent psychiatry 20091201

• Peduncular hallucinosis: a polysomnographic and spect study of a patient and efficacy of serotonergic therapy.

  Sleep medicine 20091201

• Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopram.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20091201

• Stress sensitive female macaques have decreased fifth Ewing variant (Fev) and serotonin-related gene expression that is not reversed by citalopram.

  Neuroscience 20091201

• Escitalopram is a weak inhibitor of the CYP2D6-catalyzed O-demethylation of (+)-tramadol but does not reduce the hypoalgesic effect in experimental pain.

  Clinical pharmacology and therapeutics 20091201

• Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study.

  Psychopharmacology 20091201

• Chronic therapy with citalopram decreases regional cerebral glucose utilization in OBX, and not sham-operated, rats: an autoradiographic study.

  Psychopharmacology 20091201

• Identification of a novel CYP2C19-mediated metabolic pathway of S-citalopram in vitro.

  Drug metabolism and disposition: the biological fate of chemicals 20091201

• A proteomic analysis of the ventral hippocampus of rats subjected to maternal separation and escitalopram treatment.

  Metabolic brain disease 20091201

• [Efficacy of escitalopram and severity of depression: new data].

  L'Encephale 20091201

• The intersection of pharmacology, imaging, and genetics in the development of personalized medicine.

  Dialogues in clinical neuroscience 20091201

• A new paradigm for the prediction of antidepressant treatment response.

  Dialogues in clinical neuroscience 20091201

• Association between Painful Physical Symptoms and Clinical Outcomes in Korean Patients with Major Depressive Disorder: A Three-Month Observational Study.

  Psychiatry investigation 20091201

• Comparative Analysis of Cognitive Function in Schizophrenia with and without Obsessive Compulsive Disorder.

  Psychiatry investigation 20091201

• Citalopram enhances cocaine's subjective effects in rats.

  Behavioural pharmacology 20091201

• An isolated fever associated with selective serotonin reuptake inhibitors therapy.

  Internal medicine journal 20091201

• Effect of escitalopram on white blood cells in patients with major depression.

  Journal of clinical medicine research 20091201

• Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram.

  Progress in neuro-psychopharmacology & biological psychiatry 20091113

• Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders.

  Molecular psychiatry 20091101

• The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients.

  Journal of affective disorders 20091101

• Body weight as a predictor of antidepressant efficacy in the GENDEP project.

  Journal of affective disorders 20091101

• Tryptophan depletion affects the autonomic stress response in generalized social anxiety disorder.

  Psychoneuroendocrinology 20091101

• Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake.

  Cardiovascular research 20091101

• Depletion of selective serotonin reuptake inhibitors during sewage sludge composting.

  Waste management (New York, N.Y.) 20091101

• Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20091101

• Specific effects of escitalopram on neuroendocrine response.

  Psychopharmacology 20091101

• Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder.

  International clinical psychopharmacology 20091101

• Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.

  The Journal of clinical psychiatry 20091101

• Use of antidepressants for management of hot flashes.

  Pharmacotherapy 20091101

• What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.

  Psychiatric services (Washington, D.C.) 20091101

• Pharmacogenetics studies in STAR*D: strengths, limitations, and results.

  Psychiatric services (Washington, D.C.) 20091101

• Wishing upon a STAR*D: the promise of ideal depression care by primary care providers.

  Psychiatric services (Washington, D.C.) 20091101

• Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression.

  The American journal of psychiatry 20091101

• Acute maniform reaction to a single dose of escitalopram in a social phobic patient--an atypical jitteriness syndrome?

  Pharmacopsychiatry 20091101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20091101

• The role of the serotoninergic system in the regulation of thyroid function in old rats.

  Bulletin of experimental biology and medicine 20091101

• An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant.

  Neuroscience letters 20091025

• Semi-preparative isolation and structural elucidation of an impurity in citalopram by LC/MS/MS.

  Journal of pharmaceutical and biomedical analysis 20091015

• Effects of Lorazepam and citalopram on human defensive reactions: ethopharmacological differentiation of fear and anxiety.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20091007

• In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.

  Synapse (New York, N.Y.) 20091001

• Short-term antidepressant treatment modulates amygdala response to happy faces.

  Psychopharmacology 20091001

• Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats.

  Progress in neuro-psychopharmacology & biological psychiatry 20091001

• Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use.

  The Laryngoscope 20091001

• Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder.

  Psychopharmacology 20091001

• Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder.

  Pharmacoepidemiology and drug safety 20091001

• Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia.

  Bioorganic & medicinal chemistry letters 20091001

• The synergistic interaction between morphine and maprotiline after intrathecal injection in rats.

  Anesthesia and analgesia 20091001

• Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy.

  Clinical trials (London, England) 20091001

• Recovering independent components from shifted data using fast independent component analysis and swarm intelligence.

  Applied spectroscopy 20091001

• [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani].

  L'Encephale 20091001

• A fatality due to cyproheptadine and citalopram.

  Journal of analytical toxicology 20091001

• Carbamazepine for serotonin reuptake inhibitor nonresponder case of obsessive compulsive disorder.

  Indian journal of medical sciences 20091001

• Drug fails to subdue repetitive behavior in children with autism spectrum disorders.

  The Harvard mental health letter 20091001

• Change in cognitive functioning following acute antidepressant treatment in late-life depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20091001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20091001

• Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20091001

• Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.

  Psychiatry research 20090930

• Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.

  Psychiatry research 20090930

• Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study.

  Psychiatry research 20090930

• Treatment effects of serotonergic and noradrenergic antidepressants on the intensity dependence of auditory ERP components in major depression.

  Neuroscience letters 20090929

• Effects of repeated citalopram treatment on kainic acid-induced neurogenesis in adult mouse hippocampus.

  Brain research 20090908

• Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder.

  Journal of psychopharmacology (Oxford, England) 20090901

• Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.

  Journal of psychopharmacology (Oxford, England) 20090901

• Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.

  Journal of psychopharmacology (Oxford, England) 20090901

• Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.

  Journal of affective disorders 20090901

• Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker.

  European journal of clinical pharmacology 20090901

• Serotonin affects transcranial direct current-induced neuroplasticity in humans.

  Biological psychiatry 20090901

• HMPAO SPECT in Parkinson's disease (PD) with major depression (MD) before and after antidepressant treatment.

  Journal of neurology 20090901

• A single nucleotide polymorphism in the human serotonin transporter introduces a new site for N-linked glycosylation.

  Neuropharmacology 20090901

• Subchronic SSRI administration reduces insula response during affective anticipation in healthy volunteers.

  The international journal of neuropsychopharmacology 20090901

• Serotonergic modulation of the trigeminocardiac reflex neurotransmission to cardiac vagal neurons in the nucleus ambiguus.

  Journal of neurophysiology 20090901

• Clinical and ECG effects of escitalopram overdose.

  Annals of emergency medicine 20090901

• Depressive disorders in stroke patients.

  Neuroscience and behavioral physiology 20090901

• Antidepressant medication use during breastfeeding.

  Clinical obstetrics and gynecology 20090901

• Use of the late-life function and disability instrument to assess disability in major depression.

  Journal of the American Geriatrics Society 20090901

• Adverse reactions to antidepressants.

  The British journal of psychiatry : the journal of mental science 20090901

• Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients.

  Pharmacogenetics and genomics 20090901

• Genetic studies of drug response and side effects in the STAR*D study, part 2.

  The Journal of clinical psychiatry 20090901

• Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?

  Journal of psychiatric practice 20090901

• The neurotrophic and neuroprotective effects of psychotropic agents.

  Dialogues in clinical neuroscience 20090901

• Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report.

  CNS spectrums 20090901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090901

• A case of galactorrhea associated with excitalopram.

  Psychiatry investigation 20090901

• Effects of an educational outreach campaign (IMPACT) on depression management delivered to general practitioners in one primary care trust.

  Mental health in family medicine 20090901

• The value of HMPAO SPECT in predicting treatment response to citalopram in patients with major depression.

  Psychiatry research 20090830

• Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress.

  Journal of neuroscience research 20090815

• Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse.

  European journal of pharmacology 20090815

• Two cases of herpes zoster, occurring 4 and 6 weeks after the initiation of citalopram treatment.

  Psychiatry research 20090815

• 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.

  Neuroreport 20090805

• Citalopram-associated central retinal vein occlusion.

  International ophthalmology 20090801

• Childhood narcolepsy with partial facial cataplexy: a diagnostic dilemma.

  Sleep medicine 20090801

• Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice.

  The international journal of neuropsychopharmacology 20090801

• Influence of sex and corticotropin-releasing factor pathways as determinants in serotonin sensitivity.

  Endocrinology 20090801

• Genetic predictors of response to antidepressants in the GENDEP project.

  The pharmacogenomics journal 20090801

• Serotonin modulation of cerebral glucose metabolism in depressed older adults.

  Biological psychiatry 20090801

• Reversible cerebral vasoconstriction syndrome: case report.

  The journal of headache and pain 20090801

• Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats.

  Psychopharmacology 20090801

• Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.

  Psychopharmacology 20090801

• Body temperature in patients with panic disorder treated with escitalopram.

  Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20090801

• Anterior cingulate cortical volumes and treatment remission of geriatric depression.

  International journal of geriatric psychiatry 20090801

• Antidepressants as hydrobromide salts: are they a cause for concern?

  Journal of clinical psychopharmacology 20090801

• Mean platelet volume in patients with major depression: effect of escitalopram treatment.

  Journal of clinical psychopharmacology 20090801

• Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study.

  Journal of clinical psychopharmacology 20090801

• Corticotropin-releasing factor, serotonin, and sex: keys to the castle of depressive illness.

  Endocrinology 20090801

• Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20090801

• Escitalopram modestly improves generalised anxiety disorder in older adults in treatment completers.

  Evidence-based mental health 20090801

• Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.

  Expert review of neurotherapeutics 20090801

• Fast separation of selective serotonin reuptake inhibitors antidepressants in plasma sample by nonaqueous capillary electrophoresis.

  Journal of chromatography. A 20090724

• [Turner-syndrome and psychosis: a case report and brief review of the literature].

  Psychiatrische Praxis 20090701

• Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice.

  The international journal of neuropsychopharmacology 20090701

• Pharmacological augmentation of motor recovery after stroke: antidepressants for non-depressed patients?

  Journal of neurology 20090701

• Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment.

  Clinical biochemistry 20090701

• A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients.

  Journal of neurology 20090701

• Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial.

  Head & neck 20090701

• Spatio-temporal clusters of new psychotropic medications among Michigan children insured by Medicaid.

  Pharmacoepidemiology and drug safety 20090701

• Reduced effectiveness of escitalopram in the forced swimming test is associated with increased serotonin clearance rate in food-restricted rats.

  The international journal of neuropsychopharmacology 20090701

• Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.

  Journal of the American Academy of Child and Adolescent Psychiatry 20090701

• Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients.

  The Journal of clinical psychiatry 20090701

• Validation of the sleep impact scale in patients with major depressive disorder and insomnia.

  Current medical research and opinion 20090701

• Antidepressants and sleep: a review.

  Perspectives in psychiatric care 20090701

• Sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities.

  The Annals of pharmacotherapy 20090701

• Moderation of antidepressant response by the serotonin transporter gene.

  The British journal of psychiatry : the journal of mental science 20090701

• Diagnosis and treatment of PTSD-related compulsive checking behaviors in veterans of the Iraq war: the influence of military context on the expression of PTSD symptoms.

  The American journal of psychiatry 20090701

• Initiating antidepressant therapy? Try these 2 drugs first.

  The Journal of family practice 20090701

• Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study.

  The Journal of clinical psychiatry 20090701

• Effects of bupropion augmentation in escitalopram-resistant patients with major depressive disorder: an open-label, naturalistic study.

  The Journal of clinical psychiatry 20090701

• Baseline neurocognitive profiles differentiate abstainers and non-abstainers in a cocaine clinical trial.

  Journal of addictive diseases 20090701

• Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.

  Progress in neuro-psychopharmacology & biological psychiatry 20090615

• Neuroimaging in anxiety disorders.

  Journal of neural transmission (Vienna, Austria : 1996) 20090601

• Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons.

  The international journal of neuropsychopharmacology 20090601

• Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder.

  Journal of psychiatric research 20090601

• Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090601

• Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090601

• How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database.

  Human psychopharmacology 20090601

• The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression.

  European journal of clinical pharmacology 20090601

• Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder.

  The American journal of psychiatry 20090601

• Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease.

  The Journal of clinical psychiatry 20090601

• Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.

  Journal of clinical psychopharmacology 20090601

• Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.

  Journal of clinical psychopharmacology 20090601

• Acute clozapine intoxication.

  Journal of clinical psychopharmacology 20090601

• The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration.

  Journal of neurochemistry 20090601

• Effect of a single dose of citalopram on amygdala response to emotional faces.

  The British journal of psychiatry : the journal of mental science 20090601

• Depression and cognitive complaints following mild traumatic brain injury.

  The American journal of psychiatry 20090601

• Citalopram treatment in children with autism spectrum disorders and high levels of repetitive behavior.

  Archives of general psychiatry 20090601

• Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

  Archives of general psychiatry 20090601

• Treatment of chronic hepatitis C in a slow responder: a case for extended therapy.

  Nature reviews. Gastroenterology & hepatology 20090601

• Escitalopram treatment of stereotypic movement disorder in an adolescent with mitochondrial disorder and mental retardation.

  Journal of child and adolescent psychopharmacology 20090601

• Acute dyskinesia and extrapyramidal disorder in a child after ingestion of escitalopram.

  Journal of child and adolescent psychopharmacology 20090601

• Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs.

  Journal of medical economics 20090601

• In thrombin stimulated human platelets Citalopram, Promethazine, Risperidone, and Ziprasidone, but not Diazepam, may exert their pharmacological effects also through intercalation in membrane phospholipids in a receptor-independent manner.

  Journal of chemical biology 20090601

• Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review.

  International journal of environmental research and public health 20090601

• Association study between BDNF gene polymorphisms and autism by three-dimensional gel-based microarray.

  International journal of molecular sciences 20090601

• Self-inflicted non-healing genital ulcer: a rare form of factitious disorder.

  Acta dermatovenerologica Alpina, Pannonica, et Adriatica 20090601

• [Mechanism of action of new generation antidepressants under development in Japan: focusing on dopamine neurotransmission].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20090601

• Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.

  CNS spectrums 20090601

• Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.

  Clinical therapeutics 20090601

• Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

  Clinical therapeutics 20090601

• Major depressive disorder preceding the onset of progressive supranuclear palsy.

  Psychiatry investigation 20090601

• Escitalopram treatment of generalized anxiety disorder in older adults.

  JAMA 20090520

• Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence.

  Psychiatry research 20090515

• Anhedonia and activity deficits in rats: impact of post-stroke depression.

  Journal of psychopharmacology (Oxford, England) 20090501

• What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

  The international journal of neuropsychopharmacology 20090501

• Blood pressure and white matter integrity in geriatric depression.

  Journal of affective disorders 20090501

• Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression.

  The international journal of neuropsychopharmacology 20090501

• Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis.

  Journal of psychiatric research 20090501

• Lack of CB1 receptor activity impairs serotonergic negative feedback.

  Journal of neurochemistry 20090501

• Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning.

  International clinical psychopharmacology 20090501

• Opening the white boxes: the licensing documentation of efficacy and safety of psychotropic medicines for children.

  Pharmacoepidemiology and drug safety 20090501

• Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.

  The American journal of psychiatry 20090501

• Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?

  International clinical psychopharmacology 20090501

• Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram.

  International clinical psychopharmacology 20090501

• Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area.

  Journal of psychiatry & neuroscience : JPN 20090501

• Placental transfer of SSRI and SNRI antidepressants and effects on the neonate.

  Pharmacopsychiatry 20090501

• A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.

  Contemporary clinical trials 20090501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090501

• Citalopram associated with complex visual hallucination: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20090430

• Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders.

  Brain research bulletin 20090429

• Differential behavioral and neurochemical effects of exercise, reboxetine and citalopram with the forced swim test.

  Life sciences 20090424

• 1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay.

  European journal of pharmacology 20090417

• Quantitative microdialysis using modified ultraslow microdialysis: direct rapid and reliable determination of free brain concentrations with the MetaQuant technique.

  Journal of neuroscience methods 20090415

• Sertraline versus other antidepressive agents for depression.

  The Cochrane database of systematic reviews 20090415

• Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.

  The Journal of biological chemistry 20090410

• SLC6A4 variation and citalopram response.

  American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20090405

• Influence of comedication on serum concentrations of aripiprazole and dehydroaripiprazole.

  Therapeutic drug monitoring 20090401

• The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.

  European archives of psychiatry and clinical neuroscience 20090401

• Superiority of escitalopram to paroxetine in the treatment of depression.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090401

• Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial.

  The Journal of clinical psychiatry 20090401

• Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.

  The American journal of psychiatry 20090401

• Interaction between clonidine and escitalopram.

  British journal of anaesthesia 20090401

• Treatment-resistant depression and mortality after acute coronary syndrome.

  The American journal of psychiatry 20090401

• Baseline severity of depression predicts antidepressant drug response relative to escitalopram.

  Expert opinion on pharmacotherapy 20090401

• Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20090401

• Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.

  European journal of pharmacology 20090401

• Duloxetine in the management of elderly patients with major depressive disorder: an analysis of published data.

  Expert opinion on pharmacotherapy 20090401

• Organic psychosis induced by ofloxacin and metronidazole.

  British journal of hospital medicine (London, England : 2005) 20090401

• Escitalopram in clinical practice in Greece: treatment response and tolerability in depressed patients.

  Expert opinion on pharmacotherapy 20090401

• Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review.

  Journal of the American Academy of Nurse Practitioners 20090401

• [Severe forms of depression: the efficacy of escitalopram].

  L'Encephale 20090401

• Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.

  CNS spectrums 20090401

• Attenuation of apparent new-onset ocular tics with successful treatment of PTSD.

  CNS spectrums 20090401

• Effects of escitalopram on anxiety and respiratory responses to carbon dioxide inhalation in subjects at high risk for panic disorder: a placebo-controlled, crossover study.

  Journal of clinical psychopharmacology 20090401

• High dose insulin in toxic cardiogenic shock.

  Clinical toxicology (Philadelphia, Pa.) 20090401

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090401

• [Higher probability of remission with escitalopram in comparison to citalopram].

  Lakartidningen 20090401

• US justice department sues company for off-label promotion of antidepressants for children.

  BMJ (Clinical research ed.) 20090325

• Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20090317

• The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test.

  Progress in neuro-psychopharmacology & biological psychiatry 20090317

• Incomplete financial disclosure in a study of escitalopram and problem-solving therapy for prevention of poststroke depression.

  JAMA 20090311

• Will tricyclic antidepressants make a comeback for depressed Parkinson disease patients?

  Neurology 20090310

• Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers.

  The international journal of neuropsychopharmacology 20090301

• Antidepressants influence somatostatin levels and receptor pharmacology in brain.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090301

• Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090301

• Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study.

  Psychopharmacology 20090301

• Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090301

• The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype.

  Journal of psychiatric research 20090301

• Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors.

  Journal of neurochemistry 20090301

• A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).

  European child & adolescent psychiatry 20090301

• Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20090301

• Enantioselective analysis of citalopram and escitalopram in postmortem blood together with genotyping for CYP2D6 and CYP2C19.

  Journal of analytical toxicology 20090301

• Antipsychotics and the elderly.

  The American journal of nursing 20090301

• Patients' depression treatment preferences and initiation, adherence, and outcome: a randomized primary care study.

  Psychiatric services (Washington, D.C.) 20090301

• Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.

  The British journal of psychiatry : the journal of mental science 20090301

• Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States.

  Clinical therapeutics 20090301

• Psychoactive medication and traffic safety.

  International journal of environmental research and public health 20090301

• [Escitalopram versus citalopram in true depression. Review of studies do not support clinically relevant differences of the effect].

  Lakartidningen 20090301

• Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

  Lancet (London, England) 20090227

• Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.

  The Journal of clinical psychiatry 20090210

• Escitalopram: an open-label study of bereavement-related depression and grief.

  Journal of affective disorders 20090201

• Sex differences in response to citalopram: a STAR*D report.

  Journal of psychiatric research 20090201

• A rapid and specific approach for direct measurement of donepezil concentration in human plasma by LC-MS/MS employing solid-phase extraction.

  Biomedical chromatography : BMC 20090201

• Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).

  Journal of psychiatric research 20090201

• Effects of acute citalopram on the expression of conditioned freezing in naive versus chronic citalopram-treated rats.

  Progress in neuro-psychopharmacology & biological psychiatry 20090201

• Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins.

  Synapse (New York, N.Y.) 20090201

• Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis.

  Progress in neuro-psychopharmacology & biological psychiatry 20090201

• VEGF serum levels in depressed patients during SSRI antidepressant treatment.

  Progress in neuro-psychopharmacology & biological psychiatry 20090201

• Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors.

  Pharmacogenetics and genomics 20090201

• Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database.

  Therapeutic drug monitoring 20090201

• An open study of aripiprazole and escitalopram for psychotic major depressive disorder.

  Journal of clinical psychopharmacology 20090201

• Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.

  Brain : a journal of neurology 20090201

• Citalopram intervention for hostility: results of a randomized clinical trial.

  Journal of consulting and clinical psychology 20090201

• Escitalopram and problem solving therapy reduce the incidence of post-stroke depression.

  Evidence-based mental health 20090201

• The effect of reporting methods for dosing times on the estimation of pharmacokinetic parameters of escitalopram.

  Journal of clinical pharmacology 20090201

• Memantine as an augmenting agent for severe pediatric OCD.

  The American journal of psychiatry 20090201

• Family history of depression and therapeutic outcome: findings from STAR*D.

  The Journal of clinical psychiatry 20090201

• Protective effects of antidepressants against chronic fatigue syndrome-induced behavioral changes and biochemical alterations.

  Fundamental & clinical pharmacology 20090201

• New pharmacotherapeutic approaches to obsessive-compulsive disorder.

  CNS spectrums 20090201

• Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes.

  Pediatric research 20090201

• Schizencephaly associated with bipolar II disorder.

  Singapore medical journal 20090201

• Real-World Data on SSRI Antidepressant Side Effects.

  Psychiatry (Edgmont (Pa. : Township)) 20090201

• Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy.

  Indian journal of pharmacology 20090201

• Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.

  Behavioural brain research 20090130

• Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.

  JAMA 20090121

• Bilateral ankle oedema in a patient taking escitalopram.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Pica responding to SSRI: an OCD spectrum disorder?

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• WFS1 gene as a putative biomarker for development of post-traumatic syndrome in an animal model.

  Molecular psychiatry 20090101

• Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.

  Journal of thrombosis and thrombolysis 20090101

• Use of specific serotonin reuptake inhibitors (SSRIs) (Sertraline or Citalopram) in the treatment of depression reduces the cardiovascular risk in the elderly: evidence from a Sicilian population >80 years recovered in the assisted sanitary residences (RSA).

  Archives of gerontology and geriatrics 20090101

• Glucocorticoid receptor antagonism augments fluoxetine-induced downregulation of the 5-HT transporter.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090101

• Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.

  Journal of psychiatric research 20090101

• Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats.

  Psychopharmacology 20090101

• Newer antidepressants for hot flashes--should their efficacy still be up for debate?

  Menopause (New York, N.Y.) 20090101

• Antidepressants alleviate the impact of reinforcer downshift.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090101

• Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography.

  Synapse (New York, N.Y.) 20090101

• Primary onset of bipolar disorder as rapid cycling after cessation of oral contraceptive.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.

  Drug and alcohol dependence 20090101

• Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.

  Neurochemistry international 20090101

• Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response.

  Pharmacogenetics and genomics 20090101

• Tales of bugs, delusions of parasitosis, and what to do.

  Clinics in dermatology 20090101

• Probable trimethoprim/sulfamethoxazole-induced higher-level gait disorder and nocturnal delirium in an elderly man.

  The Annals of pharmacotherapy 20090101

• Monitoring mouse serotonin transporter internalization in stem cell-derived serotonergic neurons by confocal laser scanning microscopy.

  Neurochemistry international 20090101

• Current considerations in the treatment of generalized anxiety disorder.

  CNS drugs 20090101

• Opposite effects of early maternal deprivation on neurogenesis in male versus female rats.

  PloS one 20090101

• The Pediatric Obsessive-Compulsive Disorder Treatment Study II: rationale, design and methods.

  Child and adolescent psychiatry and mental health 20090101

• Early symptom change prediction of remission in depression treatment.

  Psychopharmacology bulletin 20090101

• Escitalopram in the treatment of major depressive disorder: a meta-analysis.

  Current medical research and opinion 20090101

• [Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient].

  Enfermedades infecciosas y microbiologia clinica 20090101

• Sensitivity to change and predictive validity of the MOODS-SR questionnaire, last-month version.

  Psychotherapy and psychosomatics 20090101

• Citalopram enhances B cell numbers in a murine model of morphine-induced immunosuppression.

  Pain practice : the official journal of World Institute of Pain 20090101

• [Clinical efficacy of escitalopram in patients with ischemic heart disease and comorbid depression].

  Kardiologiia 20090101

• Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis.

  PloS one 20090101

• Diurnal mood variation in outpatients with major depressive disorder.

  Depression and anxiety 20090101

• Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approach.

  The American journal of drug and alcohol abuse 20090101

• Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD).

  Trials 20090101

• Parameters of the spectral analysis of the heart rate variability in treating depression.

  Medicina (Kaunas, Lithuania) 20090101

• Escitalopram versus other antidepressive agents for depression.

  The Cochrane database of systematic reviews 20090101

• Refractory generalized anxiety disorder.

  The Journal of clinical psychiatry 20090101

• What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia?

  Comprehensive psychiatry 20090101

• Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.

  Depression and anxiety 20090101

• Column liquid chromatography-ultraviolet and column liquid chromatography/mass spectrometry evaluation of stress degradation behavior of escitalopram oxalate.

  Journal of AOAC International 20090101

• Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief.

  Molecular pain 20090101

• Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.

  BMC emergency medicine 20090101

• Quality of life measurement in antidepressant trials. Is there an added value?

  Psychotherapy and psychosomatics 20090101

• Chronic citalopram treatment elevates serotonin synthesis in flinders sensitive and flinders resistant lines of rats, with no significant effect on Sprague-Dawley rats.

  Neurochemistry international 20090101

• Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA.

  Drug safety 20090101

• Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.

  Depression and anxiety 20090101

• Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants.

  BMC neuroscience 20090101

• Escitalopram reduces hot flashes in nondepressed menopausal women: A pilot study.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20090101

• Anxiety symptom severity and functional recovery or relapse.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20090101

• Depression in children and adolescents.

  BMJ clinical evidence 20090101

• Obsessive-compulsive disorder and related disorders: a comprehensive survey.

  Annals of general psychiatry 20090101

• Unstable prefrontal response to emotional conflict and activation of lower limbic structures and brainstem in remitted panic disorder.

  PloS one 20090101

• The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder.

  BMC psychiatry 20090101

• Factors Influencing Depression Endpoints Research (FINDER): baseline results of Italian patients with depression.

  Annals of general psychiatry 20090101

• Late life depression with cognitive impairment: evaluation and treatment.

  Clinical interventions in aging 20090101

• [Influence of citalopram selective serotonin reuptake inhibitor on circadian rhytms of excretory function of the kidneys].

  Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20090101

• Pharmacokinetics and bioequivalence study of escitalopram oxalate formulations after single-dose administration in healthy Chinese male volunteers.

  Arzneimittel-Forschung 20090101

• Duloxetine for the treatment of generalized anxiety disorder: a review.

  Neuropsychiatric disease and treatment 20090101

• A systematic review of quality of life and weight gain-related issues in patients treated for severe and persistent mental disorders: focus on aripiprazole.

  Neuropsychiatric disease and treatment 20090101

• Desvenlafaxine in the treatment of major depressive disorder.

  Neuropsychiatric disease and treatment 20090101

• Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group).

  Neuropsychiatric disease and treatment 20090101

• Management of obsessive-compulsive disorder with fluvoxamine extended release.

  Neuropsychiatric disease and treatment 20090101

• New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists.

  Neuropsychiatric disease and treatment 20090101

• Citalopram-induced bleeding due to severe thrombocytopenia.

  Psychosomatics 20090101

• [Major depressive disorder, antidepressants and sexual dysfunction].

  Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20090101

• Income and attrition in the treatment of depression: a STAR*D report.

  Depression and anxiety 20090101

• [Citalopram and syndrome of inappropriate secretion of antidiuretic hormone].

  Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20090101

• Hypomania induced by escitalopram: 2 case reports.

  Psychopharmacology bulletin 20090101

• Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder.

  BMC geriatrics 20090101

• Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression.

  Neuropsychiatric disease and treatment 20090101

• Micelle enhanced fluorimetric and thin layer chromatography densitometric methods for the determination of (+/-) citalopram and its S-enantiomer escitalopram.

  Analytical chemistry insights 20090101

• Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders.

  Clinical neuropharmacology 20090101

• Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression.

  Trials 20090101

• Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.

  BMJ (Clinical research ed.) 20090101

• Chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain.

  PloS one 20090101

• The impact of nonclinical factors on care use for patients with depression: a STAR*D report.

  CNS neuroscience & therapeutics 20090101

• [Clinical manifestation of confusion and hallucinations caused by an interaction between rasagiline and escitalopram].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101

• Brain-derived neurotrophic factor: role in depression and suicide.

  Neuropsychiatric disease and treatment 20090101

• Sheehan Suicidality Tracking Scale (Sheehan-STS): Preliminary Results from a Multicenter Clinical Trial in Generalized Anxiety Disorder.

  Psychiatry (Edgmont (Pa. : Township)) 20090101

• Antidepressant drugs in cancer patients: the case of escitalopram.

  The journal of supportive oncology 20090101

• Can bupropion unmask psychosis.

  Indian journal of psychiatry 20090101

• More questions than answers! Clinical dilemmas in psychopharmacology in pregnancy and lactation.

  Indian journal of psychiatry 20090101

• Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.

  Neuropsychiatric disease and treatment 20090101

• [Zolpidem dependence and withdrawal seizure].

  Revue medicale de Liege 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20090101

• The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.

  Depression and anxiety 20090101

• Standardized natural product cannabis in pain management and observations at a Canadian compassion society: a case report.

  Cases journal 20090101

• Twenty years of dysuria in a patient with Addison's disease: a case report.

  Cases journal 20090101

• Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.

  BMC medicine 20090101

• Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias.

  Clinical interventions in aging 20090101

• Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women.

  Neuro endocrinology letters 20090101

• Serotonin transporter 5-HTTLPR polymorphism and response to citalopram in terminally ill cancer patients: report of twenty-one cases.

  Tumori 20090101

• Postgraduate corner: Continuing medical education: Psychopharmacology.

  Indian journal of psychiatry 20090101

• Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Update on partial response in depression.

  The Journal of clinical psychiatry 20090101

• Algorithms for the assessment and management of insomnia in primary care.

  Patient preference and adherence 20090101

• Predictors of premature discontinuation of treatment in multiple disease states.

  Patient preference and adherence 20090101

• Evidence for anomalous network connectivity during working memory encoding in schizophrenia: an ICA based analysis.

  PloS one 20090101

• Adjunctive low-dose amisulpride in motor conversion disorder.

  Clinical neuropharmacology 20090101

• Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability.

  Therapeutics and clinical risk management 20090101

• Venlafaxine-induced psychotic symptoms.

  Indian journal of psychiatry 20090101

• Amoxapine-induced tardive dyskinesia.

  Indian journal of psychiatry 20090101

• Diagnostic crossover from obesity to atypical anorexia nervosa - a case report.

  Obesity facts 20090101

• Tomophobia, the phobic fear caused by an invasive medical procedure - an emerging anxiety disorder: a case report.

  Journal of medical case reports 20090101

• Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality.

  Cardiology research and practice 20090101

• Radio electric treatment vs. Es-Citalopram in the treatment of panic disorders associated with major depression: an open-label, naturalistic study.

  Acupuncture & electro-therapeutics research 20090101

• Spectrophotometric method for simultaneous estimation of escitalopram oxalate and clonazepam in tablet dosage form.

  Indian journal of pharmaceutical sciences 20090101

• Experiencing mindfulness meditation-a client narrative perspective.

  International journal of qualitative studies on health and well-being 20090101

• Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy.

  Core evidence 20090101

• Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder.

  International journal of women's health 20090101

• Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression-An Animal Model Study.

  Advances in pharmacological sciences 20090101

• Duloxetine for the management of fibromyalgia syndrome.

  Journal of pain research 20090101

• Olanzapine induced tardive dystonia in case of adolescent bipolar disorder.

  Journal of pediatric neurosciences 20090101

• Depression in acromegaly treated with escitalopram and cognitive therapy.

  Indian journal of psychological medicine 20090101

• Citalopram induced torsade de pointes, a rare life threatening side effect.

  International journal of cardiology 20081217

• No effect of six weeks of treatment with escitalopram on mood in healthy volunteers--irrespective of genotype for the promoter of the serotonin transporter.

  Psychiatry research 20081215

• Interaction between serotonin 5-HT1A receptors and beta-endorphins modulates antidepressant response.

  Progress in neuro-psychopharmacology & biological psychiatry 20081212

• [Hepatotoxicity related to escitalopram].

  Medicina clinica 20081206

• Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081201

• Trends in antidepressant use in the older population: results from the LASA-study over a period of 10 years.

  Journal of affective disorders 20081201

• Acute 5-HT reuptake blockade potentiates human amygdala reactivity.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081201

• Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081201

• Housing conditions modulate escitalopram effects on antidepressive-like behaviour and brain neurochemistry.

  The international journal of neuropsychopharmacology 20081201

• Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice.

  The international journal of neuropsychopharmacology 20081201

• The safety of the electroconvulsive therapy-escitalopram combination.

  The journal of ECT 20081201

• Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects.

  European journal of clinical pharmacology 20081201

• Hydroxychloroquine-induced hyperpigmentation: the staining pattern.

  Journal of cutaneous pathology 20081201

• Kinetic and thermodynamic assessment of binding of serotonin transporter inhibitors.

  The Journal of pharmacology and experimental therapeutics 20081201

• Depressant-like effects of parthenolide in a rodent behavioural antidepressant test battery.

  The Journal of pharmacy and pharmacology 20081201

• Prioritizing future research on off-label prescribing: results of a quantitative evaluation.

  Pharmacotherapy 20081201

• Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.

  The Journal of clinical psychiatry 20081201

• Predictive factors for generalized seizures after deliberate citalopram overdose.

  British journal of clinical pharmacology 20081201

• Treatment strategies to improve and sustain remission in major depressive disorder.

  Dialogues in clinical neuroscience 20081201

• Cellular and molecular mechanisms in the long-term action of antidepressants.

  Dialogues in clinical neuroscience 20081201

• Toward achieving optimal response: understanding and managing antidepressant side effects.

  Dialogues in clinical neuroscience 20081201

• Incomplete response in late-life depression: getting to remission.

  Dialogues in clinical neuroscience 20081201

• Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.

  Dialogues in clinical neuroscience 20081201

• Influence of selective inhibitors of phosphodiesterase 3 and 4 on cough and airway reactivity.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20081201

• Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.

  Current neuropharmacology 20081201

• Triple reuptake inhibitors: the next generation of antidepressants.

  Current neuropharmacology 20081201

• Platelet serotonin uptake in drug-naïve depressive patients before and after treatment with citalopram.

  Psychiatry research 20081130

• Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians.

  Annals of internal medicine 20081118

• Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

  Annals of internal medicine 20081118

• Apparent seizure and atrial fibrillation associated with paliperidone.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081115

• Serotonin toxicity precipitated by concomitant use of citalopram and methylene blue.

  The Medical journal of Australia 20081103

• An open-label study of citalopram for major depression following traumatic brain injury.

  Journal of psychopharmacology (Oxford, England) 20081101

• Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081101

• Restless legs syndrome as side effect of second generation antidepressants.

  Journal of psychiatric research 20081101

• Sleep deprivation disrupts prepulse inhibition of the startle reflex: reversal by antipsychotic drugs.

  The international journal of neuropsychopharmacology 20081101

• Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action.

  Journal of molecular neuroscience : MN 20081101

• SK3 K+ channel-deficient mice have enhanced dopamine and serotonin release and altered emotional behaviors.

  Genes, brain, and behavior 20081101

• Escitalopram increases cortical nitric oxide synthase (NOS) in rat brain during ethanol withdrawal.

  Nitric oxide : biology and chemistry 20081101

• Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder.

  International journal of clinical practice 20081101

• The STAR*D trial: the 300 lb gorilla is in the room, but does it block all the light?

  Evidence-based mental health 20081101

• Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D.

  Psychiatric services (Washington, D.C.) 20081101

• Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.

  Journal of psychiatry & neuroscience : JPN 20081101

• Acute voluntary intoxication with selective serotonin reuptake inhibitors during the third trimester of pregnancy: therapeutic management of mother and fetus.

  American journal of obstetrics and gynecology 20081101

• Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in rats.

  Canadian journal of physiology and pharmacology 20081101

• [Determination of plasma escitalopram with liquid chromatography-mass spectrometry].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20081101

• Effectiveness of long-term augmentation with citalopram to clomipramine in treatment-resistant OCD patients.

  CNS spectrums 20081101

• [Citalopram].

  Revue de l'infirmiere 20081101

• Possible role of citalopram and desipramine against sleep deprivation-induced anxiety like-behavior alterations and oxidative damage in mice.

  Indian journal of experimental biology 20081101

• Serotonin syndrome in a patient taking Lexapro and Flexeril: a case report.

  The American journal of emergency medicine 20081101

• Stimulus properties of venlafaxine in a conditioned taste aversion procedure.

  European journal of pharmacology 20081031

• Effects of South African traditional medicine in animal models for depression.

  Journal of ethnopharmacology 20081028

• Acute citalopram has different effects on regional 5-HT synthesis in FSL, FRL, and SDP rats: an autoradiographic evaluation.

  Brain research bulletin 20081022

• Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial.

  Pain 20081015

• Escitalopram, problem-solving therapy, and poststroke depression.

  JAMA 20081015

• Escitalopram, problem-solving therapy, and poststroke depression.

  JAMA 20081015

• Escitalopram, problem-solving therapy, and poststroke depression.

  JAMA 20081015

• Escitalopram, problem-solving therapy, and poststroke depression.

  JAMA 20081015

• Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission.

  European journal of pharmacology 20081010

• The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study.

  The journal of sexual medicine 20081001

• Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats.

  Pharmacology, biochemistry, and behavior 20081001

• Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants.

  Current medical research and opinion 20081001

• Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.

  Child and adolescent psychiatric clinics of North America 20081001

• Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response.

  Pharmacogenetics and genomics 20081001

• [Familial Alzheimer's disease with presenilin 2 N141I mutation. A case report].

  Fortschritte der Neurologie-Psychiatrie 20081001

• Effect of different challenge doses after repeated citalopram treatment on extracellular serotonin level in the medial prefrontal cortex: in vivo microdialysis study.

  Psychiatry and clinical neurosciences 20081001

• Remission of maternal depression: relations to family functioning and youth internalizing and externalizing symptoms.

  Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53 20081001

• [Sleep spindles in post traumatic stress disorder: significant importance of selective serotonin reuptake inhibitors].

  Harefuah 20081001

• Understanding of poisonings and over-doses.

  Human & experimental toxicology 20081001

• Augmentation treatment in major depressive disorder: focus on aripiprazole.

  Neuropsychiatric disease and treatment 20081001

• Errorless learning and spaced retrieval techniques to relearn instrumental activities of daily living in mild Alzheimer's disease: A case report study.

  Neuropsychiatric disease and treatment 20081001

• Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis.

  The Journal of clinical psychiatry 20081001

• Neuropharmacology.

  Indian journal of pharmacology 20081001

• Pharmacogenomics.

  Indian journal of pharmacology 20081001

• Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice.

  European journal of pharmacology 20080928

• Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice.

  British journal of pharmacology 20080901

• Munchausen's syndrome: a rare self-mutilation syndrome.

  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20080901

• Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population.

  Current medical research and opinion 20080901

• Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.

  International clinical psychopharmacology 20080901

• Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation.

  Pharmacotherapy 20080901

• Choreatic symptoms during and after treatment with paliperidone and escitalopram.

  Pharmacopsychiatry 20080901

• [Case of the month. A malignant brain tumor presenting with depression and hallucinations].

  Laeknabladid 20080901

• Effect of citalopram in treating hypersexuality in an Alzheimer's disease case.

  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20080901

• An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.

  Journal of psychiatric practice 20080901

• Role of patient experience in antidepressant adherence: a retrospective data analysis.

  Clinical therapeutics 20080901

• [Efficacy and tolerability of escitalopram in anxiety disorders: a review].

  L'Encephale 20080901

• Neonatal exposure to citalopram, a serotonin selective reuptake inhibitor, programs a delay in the reflex ontogeny in rats.

  Arquivos de neuro-psiquiatria 20080901

• Effects of different antidepressant treatments on the core of depression.

  Dialogues in clinical neuroscience 20080901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080901

• Dextromethorphan-induced serotonin syndrome.

  Clinical toxicology (Philadelphia, Pa.) 20080901

• Triple reuptake inhibitors: a premise and promise.

  Psychiatry investigation 20080901

• Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response.

  Psychiatry investigation 20080901

• Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study.

  Neuroscience letters 20080829

• Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram.

  British journal of cancer 20080819

• Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus.

  Pharmacology, biochemistry, and behavior 20080801

• Escitalopram photo-induced erythroderma.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20080801

• Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20080801

• Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.

  Psychopharmacology 20080801

• Proteomic analysis of phospholipidosis in citalopram treated U937 cells--support for the cholesterol biosynthesis hypothesis.

  Toxicology in vitro : an international journal published in association with BIBRA 20080801

• The impact of analytic method on interpretation of outcomes in longitudinal clinical trials.

  International journal of clinical practice 20080801

• Abnormal temporal difference reward-learning signals in major depression.

  Brain : a journal of neurology 20080801

• Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study.

  Journal of clinical psychopharmacology 20080801

• Quantification of citalopram or escitalopram and their demethylated metabolites in neonatal hair samples by liquid chromatography-tandem mass spectrometry.

  Therapeutic drug monitoring 20080801

• Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.

  Archives of general psychiatry 20080801

• Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.

  The Journal of clinical psychiatry 20080801

• Renal failure in a depressed adolescent on escitalopram.

  Journal of child and adolescent psychopharmacology 20080801

• Pharmacotherapy of panic disorder.

  Neuropsychiatric disease and treatment 20080801

• Severe hypoglycaemia in citalopram overdose.

  European journal of emergency medicine : official journal of the European Society for Emergency Medicine 20080801

• Medication and talk therapy help prevent depression after a stroke. Antidepressants and problem-solving therapy can prevent or delay the onset of post-stroke depression.

  DukeMedicine healthnews 20080801

• [Genomical and metabolomical abnormalities in Alzheimer disease and in experimental models].

  Ideggyogyaszati szemle 20080730

• Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.

  European journal of pharmacology 20080728

• Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.

  European journal of pharmacology 20080728

• Tablet residues in stomach content found by routine post-mortem CT.

  Forensic science international 20080718

• Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy.

  Journal of psychopharmacology (Oxford, England) 20080701

• Treating dexamethasone-induced mood disorders in children with leukemia.

  Pediatric blood & cancer 20080701

• [Serotonin syndrome as a result of escitalopram and cyclosporin combination in an 84-year-old woman].

  La Revue de medecine interne 20080701

• CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy.

  Contemporary clinical trials 20080701

• Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia.

  Pharmacoepidemiology and drug safety 20080701

• Treatment of auditory hallucinations by combining high-frequency repetitive transcranial magnetic stimulation and functional magnetic resonance imaging.

  Schizophrenia research 20080701

• Anticholinergic activity of 107 medications commonly used by older adults.

  Journal of the American Geriatrics Society 20080701

• Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials.

  International clinical psychopharmacology 20080701

• Short-term intravenous citalopram augmentation in partial/nonresponders with major depression: a randomized placebo-controlled study.

  International clinical psychopharmacology 20080701

• Effect of activated charcoal on citalopram-induced QT prolongation.

  Annals of emergency medicine 20080701

• Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines.

  The Canadian journal of cardiology 20080701

• Sequenced Treatment Alternatives to Relieve Depression (STAR*D): lessons learned.

  The Journal of clinical psychiatry 20080701

• Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

  Clinical therapeutics 20080701

• The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080701

• The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.

  Biological psychiatry 20080615

• Metabolism in adipose tissue in response to citalopram and trimipramine treatment--an in situ microdialysis study.

  Journal of psychiatric research 20080601

• Divergent effects of increased serotonergic activity on psychophysiological parameters of human attention.

  The international journal of neuropsychopharmacology 20080601

• A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression.

  International journal of geriatric psychiatry 20080601

• Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20080601

• Monoaminergic compensation in the neuropeptide Y deficient mouse brain.

  Neuropeptides 20080601

• Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.

  Pharmacoepidemiology and drug safety 20080601

• Antidepressant therapy in post-stroke depression.

  Expert opinion on pharmacotherapy 20080601

• Acute pregabalin reversal of citalopram-induced sexual dysfunction in generalized anxiety disorder.

  Journal of clinical psychopharmacology 20080601

• Emergence of electric shock-like sensations on escitalopram discontinuation.

  Journal of clinical psychopharmacology 20080601

• Citalopram-associated spontaneous ejaculations.

  Journal of clinical psychopharmacology 20080601

• Isolation and characterization of degradation products of citalopram and process-related impurities using RP-HPLC.

  Journal of separation science 20080601

• Clinical toxicology of citalopram after acute intoxication with the sole drug or in combination with other drugs: overview of 26 cases.

  Therapeutic drug monitoring 20080601

• [Escitalopram versus serotonin reuptake inhibitors].

  L'Encephale 20080601

• Differential treatment response, neuroinflammation, and psychosis associated with chromosome deletion.

  CNS spectrums 20080601

• Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy.

  CNS spectrums 20080601

• Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20080601

• Impact of close family members on older adults' early response to depression treatment.

  Psychology and aging 20080601

• Prolonged QTc interval in a 14-year-old girl with escitalopram overdose.

  Journal of child and adolescent psychopharmacology 20080601

• A case of a patient with both chorea and restless legs syndrome.

  Journal of Korean medical science 20080601

• Adverse effects of propafenone after long-term therapy with the addition of citalopram.

  The American journal of geriatric pharmacotherapy 20080601

• [Is there a preferable SSRI preparation when it comes to sexual adverse effects?].

  Lakartidningen 20080601

• Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.

  Clinical interventions in aging 20080601

• [Revisiting pharmacological actions of antidepressants: the example of escitalopram].

  L'Encephale 20080601

• [The place of escitalopram in the severe depressive episodes].

  L'Encephale 20080601

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080601

• Depletion of serotonin decreases the effects of the kappa-opioid receptor agonist U-69593 on cocaine-stimulated activity.

  European journal of pharmacology 20080531

• Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in conditioned fear stress in the rat.

  European journal of pharmacology 20080531

• Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial.

  JAMA 20080528

• From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.

  Journal of medicinal chemistry 20080522

• Hippocampal neurogenesis and behavioural studies on adult ischemic rat response to chronic mild stress.

  Behavioural brain research 20080516

• Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression model.

  Neuroscience letters 20080516

• Serotonergic mediation of the antidepressant-like effect of the green leaves odor in mice.

  Neuroscience letters 20080509

• Antidepressive therapy with escitalopram improves mood, cognitive symptoms, and identity memory for angry faces in elderly depressed patients.

  The international journal of neuropsychopharmacology 20080501

• Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.

  Biological psychiatry 20080501

• Caffeine consumption, sleep, and affect in the natural environments of depressed youth and healthy controls.

  Journal of pediatric psychology 20080501

• Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.

  Journal of affective disorders 20080501

• Regulation of the human serotonin transporter mediated by long-term action of serotonin in Caco-2 cells.

  Acta physiologica (Oxford, England) 20080501

• Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regions.

  Psychopharmacology 20080501

• Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.

  Journal of general internal medicine 20080501

• Chronic intermittent nicotine treatment dose-dependently alters serotonergic neurons response to citalopram in the rat.

  Pharmacology, biochemistry, and behavior 20080501

• Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.

  Psychopharmacology 20080501

• The clinical relevance of changes in the Montgomery-Asberg Depression Rating Scale using the minimum clinically important difference approach.

  Current medical research and opinion 20080501

• [Treatment of generalized anxiety disorders].

  Presse medicale (Paris, France : 1983) 20080501

• Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action.

  Neuropharmacology 20080501

• Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

  International clinical psychopharmacology 20080501

• Efficacy and tolerability of second-generation antidepressants in social anxiety disorder.

  International clinical psychopharmacology 20080501

• Cost-effectiveness of escitalopram for generalized anxiety disorder in Canada.

  Current medical research and opinion 20080501

• Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.

  Obstetrics and gynecology 20080501

• Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.

  Archives of general psychiatry 20080501

• A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer.

  Archives of otolaryngology--head & neck surgery 20080501

• Use of escitalopram in psychogenic excoriation.

  The Australian and New Zealand journal of psychiatry 20080501

• The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20080501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080501

• Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.

  Movement disorders : official journal of the Movement Disorder Society 20080430

• Implementation and performance evaluation of a database of chemical formulas for the screening of pharmaco/toxicologically relevant compounds in biological samples using electrospray ionization-time-of-flight mass spectrometry.

  Analytical chemistry 20080415

• Development and validation of a capillary electrophoresis method for the simultaneous determination of impurities of escitalopram including the R-enantiomer.

  Journal of pharmaceutical and biomedical analysis 20080414

• Rats with high or low sociability are differently affected by chronic variable stress.

  Neuroscience 20080409

• Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20080402

• Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080401

• Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080401

• Effects of anti-depressants on olfactory sensitivity in mice.

  Progress in neuro-psychopharmacology & biological psychiatry 20080401

• Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study.

  Gut 20080401

• Qualitative changes in symptomatology as an effect of treatment with escitalopram in generalized anxiety disorder and major depressive disorder.

  European archives of psychiatry and clinical neuroscience 20080401

• The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram.

  Psychopharmacology 20080401

• Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression.

  Psychopharmacology 20080401

• An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline.

  Human psychopharmacology 20080401

• Sustained attention and serotonin: a pharmaco-fMRI study.

  Human psychopharmacology 20080401

• A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder.

  Current medical research and opinion 20080401

• The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.

  Journal of clinical psychopharmacology 20080401

• Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder.

  Journal of clinical psychopharmacology 20080401

• Drug-induced liver disease related to citalopram.

  Journal of clinical psychopharmacology 20080401

• Escitalopram for the treatment of major depression and anxiety disorders.

  Expert review of neurotherapeutics 20080401

• [Escitalopram, labial pigmentation and lichenoid eruption].

  Annales de dermatologie et de venereologie 20080401

• Changes in antidepressant metabolism and dosing across pregnancy and early postpartum.

  The Journal of clinical psychiatry 20080401

• An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients.

  Pharmacological research 20080401

• Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia.

  Sleep 20080401

• Post-traumatic stress disorder and its treatment in children and adolescents.

  Current psychiatry reports 20080401

• Effect of 17beta-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats.

  Neuropsychiatric disease and treatment 20080401

• Differential regulation of serotonin-1A receptor-stimulated [35S]GTP gamma S binding in the dorsal raphe nucleus by citalopram and escitalopram.

  European journal of pharmacology 20080331

• Micellar electrokinetic chromatographic method for the determination of letrozole, citalopram and their metabolites in human urine.

  Journal of chromatography. A 20080328

• The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats.

  European journal of pharmacology 20080317

• Effect of pharmacological treatment on temperament and character in panic disorder.

  Psychiatry research 20080315

• Liquid-phase microextraction with porous hollow fibers, a miniaturized and highly flexible format for liquid-liquid extraction.

  Journal of chromatography. A 20080314

• Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatography.

  Journal of pharmaceutical and biomedical analysis 20080313

• Modified solvent microextraction with back extraction combined with liquid chromatography-fluorescence detection for the determination of citalopram in human plasma.

  Analytica chimica acta 20080310

• The specificity of neuropsychological impairment in predicting antidepressant non-response in the very old depressed.

  International journal of geriatric psychiatry 20080301

• The effects of increased serotonergic activity on human sensory gating and its neural generators.

  Psychopharmacology 20080301

• Identification of antidepressant drug leads through the evaluation of marine natural products with neuropsychiatric pharmacophores.

  Pharmacology, biochemistry, and behavior 20080301

• Escitalopram effects on insula and amygdala BOLD activation during emotional processing.

  Psychopharmacology 20080301

• Stereoselective determination of demethyl- and didemethyl-citalopram in rat plasma and brain tissue by liquid chromatography with fluorescence detection using precolumn derivatization.

  Biomedical chromatography : BMC 20080301

• The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment.

  Neuropharmacology 20080301

• Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

  The American journal of psychiatry 20080301

• Escitalopram in specific phobia: results of a placebo-controlled pilot trial.

  Journal of psychopharmacology (Oxford, England) 20080301

• Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze.

  Journal of psychopharmacology (Oxford, England) 20080301

• Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.

  The Journal of clinical psychiatry 20080301

• MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.

  Journal of psychopharmacology (Oxford, England) 20080301

• Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.

  Pharmacopsychiatry 20080301

• Citalopram neuropharmacological challenge in alcohol-dependent patients and controls: pharmacogenetic, endocrine and psychobehavioral results.

  Pharmacopsychiatry 20080301

• Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase.

  The Journal of clinical psychiatry 20080301

• Anxious depression and response to treatment.

  The American journal of psychiatry 20080301

• Escitalopram in the treatment of obsessive-compulsive disorder.

  Expert review of neurotherapeutics 20080301

• Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.

  The Journal of clinical psychiatry 20080301

• Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery.

  European journal of physical and rehabilitation medicine 20080301

• Quetiapine treatment for mania secondary to brain injury in 2 patients.

  The Journal of clinical psychiatry 20080301

• Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalopram and ondansetron use.

  Pediatric annals 20080301

• Citalopram in the treatment of women with chronic pelvic pain: an open-label trial.

  The Journal of reproductive medicine 20080301

• A flexible nonlinear feedback system that captures diverse patterns of adaptation and rebound.

  The AAPS journal 20080301

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080301

• Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.

  JAMA 20080227

• Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.

  Biological psychiatry 20080215

• Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20080215

• Regulation of extracellular serotonin levels and brain-derived neurotrophic factor in rats with high and low exploratory activity.

  Brain research 20080215

• Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype.

  The international journal of neuropsychopharmacology 20080201

• Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients.

  Clinical pharmacology and therapeutics 20080201

• Long-term citalopram maintenance in mice: selective reduction of alcohol-heightened aggression.

  Psychopharmacology 20080201

• The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatment.

  Neuropharmacology 20080201

• Microstructural white matter abnormalities and remission of geriatric depression.

  The American journal of psychiatry 20080201

• High-dose escitalopram treatment in patients with obsessive-compulsive disorder: a naturalistic case series.

  Journal of clinical psychopharmacology 20080201

• Restless legs syndrome induced by escitalopram: case report and review of the literature.

  Pharmacotherapy 20080201

• Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders.

  International review of psychiatry (Abingdon, England) 20080201

• Magnetic resonance imaging and late-life depression: potential biomarkers in the era of personalized medicine.

  The American journal of psychiatry 20080201

• Escitalopram-associated mania in a child.

  Journal of child and adolescent psychopharmacology 20080201

• A review of ramelteon in the treatment of sleep disorders.

  Neuropsychiatric disease and treatment 20080201

• Pharmacological management of panic disorder.

  Neuropsychiatric disease and treatment 20080201

• Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.

  Depression and anxiety 20080101

• Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080101

• Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial.

  Digestive diseases and sciences 20080101

• Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.

  Pharmacy world & science : PWS 20080101

• The effects of the dopamine and serotonin transporter polymorphisms on clinical features and treatment response in geriatric depression: a pilot study.

  International journal of geriatric psychiatry 20080101

• Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20080101

• Rat behavior after chronic variable stress and partial lesioning of 5-HT-ergic neurotransmission: effects of citalopram.

  Progress in neuro-psychopharmacology & biological psychiatry 20080101

• An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study.

  Neurochemistry international 20080101

• Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20080101

• Serotonergic anti-depressants and ethanol withdrawal syndrome: a review.

  Alcohol and alcoholism (Oxford, Oxfordshire) 20080101

• Glycine residues G338 and G342 are important determinants for serotonin transporter dimerisation and cell surface expression.

  Neurochemistry international 20080101

• Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.

  Depression and anxiety 20080101

• High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial.

  Human psychopharmacology 20080101

• A surveillance study of escitalopram treatment of depressed patients.

  Expert opinion on pharmacotherapy 20080101

• Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial.

  International clinical psychopharmacology 20080101

• High-dose escitalopram for the treatment of obsessive-compulsive disorder.

  International clinical psychopharmacology 20080101

• Escitalopram in the acute treatment of depressed patients aged 60 years or older.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20080101

• Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20080101

• Use of medication for the management of behavior problems among adults with intellectual disabilities: a clinicians' consensus survey.

  American journal of mental retardation : AJMR 20080101

• Citalopram improves dexterity in chronic stroke patients.

  Neurorehabilitation and neural repair 20080101

• The STAR*D study: treating depression in the real world.

  Cleveland Clinic journal of medicine 20080101

• Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan.

  Malaria journal 20080101

• Cotard's syndrome and delayed diagnosis in Kashmir, India.

  International journal of mental health systems 20080101

• Relevant issues in the monitoring and the toxicology of antidepressants.

  Critical reviews in clinical laboratory sciences 20080101

• Histamine uptake into human vascular endothelial cells and influence of three different antidepressant drugs.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20080101

• Escitalopram regulates expression of TRH and TRH-like peptides in rat brain and peripheral tissues.

  Neuroendocrinology 20080101

• A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder.

  Psychopharmacology bulletin 20080101

• Bupropion: a review of its use in the management of major depressive disorder.

  Drugs 20080101

• Spectrophotometric and reversed-phase high-performance liquid chromatographic methods for simultaneous determination of escitalopram oxalate and clonazepam in combined tablet dosage form.

  Journal of AOAC International 20080101

• Development and validation of column high-performance liquid chromatographic and ultraviolet spectrophotometric methods for citalopram in tablets.

  Journal of AOAC International 20080101

• [Neuropsychiatric symptoms in Sotos syndrome. Case report and review of the literature].

  Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20080101

• Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample.

  PloS one 20080101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20080101

• [Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101

• Comparison of sertraline and citalopram for treatment of premature ejaculation.

  Urology journal 20080101

• Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?

  Philosophy, ethics, and humanities in medicine : PEHM 20080101

• [Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

  L'Encephale 20080101

• Spotlight on bupropion in major depressive disorder.

  CNS drugs 20080101

• Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussion.

  General hospital psychiatry 20080101

• Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.

  PloS one 20080101

• An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features.

  Primary care companion to the Journal of clinical psychiatry 20080101

• The precipitation of mania by citalopram in a patient with interferon-induced depression.

  Psychosomatics 20080101

• Serotonergic antidepressants and linezolid: a retrospective chart review and presentation of cases.

  International journal of psychiatry in medicine 20080101

• [Experimental study of the effects of citalopram, olanzapine, and their combinations in tests for antipsychotic, antidepressant and anxiolytic activities of drugs].

  Eksperimental'naia i klinicheskaia farmakologiia 20080101

• Are SNRIs more effective than SSRIs? A review of the current state of the controversy.

  Psychopharmacology bulletin 20080101

• Remission of migraine attacks in a patient with depression who is taking pregabalin.

  Clinical neuropharmacology 20080101

• Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants.

  Neuropsychobiology 20080101

• Clinicians' views on clinical examination and treatment of children and adolescents with obsessive-compulsive disorder (OCD). A Danish national survey study.

  Nordic journal of psychiatry 20080101

• Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use.

  PloS one 20080101

• Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon Calcitonin.

  BMC clinical pharmacology 20080101

• Antidepressant treatment of caregivers of children with asthma.

  Psychosomatics 20080101

• Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication.

  Substance abuse treatment, prevention, and policy 20080101

• Use of escitalopram during pregnancy: navigating towards international guidelines and the real world.

  Clinical drug investigation 20080101

• Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.

  CNS drugs 20080101

• Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.

  PharmacoEconomics 20080101

• Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study.

  Pharmacological research 20080101

• Life-threatening overdose with lamotrigine, citalopram, and chlorpheniramine.

  Journal of postgraduate medicine 20080101

• [Sexsomnia during treatment with a selective serotonin reuptake inhibitor].

  Tijdschrift voor psychiatrie 20080101

• Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial.

  Depression and anxiety 20080101

• Clinical and neurophysiological study of peroneal nerve mononeuropathy after substantial weight loss in patients suffering from major depressive and schizophrenic disorder: Suggestions on patients' management.

  Journal of brachial plexus and peripheral nerve injury 20080101

• Remission in depression--is it a realistic goal?

  Nordic journal of psychiatry 20080101

• Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective.

  Child and adolescent psychiatry and mental health 20080101

• Successful use of clozapine with immunosuppressive therapy in a renal-transplant patient.

  Psychosomatics 20080101

• Bioequivalence of two commercial preparations of escitalopram oxalate/clonazepam using a liquid chromatography-electrospray mass spectrometry method.

  Arzneimittel-Forschung 20080101

• Withdrawal symptoms of trifluoperazine.

  The Journal of neuropsychiatry and clinical neurosciences 20080101

• Antidepressant treatments-induced modifications of glutamatergic transmission in rat frontal cortex.

  Pharmacological reports : PR 20080101

• [Depressive disorders in patients after stroke].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101

• [Association between polymorphisms of ins/del in the 5-HTT gene and T102C in the 5HTR2A gene and the drug response for escitalopram and nortriptyline in depressed patients].

  Psychiatria polska 20080101

• [Association between polymorphisms of Val66Met in the BDNF gene and the response to escitalopram and nortriptyline treatment in the light of the neurodevelopmental hypothesis of depression].

  Psychiatria polska 20080101

• Continuing medical education.

  Indian journal of psychiatry 20080101

• Cough up for just a cup of coffee: Pharmacoeconomics of depression.

  Indian journal of psychiatry 20080101

• Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study.

  Indian journal of psychiatry 20080101

• Brief report: Characteristics of antidepressant use in patients with heart failure.

  Patient preference and adherence 20080101

• Synthesis of some tropane derivatives of anticipated activity on the reuptake of norepinephrine and/or serotonin.

  Bioorganic & medicinal chemistry 20071215

• Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex.

  Brain research 20071212

• Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram.

  European journal of pharmacology 20071208

• Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats.

  Behavioural brain research 20071203

• Preparation of antidepressants for use in preclinical research.

  The international journal of neuropsychopharmacology 20071201

• PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram.

  The international journal of neuropsychopharmacology 20071201

• Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.

  Journal of affective disorders 20071201

• Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder.

  Biological psychiatry 20071201

• Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF).

  European journal of heart failure 20071201

• AIDS dementia complex and Hashimoto encephalopathy in a senescent woman.

  International journal of geriatric psychiatry 20071201

• Therapeutic drug monitoring of escitalopram in an outpatient setting.

  Therapeutic drug monitoring 20071201

• Variants in PDE11A and PDE1A are not associated with citalopram response.

  Molecular psychiatry 20071201

• Subsyndromal depressive symptoms in middle-aged and older persons with schizophrenia.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20071201

• Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials.

  The Journal of clinical psychiatry 20071201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20071201

• Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20071201

• Behavioral disinhibition without persistent mood elevation after high dose citalopram treatment.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20071201

• Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders.

  Journal of child and adolescent psychopharmacology 20071201

• An open-label trial of escitalopram in children and adolescents with social anxiety disorder.

  Journal of child and adolescent psychopharmacology 20071201

• [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].

  L'Encephale 20071201

• The therapeutic potential of escitalopram in the treatment of panic disorder.

  Neuropsychiatric disease and treatment 20071201

• A review of quetiapine in combination with antidepressant therapy in patients with depression.

  Neuropsychiatric disease and treatment 20071201

• Emerging synergisms between drugs and physiologically-patterned weak magnetic fields: implications for neuropharmacology and the human population in the twenty-first century.

  Current neuropharmacology 20071201

• Efficacy, effectiveness and efficiency of escitalopram in the treatment of major depressive and anxiety disorders.

  Expert review of pharmacoeconomics & outcomes research 20071201

• Tickling-induced 50-kHz ultrasonic vocalization is individually stable and predicts behaviour in tests of anxiety and depression in rats.

  Behavioural brain research 20071122

• Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist.

  Biological psychiatry 20071115

• Lu 35-138 ((+)-(S)-3-{1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-3,6-dihydro-2H-pyridin-4-yl}-6-chloro-1H-indole), a dopamine D4 receptor antagonist and serotonin reuptake inhibitor: characterisation of its in vitro profile and pre-clinical antipsychotic potential.

  European journal of pharmacology 20071114

• Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro study.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20071101

• Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder.

  International journal of geriatric psychiatry 20071101

• Brain metabolic changes following 4-week citalopram infusion: increased 18FDG uptake and gamma-amino butyric acid levels.

  Synapse (New York, N.Y.) 20071101

• Neuroimaging of the serotonin reuptake site requires high-affinity ligands.

  Synapse (New York, N.Y.) 20071101

• Strain differences in basal and post-citalopram extracellular 5-HT in the mouse medial prefrontal cortex and dorsal hippocampus: relation with tryptophan hydroxylase-2 activity.

  Journal of neurochemistry 20071101

• Chronic citalopram treatment does not sensitize the adrenal gland to ACTH (1-24) in rats.

  Journal of psychopharmacology (Oxford, England) 20071101

• Activated charcoal decreases the risk of QT prolongation after citalopram overdose.

  Annals of emergency medicine 20071101

• Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: application to pharmacokinetics.

  Chirality 20071101

• A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20071101

• Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.

  International clinical psychopharmacology 20071101

• Which antidepressants have demonstrated superior efficacy? A review of the evidence.

  International clinical psychopharmacology 20071101

• Treatment of drop attacks in Coffin-Lowry syndrome with the use of sodium oxybate.

  Pediatric neurology 20071101

• Effects of serotonergic anxiolytics on the freezing behavior in the elevated open-platform test in mice.

  Journal of pharmacological sciences 20071101

• Complicated grief: a case series using escitalopram.

  The American journal of psychiatry 20071101

• Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.

  Journal of psychopharmacology (Oxford, England) 20071101

• An effect-size analysis of pharmacologic treatments for generalized anxiety disorder.

  Journal of psychopharmacology (Oxford, England) 20071101

• Torsade de pointes during combined treatment with risperidone and citalopram.

  Pharmacopsychiatry 20071101

• Can chemotherapy induce reactions of recollection?

  Psycho-oncology 20071101

• Ethnicity/race and outcome in the treatment of depression: results from STAR*D.

  Medical care 20071101

• Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.

  Clinical therapeutics 20071101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20071101

• First time, low dose citalopram use-related serotonin syndrome.

  Neurotoxicology 20071101

• [Compulsive buying: psychological and biological treatment].

  L'Encephale 20071101

• Antidepressant effect of stem cell-derived monoaminergic grafts.

  Neuroreport 20071029

• [The effects of citalopram on proliferation and differentiation of neural precursor cells from embryonic rat hippocampus].

  Zhonghua yi xue za zhi 20071023

• R-citalopram prevents the neuronal adaptive changes induced by escitalopram.

  Neuroreport 20071008

• The effects of increased central serotonergic activity on prepulse inhibition and habituation of the human startle response.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20071001

• Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20071001

• Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20071001

• Preventing relapse of major depression during interferon-alpha therapy for hepatitis C--A pilot study.

  Digestive diseases and sciences 20071001

• Decreased sensitivity to thermal pain in rats bred for high anxiety-related behaviour is attenuated by citalopram or diazepam treatment.

  Behavioural brain research 20071001

• Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison.

  Human psychopharmacology 20071001

• Pharmacokinetic modelling of blood-brain barrier transport of escitalopram in rats.

  Biopharmaceutics & drug disposition 20071001

• Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial.

  Current medical research and opinion 20071001

• Escitalopram therapy for major depression and anxiety disorders.

  The Annals of pharmacotherapy 20071001

• Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.

  Journal of clinical psychopharmacology 20071001

• Unfavorable smell with citalopram?

  Journal of clinical psychopharmacology 20071001

• Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache.

  Psychiatry and clinical neurosciences 20071001

• Genetic markers of suicidal ideation emerging during citalopram treatment of major depression.

  The American journal of psychiatry 20071001

• Effect of age at onset on the course of major depressive disorder.

  The American journal of psychiatry 20071001

• The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.

  Expert opinion on drug metabolism & toxicology 20071001

• Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.

  The Journal of clinical psychiatry 20071001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20071001

• Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease.

  Neuropsychiatric disease and treatment 20071001

• Complex obsessive compulsive and impulsive symptoms in Tourette's syndrome.

  Neuropsychiatric disease and treatment 20071001

• The serotonin reuptake inhibitor citalopram does not affect colonic sensitivity or compliance in rats.

  European journal of pharmacology 20070910

• A single dose of citalopram increases fear recognition in healthy subjects.

  Journal of psychopharmacology (Oxford, England) 20070901

• Dissolution test for citalopram in tablets and comparison of in vitro dissolution profiles.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20070901

• Acute hormonal changes after IV citalopram and treatment response in OCD.

  Psychopharmacology 20070901

• Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.

  Psychopharmacology 20070901

• Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons.

  Psychopharmacology 20070901

• Long-term administration of citalopram reduces basal and stress-induced extracellular noradrenaline levels in rat brain.

  Psychopharmacology 20070901

• An in vitro approach to potential methadone metabolic-inhibition interactions.

  European journal of clinical pharmacology 20070901

• White matter abnormalities in drug-naïve patients with obsessive-compulsive disorder: a diffusion tensor study before and after citalopram treatment.

  Acta psychiatrica Scandinavica 20070901

• Open-label escitalopram treatment for pathological skin picking.

  International clinical psychopharmacology 20070901

• [(3)H] citalopram binding to serotonin transporter sites in minnow brains.

  Basic & clinical pharmacology & toxicology 20070901

• Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events.

  The American journal of psychiatry 20070901

• Pharmacological treatment of post-stroke pathological laughing and crying.

  Journal of psychiatry & neuroscience : JPN 20070901

• Effects of citalopram and fluoxetine on the corticocerebral blood flow in conscious rabbits.

  Acta physiologica Hungarica 20070901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20070901

• Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study.

  Neuroreport 20070827

• Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists.

  European journal of pharmacology 20070813

• The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice.

  Brain research 20070803

• Citalopram-induced SIADH in a hypertensive patient on salt restricted diet.

  Journal of psychopharmacology (Oxford, England) 20070801

• Amygdala serotonin transporters in alcoholics measured by whole hemisphere autoradiography.

  Synapse (New York, N.Y.) 20070801

• Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.

  Stress (Amsterdam, Netherlands) 20070801

• Imaging the availability of serotonin transporter in rat brain with 123I-ADAM and small-animal SPECT.

  Nuclear medicine communications 20070801

• Lower central serotonergic responsivity is associated with preclinical carotid artery atherosclerosis.

  Stroke 20070801

• Lithium toxicity presenting as catatonia in an adolescent girl.

  Journal of clinical psychopharmacology 20070801

• Bilateral symptomatic angle closure associated with a regular dose of citalopram, an SSRI antidepressant.

  The British journal of ophthalmology 20070801

• Serotonin 5HT1A receptor availability and pathological crying after stroke.

  Acta neurologica Scandinavica 20070801

• Pain in depression: STAR*D study findings.

  Journal of psychosomatic research 20070801

• Keeping our depressed patients in the right treatment long enough for them to get better: some hopeful findings.

  The American journal of psychiatry 20070801

• Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.

  The American journal of psychiatry 20070801

• Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.

  The American journal of psychiatry 20070801

• Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.

  The Journal of clinical psychiatry 20070801

• Ziprasidone-associated mania in a case of obssessive-compulsive disorder.

  CNS spectrums 20070801

• A randomized study examining the effect of 3 SSRI on premature ejaculation using a validated questionnaire.

  Therapeutics and clinical risk management 20070801

• An emerging role for escitalopram in the treatment of obsessive-compulsive disorder.

  Neuropsychiatric disease and treatment 20070801

• Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.

  The Cochrane database of systematic reviews 20070718

• Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites.

  European journal of pharmacology 20070712

• Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI.

  Journal of psychopharmacology (Oxford, England) 20070701

• Hysterical paralysis.

  Rheumatology international 20070701

• Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070701

• Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain.

  Neurochemical research 20070701

• Atomoxetine increases salivary cortisol in healthy volunteers.

  Journal of psychopharmacology (Oxford, England) 20070701

• A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder.

  Current medical research and opinion 20070701

• Escitalopram prevents relapse in older patients with major depressive disorder.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20070701

• Obsessive-compulsive disorder: an open-label pilot trial of escitalopram.

  CNS spectrums 20070701

• Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.

  Archives of general psychiatry 20070701

• Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.

  The journal of sexual medicine 20070701

• Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series.

  Journal of psychopharmacology (Oxford, England) 20070701

• SSRI effects on pyschomotor performance: assessment of citalopram and escitalopram on normal subjects.

  Aviation, space, and environmental medicine 20070701

• Improvement of quality of life in panic disorder with escitalopram, citalopram, or placebo.

  Pharmacopsychiatry 20070701

• A budget-impact and cost-effectiveness model for second-line treatment of major depression.

  Journal of managed care pharmacy : JMCP 20070701

• An open-label multicentric study of the tolerability and response to escitalopram treatment in Indian patients with major depressive disorder.

  Journal of the Indian Medical Association 20070701

• Effects of tobacco and cigarette smoke extracts on serotonergic raphe neurons in the rat.

  Neuroreport 20070611

• Antipsychotic-like effect by combined treatment with citalopram and WAY 100635: involvement of the 5-HT2C receptor.

  The international journal of neuropsychopharmacology 20070601

• Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.

  Psychopharmacology 20070601

• Homology modeling of the serotonin transporter: insights into the primary escitalopram-binding site.

  ChemMedChem 20070601

• Molecular dynamics simulations of Na+/Cl(-)-dependent neurotransmitter transporters in a membrane-aqueous system.

  ChemMedChem 20070601

• Escitalopram in a working population: results from an observational study of 2378 outpatients in Austria.

  Human psychopharmacology 20070601

• [Prospective study using a modified Montgomery-Asberg Depression Scale].

  Der Nervenarzt 20070601

• The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19.

  Journal of clinical psychopharmacology 20070601

• Recurrent hyponatremia after substitution of citalopram with duloxetine.

  Journal of clinical psychopharmacology 20070601

• Selective serotonin reuptake inhibitors in adolescent depression still controversial.

  Journal of clinical psychopharmacology 20070601

• Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

  Archives of general psychiatry 20070601

• Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.

  Current medical research and opinion 20070601

• The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

  The Journal of clinical psychiatry 20070601

• Post-traumatic stress disorder in an elderly combat veteran: a case report.

  Military medicine 20070601

• Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases.

  Journal of child and adolescent psychopharmacology 20070601

• Citalopram to treat depression in pediatric oncology.

  Journal of child and adolescent psychopharmacology 20070601

• Escitalopram ingestions reported to Texas poison control centers, 2002-2005.

  Human & experimental toxicology 20070601

• Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate.

  Journal of medicinal chemistry 20070531

• [Establishment of rat model of post-stroke depression and the effects of citalopram on behavior thereof].

  Zhonghua yi xue za zhi 20070522

• Treatment of depression in patients with coronary artery disease.

  JAMA 20070502

• Treatment of depression in patients with coronary artery disease.

  JAMA 20070502

• Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.

  The Journal of pharmacology and experimental therapeutics 20070501

• Oral adverse effects for escitalopram (Cipralex).

  The British journal of dermatology 20070501

• Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response.

  Psychoneuroendocrinology 20070501

• The role of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.

  Gut 20070501

• Escitalopram 10 mg daily is more effective than paroxetine and placebo for generalised anxiety disorder.

  Evidence-based mental health 20070501

• Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.

  The American journal of psychiatry 20070501

• Acceptability of second-step treatments to depressed outpatients: a STAR*D report.

  The American journal of psychiatry 20070501

• Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management.

  Clinical toxicology (Philadelphia, Pa.) 20070501

• A case report of reemergence of antipsychotic-induced dyskinesia with citalopram.

  The Journal of clinical psychiatry 20070501

• Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion.

  Pharmacopsychiatry 20070501

• Obsessive-compulsive disorders due to neuroacanthocytosis treated with citalopram.

  Pharmacopsychiatry 20070501

• Pharmacokinetic comparison of two 40 mg tablet formulations of citalopram using a new amperometric detection technique.

  International journal of clinical pharmacology and therapeutics 20070501

• FLUOXETINE modifies the expression of serotonergic markers in a differentiation-dependent fashion in the mesencephalic neural cell line A1 mes c-myc.

  Brain research 20070427

• White-matter integrity predicts stroop performance in patients with geriatric depression.

  Biological psychiatry 20070415

• Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.

  Biological psychiatry 20070415

• Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070415

• Citalopram-induced Raynaud's phenomenon.

  Rheumatology international 20070401

• Determination of citalopram and escitalopram together with their active main metabolites desmethyl(es-)citalopram in human serum by column-switching high performance liquid chromatography (HPLC) and spectrophotometric detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070401

• Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.

  Psychopharmacology 20070401

• Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis.

  The Journal of pharmacology and experimental therapeutics 20070401

• In response to Isbister et al.: Application of pharmacokinetic-pharmacodynamic modeling in management of QT abnormalities after citalopram overdose.

  Intensive care medicine 20070401

• Serotonin syndrome caused by interaction between citalopram and fentanyl.

  Journal of clinical pharmacy and therapeutics 20070401

• Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.

  International journal of clinical practice 20070401

• Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study.

  Current medical research and opinion 20070401

• Motor cortex excitability after vagus nerve stimulation in major depression.

  Journal of clinical psychopharmacology 20070401

• A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder.

  Journal of clinical psychopharmacology 20070401

• Escitalopram for compulsive buying disorder: a double-blind discontinuation study.

  Journal of clinical psychopharmacology 20070401

• Escitalopram-associated serotonin toxicity.

  Journal of clinical psychopharmacology 20070401

• Serotonin syndrome associated with the use of escitalopram.

  CNS spectrums 20070401

• [Determination of citalopram in human plasma with LC-MS/MS method and its bioequivalent evaluation].

  Yao xue xue bao = Acta pharmaceutica Sinica 20070401

• Role of pregabalin in the treatment of generalized anxiety disorder.

  Neuropsychiatric disease and treatment 20070401

• Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample.

  Biological psychiatry 20070315

• Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain.

  Biological psychiatry 20070301

• Prediction of treatment response in major depression: integration of concepts.

  Journal of affective disorders 20070301

• Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy.

  Experimental neurology 20070301

• 1H NMR spectroscopic study of complexation of citalopram with beta-cyclodextrin in aqueous solution.

  Magnetic resonance in chemistry : MRC 20070301

• Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.

  International clinical psychopharmacology 20070301

• Alopecia associated with quetiapine.

  International clinical psychopharmacology 20070301

• Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats.

  Pharmacology, biochemistry, and behavior 20070301

• Pharmacokinetic/pharmacodynamic feedback modelling of the functional corticosterone response in rats after acute treatment with escitalopram.

  Basic & clinical pharmacology & toxicology 20070301

• Second-trimester prenatal diagnosis of total arhinia.

  Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 20070301

• Retrospective case review of lamotrigine use for affective instability of borderline personality disorder.

  CNS spectrums 20070301

• Further evidence supporting a psychological component to irritable bowel syndrome.

  Gut 20070301

• Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.

  Journal of the American Academy of Nurse Practitioners 20070301

• Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation.

  The Journal of clinical psychiatry 20070301

• Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany.

  Pharmacopsychiatry 20070301

• Obsessive-compulsive disorders due to neuroacanthocytosis treated with citalopram.

  Pharmacopsychiatry 20070301

• [Amnesic syndrome following lesion of the fornix or does reversible Korsakow's syndrome exist?].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20070301

• Rapid on-line extraction and quantification of escitalopram from urine using sol-gel columns and mass spectrometric detection.

  Journal of pharmaceutical and biomedical analysis 20070219

• Event-related potentials in an emotional go/no-go task and remission of geriatric depression.

  Neuroreport 20070212

• Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.

  BMJ (Clinical research ed.) 20070203

• Discontinuation symptoms in depression and anxiety disorders.

  The international journal of neuropsychopharmacology 20070201

• Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.

  The international journal of neuropsychopharmacology 20070201

• Effect of antidepressant drugs on 6-OHDA-treated mice in the FST.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070201

• The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070201

• Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.

  Synapse (New York, N.Y.) 20070201

• The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.

  Psychopharmacology 20070201

• Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers.

  Journal of clinical psychopharmacology 20070201

• Escitalopram-associated hyponatremia.

  Psychiatry and clinical neurosciences 20070201

• Lamotrigine-induced Stevens-Johnson syndrome.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070201

• Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram.

  Journal of perinatology : official journal of the California Perinatal Association 20070201

• Modafinil therapy for apathy in an elderly patient.

  The Annals of pharmacotherapy 20070201

• Placebo response and antidepressant response.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20070201

• Amisulpride augmentation after the failure of citalopram for depression: a case report.

  Journal of clinical pharmacy and therapeutics 20070201

• Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.

  Current medical research and opinion 20070201

• Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder.

  Current medical research and opinion 20070201

• Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

  Current medical research and opinion 20070201

• Escitalopram oxalate: co-existence of oxalate dianions and oxalic acid molecules in the same crystal.

  Acta crystallographica. Section C, Crystal structure communications 20070201

• Quetiapine in combination with citalopram in patients with unipolar psychotic depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20070130

• Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population.

  Progress in neuro-psychopharmacology & biological psychiatry 20070130

• Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

  JAMA 20070124

• Antidepressants in coronary heart disease: SSRIs reduce depression, but do they save lives?

  JAMA 20070124

• Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice.

  European journal of pharmacology 20070119

• Enantiospecific assay of citadiol--a key intermediate of escitalopram by liquid chromatography on Chiralpak AD-H column connected with UV and polarimetric detectors in series.

  Journal of pharmaceutical and biomedical analysis 20070104

• Hyponatremia associated with escitalopram.

  The New England journal of medicine 20070104

• Electrical alternans and hemodynamics in the anesthetized guinea pig can discriminate the cardiac safety of antidepressants.

  Journal of pharmacological and toxicological methods 20070101

• The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.

  Journal of psychopharmacology (Oxford, England) 20070101

• Escitalopram in the treatment of anxiety symptoms associated with depression.

  Depression and anxiety 20070101

• A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070101

• An integrated microdialysis rat model for multiple pharmacokinetic/pharmacodynamic investigations of serotonergic agents.

  Journal of pharmacological and toxicological methods 20070101

• In silico prediction of pregnane X receptor activators by machine learning approaches.

  Molecular pharmacology 20070101

• A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.

  Depression and anxiety 20070101

• Severe bradycardia in a stroke patient caused by a single low dose of escitalopram.

  European neurology 20070101

• Escitalopram treatment of trichotillomania.

  International clinical psychopharmacology 20070101

• Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070101

• Restless legs syndrome induced by citalopram: a psychiatric emergency?

  General hospital psychiatry 20070101

• Syndrome of inappropriate secretion of antidiuretic hormone due to citalopram and venlafaxine.

  General hospital psychiatry 20070101

• Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.

  Human psychopharmacology 20070101

• Do your patients suffer from excessive yawning?

  Acta psychiatrica Scandinavica 20070101

• Attention to side effects enhances medical adherence.

  Acta psychiatrica Scandinavica 20070101

• Effect of pioglitazone treatment on behavioral symptoms in autistic children.

  Journal of neuroinflammation 20070101

• Effects of antidepressant treatment on cognitive performance in elderly subjects with heart failure and comorbid major depression: an exploratory study.

  Psychosomatics 20070101

• Exacerbation of Psychogenic Movement Disorder by Interferon{alpha} Treatment of Hepatitis C.

  Psychosomatics 20070101

• Efficacy of citalopram on climacteric symptoms.

  Menopause (New York, N.Y.) 20070101

• Escitalopram prevents relapse of obsessive-compulsive disorder.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070101

• The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline.

  Journal of psychiatric practice 20070101

• Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice.

  Psychopharmacology bulletin 20070101

• By the way, doctor. My physician prescribed Celexa for me three years ago when I was upset over a family problem. I'm feeling better, and my situation has changed. I'd like to get off the medication. How do I do that?

  Harvard women's health watch 20070101

• Escitalopram in seasonal affective disorder: results of an open trial.

  Pharmacopsychiatry 20070101

• [The use of P300 event-related potentials in the evaluation of the effectiveness of therapy of episodic exertional headaches].

  Vestnik Rossiiskoi akademii meditsinskikh nauk 20070101

• The clinical pharmacokinetics of escitalopram.

  Clinical pharmacokinetics 20070101

• The influence of primary care prescribing rates for new drugs on spontaneous reporting of adverse drug reactions.

  Drug safety 20070101

• Escitaloparm-induced paroxysmal dystonia.

  Clinical neuropharmacology 20070101

• Symptom-onset dosing with citalopram in the treatment of premenstrual dysphoric disorder (PMDD): a case series.

  Archives of women's mental health 20070101

• Risk and predictability of drug interactions in the elderly.

  International review of neurobiology 20070101

• Fluorimetric quantitation of citalopram and escitalopram in plasma: developing an express method to monitor compliance in clinical trials.

  Clinical chemistry and laboratory medicine 20070101

• Suicide risk and symptom reduction in patients assigned to placebo in duloxetine and escitalopram clinical trials: analysis of the FDA summary basis of approval reports.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101

• A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care.

  Nordic journal of psychiatry 20070101

• The influence of educational information on depressed outpatients treated with escitalopram: a semi-naturalistic study.

  Nordic journal of psychiatry 20070101

• [Pharmacological treatment of generalized anxiety disorders: rationale and limitations].

  L'Encephale 20070101

• Urinary serotonin level is associated with serotonin syndrome after moclobemide, sertraline, and citalopram overdose.

  Clinical toxicology (Philadelphia, Pa.) 20070101

• Simple options for improving signal detection in antidepressant clinical trials.

  Psychopharmacology bulletin 20070101

• Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

  Clinical drug investigation 20070101

• Duloxetine: a review of its use in the treatment of major depressive disorder.

  CNS drugs 20070101

• Manic episode associated with citalopram therapy for interferon-induced depression in a patient with chronic hepatitis C infection.

  General hospital psychiatry 20070101

• Migraine with aura triggered by citalopram.

  Neuropsychobiology 20070101

• Serotonin syndrome associated with citalopram and meperidine.

  Psychosomatics 20070101

• Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients.

  The American journal on addictions 20070101

• Pharmaceutical modulation of illicit drug effects.

  The American journal on addictions 20070101

• Insured and non-insured depressed outpatients: how do they compare?

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101

• Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial.

  The American journal of drug and alcohol abuse 20070101

• Bupropion in the treatment of outpatients with asthma and major depressive disorder.

  International journal of psychiatry in medicine 20070101

• Characterization of the trace-level impurities in the bulk drug citalopram by high-performance liquid chromatography/tandem multistage mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20070101

• [Escitalopram and citalopram: the unexpected role of the R-enantiomer].

  L'Encephale 20070101

• Combined brief dynamic therapy and pharmacotherapy in the treatment of major depressive disorder: a pilot study.

  Psychotherapy and psychosomatics 20070101

• [New developments in hypericum extracts: data on efficacy and interactions].

  Wiener medizinische Wochenschrift (1946) 20070101

• Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia.

  Pain research & management 20070101

• Serotonergic mechanisms in human allergic contact dermatitis.

  Acta dermato-venereologica 20070101

• Duloxetine in the treatment of major depressive disorder: an open-label study.

  BMC psychiatry 20070101

• Simultaneous determination of nontricyclic antidepressants in human plasma by solid-phase microextraction and liquid chromatography (SPME-LC).

  Journal of analytical toxicology 20070101

• An open-label trial of escitalopram in the treatment of pathological gambling.

  Clinical neuropharmacology 20070101

• Citalopram-induced macropsia.

  Clinical neuropharmacology 20070101

• Consecutive exposure to lamotrigine and citalopram during pregnancy.

  Archives of women's mental health 20070101

• Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress model of depression.

  Journal of molecular neuroscience : MN 20070101

• Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.

  PharmacoEconomics 20070101

• Limitations in efficacy of antidepressant monotherapy.

  The Journal of clinical psychiatry 20070101

• Augmentation strategies to increase antidepressant efficacy.

  The Journal of clinical psychiatry 20070101

• Molecular pathways associated with stress resilience and drug resistance in the chronic mild stress rat model of depression: a gene expression study.

  Journal of molecular neuroscience : MN 20070101

• Cognitive Behavioral Therapy versus Short Psychodynamic Supportive Psychotherapy in the outpatient treatment of depression: a randomized controlled trial.

  BMC psychiatry 20070101

• Re: Efficacy of citalopram on climacteric symptoms.

  Menopause (New York, N.Y.) 20070101

• Antidepressant treatment increases quality of life in patients with chronic renal failure.

  Renal failure 20070101

• The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study.

  BMC pediatrics 20070101

• Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).

  Neuropsychobiology 20070101

• Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: results from a population-based study.

  BMC neurology 20070101

• Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma.

  The Journal of neuropsychiatry and clinical neurosciences 20070101

• Escitalopram in obsessive-compulsive disorder: a case series.

  Primary care companion to the Journal of clinical psychiatry 20070101

• Effect of citalopram in the modified forced swim test in rats.

  Pharmacological reports : PR 20070101

• A case with euprolactinemic galactorrhea induced by escitalopram.

  International journal of psychiatry in medicine 20070101

• [Antidepressants with different action mechanisms in the treatment of chronic daily headache].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20070101

• [Psychopharmacotherapy of patients with arterial hypertension complicated with metabolic disturbances and depression].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20070101

• Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.

  International journal of psychiatry in medicine 20070101

• Escitalopram in the treatment of obsessive-compulsive disorder: a double blind placebo control trial.

  Journal of Ayub Medical College, Abbottabad : JAMC 20070101

• Generalised anxiety disorder.

  BMJ clinical evidence 20070101

• The new patent regime: Implications for patients in India.

  Indian journal of psychiatry 20070101

• Mania as an unique life event.

  Indian journal of psychiatry 20070101

• Escitalopram induced mania.

  Indian journal of psychiatry 20070101

• Cerebellar syndrome in a patient with pneumonia under lithium treatment: A case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20061230

• Evidence that the deficit in sexual behavior in adult rats neonatally exposed to citalopram is a consequence of 5-HT1 receptor stimulation during development.

  Brain research 20061213

• Digitalis intoxication induced by paroxetine co-administration.

  Lancet (London, England) 20061202

• The role of group I metabotropic glutamate receptors in acquisition and expression of contextual and auditory fear conditioning in rats - a comparison.

  Neuropharmacology 20061201

• Epidemiologic and clinical updates on impulse control disorders: a critical review.

  European archives of psychiatry and clinical neuroscience 20061201

• Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20061201

• Delayed effects of antidepressant drugs in rats.

  Behavioural pharmacology 20061201

• Urinary obstruction with citalopram and aripiprazole combination in an elderly patient.

  Journal of clinical psychopharmacology 20061201

• A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men.

  The Journal of clinical psychiatry 20061201

• [Neonatal treatment effect with selective inhibitor of 5-HT recapture on [corrected] the cranium-encephalic anatomic development].

  Arquivos de neuro-psiquiatria 20061201

• [Alopecia associated with the use of serotonin selective reuptake inhibitors: two case reports].

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20061201

• Trichotillomania: a treatment overview.

  The Journal of practical nursing 20061201

• Atomoxetine: a novel treatment for child and adult ADHD.

  Neuropsychiatric disease and treatment 20061201

• [Nausea and confusion in a diabetic patient. Hyponatremia as an incidental finding].

  MMW Fortschritte der Medizin 20061109

• Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.

  Brain research 20061106

• Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20061101

• Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20061101

• Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20061101

• Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression.

  Journal of affective disorders 20061101

• [The serotonin syndrome. Fatal course of intoxication with citalopram and moclobemide].

  Der Anaesthesist 20061101

• Neuroendocrine effects of citalopram infusion in anorexia nervosa.

  Psychoneuroendocrinology 20061101

• The onset of effect for escitalopram and its relevance for the clinical management of depression.

  Current medical research and opinion 20061101

• Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR.

  Current medical research and opinion 20061101

• S-Citalopram in neuroendocrine challenge-tests: serotonergic responsivity in healthy male and female human participants.

  Psychoneuroendocrinology 20061101

• Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram.

  The Journal of clinical psychiatry 20061101

• Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy.

  The Journal of clinical psychiatry 20061101

• Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.

  The Journal of clinical psychiatry 20061101

• Nucleus accumbens serotonin transporters in alcoholics measured by whole-hemisphere autoradiography.

  Alcohol (Fayetteville, N.Y.) 20061101

• Prevention of relapse in generalized anxiety disorder by escitalopram treatment.

  The international journal of neuropsychopharmacology 20061001

• Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20061001

• Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine.

  Journal of affective disorders 20061001

• Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs).

  Pharmacoepidemiology and drug safety 20061001

• Cytochrome P450 (CYP) inhibition screening: comparison of three tests.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20061001

• Pharmacotherapy of child and adolescent depression.

  Child and adolescent psychiatric clinics of North America 20061001

• In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.

  Psychopharmacology 20061001

• Excretion of escitalopram in breast milk.

  Journal of clinical psychopharmacology 20061001

• Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.

  Journal of clinical psychopharmacology 20061001

• Cost-effectiveness analysis of escitalopram compared with paroxetine in treatment of generalized anxiety disorder in the United Kingdom.

  The Annals of pharmacotherapy 20061001

• Recurrent hyponatremia associated with citalopram and mirtazapine.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20061001

• Cutaneous vasculitis during selective serotonin reuptake inhibitor therapy.

  The American journal of medicine 20061001

• [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].

  Presse medicale (Paris, France : 1983) 20061001

• Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects?

  Human psychopharmacology 20061001

• Verbal memory performance during subchronic challenge with a selective serotonergic and a mixed action antidepressant.

  Human psychopharmacology 20061001

• Serotonin transporter and dopamine transporter imaging in the canine brain.

  Nuclear medicine and biology 20061001

• Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.

  The Journal of clinical psychiatry 20061001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20061001

• Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: a case report.

  Progress in neuro-psychopharmacology & biological psychiatry 20060930

• Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women.

  Progress in neuro-psychopharmacology & biological psychiatry 20060930

• Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.

  Behavioural brain research 20060925

• Influence of blood loss on the pharmacokinetics of citalopram.

  Forensic science international 20060912

• [A 74-year-old unconscious woman with myoclonia and seizures].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20060907

• SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain.

  Neuropharmacology 20060901

• Psychopharmacology of maternal separation anxiety in vervet monkeys.

  Metabolic brain disease 20060901

• A comparison of the effects of citalopram and moclobemide on resting brain perfusion in social anxiety disorder.

  Metabolic brain disease 20060901

• Escitalopram versus venlafaxine XR in the treatment of depression.

  International clinical psychopharmacology 20060901

• Increased antidepressant use and fewer suicides in Jämtland county, Sweden, after a primary care educational programme on the treatment of depression.

  Acta psychiatrica Scandinavica 20060901

• Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults.

  The Annals of pharmacotherapy 20060901

• Pindolol does not augment central serotonin function increases to citalopram in humans: an auditory evoked potential investigation.

  Pharmacology, biochemistry, and behavior 20060901

• Escitalopram late in pregnancy and while breast-feeding.

  The Annals of pharmacotherapy 20060901

• The effects of serotonin reuptake inhibitors on locomotor activity in gerbils.

  Pharmacology, biochemistry, and behavior 20060901

• Clinical problem solving: the case of John, part I.

  Journal of the American Academy of Child and Adolescent Psychiatry 20060901

• Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk.

  British journal of clinical pharmacology 20060901

• The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: an extended analysis.

  Pharmacopsychiatry 20060901

• Obsessive-compulsive disorder due to neuroacanthocytosis treated with citalopram. A case report.

  Pharmacopsychiatry 20060901

• Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study.

  The British journal of psychiatry : the journal of mental science 20060901

• Psychopharmacology of smoking cessation in patients with mental illness.

  Journal of psychiatry & neuroscience : JPN 20060901

• Associated Professional Sleep Societies--SLEEP 2006 20th Anniversary Meeting. 17-22 June 2006, Salt Lake City, UT, USA.

  IDrugs : the investigational drugs journal 20060901

• Escitalopram for perimenopausal depression: an open-label pilot study.

  Journal of women's health (2002) 20060901

• The effect of CYP2C19 substrate on the metabolism of melatonin in the elderly: A randomized, double-blind, placebo-controlled study.

  Methods and findings in experimental and clinical pharmacology 20060901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060901

• What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?

  The Journal of clinical psychiatry 20060901

• Imipramine and citalopram reverse corticosterone-induced alterations in the effects of the activation of 5-HT(1A) and 5-HT(2) receptors in rat frontal cortex.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20060901

• Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.

  The American journal of geriatric pharmacotherapy 20060901

• Usefulness of serotoninergic challenge with oral citalopram.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20060901

• Effects of escitalopram on ethanol withdrawal syndrome in rats.

  Progress in neuro-psychopharmacology & biological psychiatry 20060830

• [Suspected depression].

  MMW Fortschritte der Medizin 20060817

• (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.

  European journal of pharmacology 20060807

• Screening of citalopram, fluoxetine and their metabolites in human urine samples by gas chromatography-mass spectrometry. A global robustness/ruggedness study.

  Journal of chromatography. A 20060804

• A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.

  Gut 20060801

• From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060801

• Characterization of the serotonin transporter in lymphocytes and platelets of schizophrenia patients treated with atypical or typical antipsychotics compared to healthy individuals.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060801

• 3-Aza-6,8-dioxabicyclo[3.2.1]octanes as new enantiopure heteroatom-rich tropane-like ligands of human dopamine transporter.

  Bioorganic & medicinal chemistry 20060801

• How do SSRIs help patients with irritable bowel syndrome?

  Gut 20060801

• Mood and neuropsychological changes in women with midlife depression treated with escitalopram.

  Journal of clinical psychopharmacology 20060801

• Phenotype-genotype relationship and clinical effects of citalopram in Chinese patients.

  Journal of clinical psychopharmacology 20060801

• After the failure of citalopram for depression, what next?

  Expert opinion on pharmacotherapy 20060801

• Response-dependent differences in regional cerebral blood flow changes with citalopram in treatment of major depression.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20060801

• The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram.

  Basic & clinical pharmacology & toxicology 20060801

• Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse.

  The European journal of neuroscience 20060801

• Quetiapine and citalopram: aetiological significances in serotonin syndrome.

  The New Zealand medical journal 20060707

• Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.

  Progress in neuro-psychopharmacology & biological psychiatry 20060701

• Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.

  Neuropharmacology 20060701

• Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation.

  International clinical psychopharmacology 20060701

• Effect of combined treatment with noradrenaline and serotonin reuptake inhibitors on conditioned freezing.

  European journal of pharmacology 20060701

• Do antidepressants cure or create abnormal brain states?

  PLoS medicine 20060701

• Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting.

  The American journal of cardiology 20060701

• Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose.

  Intensive care medicine 20060701

• A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

  The American journal of psychiatry 20060701

• A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder.

  The American journal of psychiatry 20060701

• Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.

  Expert review of neurotherapeutics 20060701

• Delirium in HIV-associated dementia.

  Journal of the American Academy of Child and Adolescent Psychiatry 20060701

• A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.

  Current medical research and opinion 20060701

• Sustained citalopram treatment in experimental hepatic encephalopathy: effects on entrainment to the light-dark cycle and melatonin.

  Basic & clinical pharmacology & toxicology 20060701

• Effective dose of escitalopram in moderate versus severe DSM-IV major depression.

  Pharmacopsychiatry 20060701

• Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice.

  Neuroscience 20060619

• Depression--augmentation or switch after initial SSRI treatment.

  The New England journal of medicine 20060615

• Neurotoxic reaction to citalopram.

  The New Zealand medical journal 20060602

• SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study.

  Journal of affective disorders 20060601

• Effects of oral racemic citalopram on neuroendocrine responses.

  Progress in neuro-psychopharmacology & biological psychiatry 20060601

• A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.

  Journal of clinical psychopharmacology 20060601

• Combination therapy of lamotrigine and escitalopram may cause myoclonus.

  Journal of clinical psychopharmacology 20060601

• Escitalopram-induced uveal effusions and bilateral angle closure glaucoma.

  American journal of ophthalmology 20060601

• Syndrome of inappropriate antidiuretic hormone associated with escitalopram therapy.

  CNS spectrums 20060601

• Rating scales in depression: limitations and pitfalls.

  Dialogues in clinical neuroscience 20060601

• Cognitive improvement after treatment of depressive symptoms in the acute phase of stroke.

  Arquivos de neuro-psiquiatria 20060601

• Major depressive disorder and medical illness: STAR*D outcomes.

  Current psychiatry reports 20060601

• Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway.

  Journal of chromatography. A 20060519

• Differential effects of indoleamines on auditory choice reaction, selective attention, and pitch discrimination.

  Neuroscience letters 20060508

• L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI.

  Psychoneuroendocrinology 20060501

• Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20060501

• Antidepressant drug treatment modifies the neural processing of nonconscious threat cues.

  Biological psychiatry 20060501

• Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM.

  Journal of neural transmission (Vienna, Austria : 1996) 20060501

• A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.

  International clinical psychopharmacology 20060501

• An open-label study of escitalopram in body dysmorphic disorder.

  International clinical psychopharmacology 20060501

• Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.

  Psychopharmacology 20060501

• Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress.

  Behavioural pharmacology 20060501

• Continued escitalopram reduces risk of relapse in people with generalised social anxiety disorder.

  Evidence-based mental health 20060501

• Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.

  American journal of human genetics 20060501

• The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites.

  Nuclear medicine and biology 20060501

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060501

• Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

  The Journal of clinical psychiatry 20060501

• Development and validation of a liquid chromatographic method for determination of enantiomeric purity of citalopram in bulk drugs and pharmaceuticals.

  Journal of pharmaceutical and biomedical analysis 20060411

• Allopregnanolone and ganaxolone increase the firing activity of dorsal raphe nucleus serotonergic neurons in female rats.

  The international journal of neuropsychopharmacology 20060401

• Dissection of an allosteric mechanism on the serotonin transporter: a cross-species study.

  Molecular pharmacology 20060401

• T3 augmentation of SSRI resistant depression.

  Journal of affective disorders 20060401

• Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex.

  Psychopharmacology 20060401

• The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task.

  Psychopharmacology 20060401

• Influence of centrally acting amitriptyline and citalopram on histamine-induced cardiovascular effects in rats.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20060401

• Inhibition of [3H]citalopram binding to the rat brain serotonin transporter by Amaryllidaceae alkaloids.

  Planta medica 20060401

• A genetic algorithm-based, hybrid machine learning approach to model selection.

  Journal of pharmacokinetics and pharmacodynamics 20060401

• Development and application of spectrophotometric methods for the determination of citalopram hydrobromide in dosage forms.

  Chemical & pharmaceutical bulletin 20060401

• Tolerability and safety of fluvoxamine and other antidepressants.

  International journal of clinical practice 20060401

• Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.

  Journal of clinical psychopharmacology 20060401

• Escitalopram, but not its major metabolites, exhibits antiplatelet activity in humans.

  Journal of clinical psychopharmacology 20060401

• [Drug-induced arrhythmia a difficult to catch adverse effect. New guidelines for increased cardiovascular safety].

  Lakartidningen 20060401

• [Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time].

  Lakartidningen 20060401

• [Citalopram should not be the first choice].

  Lakartidningen 20060401

• Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism.

  Neurochemical research 20060401

• Medication augmentation after the failure of SSRIs for depression.

  The New England journal of medicine 20060323

• Treatment strategies after SSRI failure--good news and bad news.

  The New England journal of medicine 20060323

• Rapid and sensitive liquid chromatography-mass spectrometry method for determination of ropinirole in human plasma.

  Journal of pharmaceutical and biomedical analysis 20060318

• Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor.

  European journal of pharmacology 20060318

• An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.

  Biological psychiatry 20060315

• Differential involvement of 5-HT projections within the amygdala in prepulse inhibition but not in psychotomimetic drug-induced hyperlocomotion.

  Behavioural brain research 20060315

• Unique patterns of FOS, phospho-CREB and BrdU immunoreactivity in the female rat brain following chronic stress and citalopram treatment.

  Neuropharmacology 20060301

• Lower serotonin transporter binding in caudate in alcoholics.

  Synapse (New York, N.Y.) 20060301

• Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis.

  International clinical psychopharmacology 20060301

• An open-label study of escitalopram (Lexapro) for the treatment of 'Depression of Alzheimer's disease' (dAD).

  International journal of geriatric psychiatry 20060301

• Genetic predisposition to neuroleptic malignant syndrome in siblings.

  The Annals of pharmacotherapy 20060301

• Managing depressive and anxiety disorders with escitalopram.

  Expert opinion on pharmacotherapy 20060301

• Noradrenergic and serotonergic modulation to treat vasomotor symptoms.

  The journal of the British Menopause Society 20060301

• Acute and long-term administration of citalopram desensitizes alpha2-adrenoceptors in the rat vas deferens.

  The Journal of pharmacy and pharmacology 20060301

• A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.

  Journal of the American Academy of Child and Adolescent Psychiatry 20060301

• Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.

  Pharmacopsychiatry 20060301

• Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study.

  Pharmacopsychiatry 20060301

• Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

  Journal of psychiatry & neuroscience : JPN 20060301

• The pharmacokinetics of escitalopram in patients with hepatic impairment.

  The AAPS journal 20060301

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060301

• Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.

  The Journal of clinical psychiatry 20060301

• Outcomes of late-life anxiety disorders during 32 weeks of citalopram treatment.

  The Journal of clinical psychiatry 20060301

• Chronic antidepressant treatment modulates the release of somatostatin in the rat nucleus accumbens.

  Neuroscience letters 20060227

• Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity.

  Neuroscience letters 20060227

• Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment.

  European journal of pharmacology 20060227

• Evidence of reuptake inhibition responsible for mecamylamine-evoked increases in extracellular serotonin.

  Brain research 20060216

• Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis.

  European journal of pharmacology 20060215

• Neurochemical modulation of response inhibition and probabilistic learning in humans.

  Science (New York, N.Y.) 20060210

• Putative drug binding conformations of monoamine transporters.

  Bioorganic & medicinal chemistry 20060201

• Selective serotonin re-uptake inhibition attenuates evoked glutamate release in the dorsal horn of the anaesthetised rat in vivo.

  Pharmacological research 20060201

• The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers.

  The Journal of clinical endocrinology and metabolism 20060201

• Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.

  Journal of affective disorders 20060201

• Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats.

  Behavioural pharmacology 20060201

• New possibilities of treatment for panic attacks in elderly patients: escitalopram versus citalopram.

  Journal of clinical psychopharmacology 20060201

• Treatment of chronic posttraumatic stress disorder in combat veterans with citalopram: an open trial.

  Journal of clinical psychopharmacology 20060201

• Response to SSRI-induced enuresis: a case report.

  Journal of clinical psychopharmacology 20060201

• Citalopram serum and milk levels in mother and infant during lactation.

  Therapeutic drug monitoring 20060201

• Heterozygous mutation in CYP2C19 significantly increases the concentration/dose ratio of racemic citalopram and escitalopram (S-citalopram).

  Therapeutic drug monitoring 20060201

• Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study.

  Alimentary pharmacology & therapeutics 20060201

• Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses.

  British journal of clinical pharmacology 20060201

• Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature.

  Pharmacotherapy 20060201

• Enantiomeric screening of racemic citalopram and metabolites in human urine by entangled polymer solution capillary electrophoresis: an innovatory robustness/ruggedness study.

  Electrophoresis 20060201

• Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060201

• Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.

  The Journal of clinical psychiatry 20060201

• [Pharmacologic therapy of depression during pregnancy].

  Recenti progressi in medicina 20060201

• Comparison of first refill rates among users of sertraline, paroxetine, and citalopram.

  Clinical therapeutics 20060201

• Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.

  The Journal of biological chemistry 20060127

• Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man.

  Alimentary pharmacology & therapeutics 20060115

• Red blood cell triiodothyronine uptake as membrane parameter of depression.

  Physiological research 20060101

• Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060101

• Escitalopram versus paroxetine for social anxiety disorder: an analysis of efficacy for different symptom dimensions.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060101

• Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study.

  International journal of impotence research 20060101

• Early life trauma decreases glucocorticoid receptors in rat dentate gyrus upon adult re-stress: reversal by escitalopram.

  Neuroscience 20060101

• Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function.

  Human psychopharmacology 20060101

• Case study: delirium in an adolescent girl with human immunodeficiency virus-associated dementia.

  Journal of the American Academy of Child and Adolescent Psychiatry 20060101

• Perspectives on the efficacy of antidepressants for child and adolescent depression.

  PLoS medicine 20060101

• Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

  Psychosomatics 20060101

• Beyond efficacy: the STAR*D trial.

  The American journal of psychiatry 20060101

• Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

  The American journal of psychiatry 20060101

• Electric sensations: neglected symptom of escitalopram discontinuation.

  The American journal of psychiatry 20060101

• Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder.

  Neuropsychobiology 20060101

• Mild behavioral impairment: a prodromal stage of frontotemporal lobar degeneration.

  Journal of the American Geriatrics Society 20060101

• An open trial of adjunctive escitalopram in bipolar depression.

  The Journal of clinical psychiatry 20060101

• Outcomes after supratherapeutic escitalopram ingestions.

  The Journal of emergency medicine 20060101

• Attention network dysfunction and treatment response of geriatric depression.

  Journal of clinical and experimental neuropsychology 20060101

• Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE).

  Psychosomatic medicine 20060101

• Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain.

  Pharmacopsychiatry 20060101

• Spotlight on escitalopram in the management of major depressive disorder.

  CNS drugs 20060101

• Bronchoscopic assessment of airway retention time of aerosolized xylitol.

  Respiratory research 20060101

• Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization.

  Pharmacology, biochemistry, and behavior 20060101

• [Citalopram overdose poisoning in QTc interval prolongation].

  Duodecim; laaketieteellinen aikakauskirja 20060101

• Liquid chromatography determination of citalopram enantiomers using beta-cyclodextrin as a chiral mobile phase additive.

  Journal of AOAC International 20060101

• Oculogyric dystonic reaction to escitalopram with features of anaphylaxis including response to epinephrine.

  International archives of allergy and immunology 20060101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060101

• The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression.

  Journal of child and adolescent psychopharmacology 20060101

• Increased deep sleep in a medication-free, detoxified female offender with schizophrenia, alcoholism and a history of attempted homicide: effect of concomitant administration of quetiapine and citalopram.

  Criminal behaviour and mental health : CBMH 20060101

• Clinical course and toxicokinetic data following isolated citalopram overdose in an infant.

  Clinical toxicology (Philadelphia, Pa.) 20060101

• Persistent sexual side effects after SSRI discontinuation.

  Psychotherapy and psychosomatics 20060101

• Cataplexy treated with escitalopram--clinical experience.

  Neuro endocrinology letters 20060101

• Three-dimensional models of neurotransmitter transporters and their interactions with cocaine and S-citalopram.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20060101

• [Effectiveness of venlafaxine extended release and conventional antidepressants in elderly patients with depressive disorder].

  Actas espanolas de psiquiatria 20060101

• Escitalopram in the long-term treatment of major depressive disorder.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20060101

• Decreased hippocampal neurogenesis following olfactory bulbectomy is reversed by repeated citalopram administration.

  Cellular and molecular neurobiology 20060101

• Dose response to adjunctive light therapy in citalopram-treated patients with post-stroke depression. A randomised, double-blind pilot study.

  Psychotherapy and psychosomatics 20060101

• A national survey of cardiovascular physicians' beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease.

  Cardiology in review 20060101

• Mood, anxiety, and physical illness: body and mind, or mind and body?

  Depression and anxiety 20060101

• Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.

  Depression and anxiety 20060101

• [The influence of cypramil on depressive disorders of behavior in young thyroidectomized male rats].

  Eksperimental'naia i klinicheskaia farmakologiia 20060101

• Psychiatric services in primary care settings: a survey of general practitioners in Thailand.

  BMC family practice 20060101

• Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort.

  The American journal on addictions 20060101

• [Pharmacotherapy: migraine and depression. Therapy with sumatripten and citalopram: perioperative anaesthesiological risk assessment].

  Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20060101

• Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life.

  Menopause (New York, N.Y.) 20060101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20060101

• [Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram, in patients with major depressive disorder--the navigade switch study].

  L'Encephale 20060101

• Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial.

  Advances in therapy 20060101

• Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program.

  Journal of managed care pharmacy : JMCP 20060101

• Patterns of early adherence to the antidepressant citalopram among older primary care patients: the prospect study.

  International journal of psychiatry in medicine 20060101

• Escitalopram: a review of its use in the management of anxiety disorders.

  CNS drugs 20060101

• [Galactorrhoea and the use of selective serotonin reuptake inhibitors].

  Tijdschrift voor psychiatrie 20060101

• Challenging the serotonergic system in Parkinson disease patients: effects on cognition, mood, and motor performance.

  Clinical neuropharmacology 20060101

• Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.

  The Journal of neuropsychiatry and clinical neurosciences 20060101

• Citalopram and suicidality in adult major depression and anxiety disorders.

  Nordic journal of psychiatry 20060101

• Spectrofluorometric determination of citalopram in pharmaceutical preparations and spiked human plasma using organized media.

  Journal of AOAC International 20060101

• Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia.

  Acta psychiatrica Scandinavica. Supplementum 20060101

• Pharmacotherapy of social anxiety disorder: what does the evidence tell us?

  The Journal of clinical psychiatry 20060101

• Renal tubular defects from antidepressant use in an older adult: An uncommon but reversible adverse drug effect.

  Clinical drug investigation 20060101

• Resistant social anxiety disorder response to Escitalopram.

  Clinical practice and epidemiology in mental health : CP & EMH 20060101

• Escitalopram in the long-term treatment of major depressive disorder in elderly patients.

  Neuropsychobiology 20060101

• [An electrophysiological study of the rehabilitation of cognitive functions during the treatment of patients with panic disorders].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20060101

• Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder.

  Neuropsychobiology 20060101

• Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus.

  Neuropsychobiology 20060101

• Prenatal bupropion exposure enhances the cocaine reward and stress susceptibility in adult mice.

  The Chinese journal of physiology 20051231

• Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051227

• N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.

  Bioorganic & medicinal chemistry letters 20051215

• Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis.

  Journal of chromatography. A 20051209

• Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies.

  Pharmacoepidemiology and drug safety 20051201

• Hypersexuality and its response to citalopram in a patient with hypothalamic hamartoma and precocious puberty.

  The international journal of neuropsychopharmacology 20051201

• A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.

  Biological psychiatry 20051201

• The effect of pharmacotherapy on personality disorders in panic disorder: a one year naturalistic study.

  Journal of affective disorders 20051201

• Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test.

  Psychopharmacology 20051201

• Linezolid-associated serotonin syndrome: what we can learn from cases reported so far.

  The Journal of antimicrobial chemotherapy 20051201

• Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany.

  The European journal of health economics : HEPAC : health economics in prevention and care 20051201

• Serotonin and depression: a disconnect between the advertisements and the scientific literature.

  PLoS medicine 20051201

• An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.

  Journal of clinical psychopharmacology 20051201

• Diplopia with citalopram: a case report.

  Journal of clinical psychopharmacology 20051201

• The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects.

  Journal of clinical pharmacology 20051201

• Sudden cardiac death in a young woman: tumor of the atrioventricular (AV) node or citalopram intoxication?

  The American journal of forensic medicine and pathology 20051201

• Case report of a fatal intoxication by citalopram.

  The American journal of forensic medicine and pathology 20051201

• Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome.

  American journal of obstetrics and gynecology 20051201

• Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.

  International journal of clinical practice 20051201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20051201

• Antidepressant treatment outcomes of psychogenic movement disorder.

  The Journal of clinical psychiatry 20051201

• Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial.

  The Journal of clinical psychiatry 20051201

• Combination/augmentation strategies for improving the treatment of depression.

  Neuropsychiatric disease and treatment 20051201

• Repeated administration of citalopram and imipramine alters the responsiveness of rat hippocampal circuitry to the activation of 5-HT7 receptors.

  European journal of pharmacology 20051107

• Harmane inhibits serotonergic dorsal raphe neurons in the rat.

  Psychopharmacology 20051101

• Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study.

  European journal of nuclear medicine and molecular imaging 20051101

• Interferon beta-1a overdose in a multiple sclerosis patient.

  The Annals of pharmacotherapy 20051101

• The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls.

  Alimentary pharmacology & therapeutics 20051101

• Conclusions inconsistent with results with citalopram.

  The American journal of psychiatry 20051101

• [Brief case report. Duloxetine in Cotard syndrome].

  Psychiatrische Praxis 20051101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20051101

• [Treatment of anxiety syndrome. A systematic literature review. Summary and conclusions by the SBU].

  Lakartidningen 20051101

• Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder.

  The Journal of clinical psychiatry 20051101

• Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20051101

• Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats.

  European journal of pharmacology 20051017

• alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice.

  Behavioural brain research 20051014

• Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.

  Psychopharmacology 20051001

• SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD).

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20051001

• Seasonal variations in [3H]citalopram platelet binding between healthy controls and violent offenders in Finland.

  Human psychopharmacology 20051001

• [The serotonin syndrome].

  Psychiatrische Praxis 20051001

• Escitalopram in the treatment of depressed elderly patients.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20051001

• Atrioventricular blocks associated with citalopram.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20051001

• Implications of an SSRI generic step therapy pharmacy benefit design: an economic model in anxiety disorders.

  The American journal of managed care 20051001

• Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.

  Journal of palliative medicine 20051001

• Differences in compliance patterns across the selective serotonin reuptake inhibitors (SSRIs).

  Current medical research and opinion 20051001

• A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.

  Current medical research and opinion 20051001

• A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.

  The Journal of clinical psychiatry 20051001

• Possible antipsychotic effect of fluvoxamine.

  CNS spectrums 20051001

• [Bipolar disorder type I].

  L'Encephale 20051001

• [Prescription of selective serotonin reuptake inhibitors 1990-2004].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20050922

• Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20050907

• Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram.

  The international journal of neuropsychopharmacology 20050901

• The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050901

• Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050901

• The effect of cimetidine or omeprazole on the pharmacokinetics of escitalopram in healthy subjects.

  British journal of clinical pharmacology 20050901

• Citalopram and the Curate's egg in geriatric depression.

  The American journal of psychiatry 20050901

• Interactive case conference. First episode: depression and panic disorder.

  CNS spectrums 20050901

• The pharmacological management of depression.

  Dialogues in clinical neuroscience 20050901

• Dose-response relationship of recent antidepressants in the short-term treatment of depression.

  Dialogues in clinical neuroscience 20050901

• Escitalopram for social anxiety disorder.

  The British journal of psychiatry : the journal of mental science 20050901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050901

• Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age.

  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050901

• [1+1 or 2x1? Another form of dual antidepressive mechanism of action].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20050901

• Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach.

  Psychiatry research 20050830

• Opioid receptor-like 1 (NOP) receptors in the rat dorsal raphe nucleus: evidence for localization on serotoninergic neurons and functional adaptation after 5,7-dihydroxytryptamine lesion.

  Journal of neuroscience research 20050815

• Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 4: 3-Alkyl-4-halo-6-nitroquipazines.

  Bioorganic & medicinal chemistry 20050815

• A comparison of methods for alignment of NMR peaks in the context of cluster analysis.

  Journal of pharmaceutical and biomedical analysis 20050810

• High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions.

  Neuroscience letters 20050805

• Screening antidepressants in the chick separation-stress paradigm.

  Psychopharmacology 20050801

• Neuronal effects of acute citalopram detected by pharmacoMRI.

  Psychopharmacology 20050801

• Serotonin, but not melatonin, plays a role in shaping dominant-subordinate relationships and aggression in rainbow trout.

  Hormones and behavior 20050801

• siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain.

  Molecular psychiatry 20050801

• Imipramine and citalopram facilitate amyloid precursor protein secretion in vitro.

  Neurochemistry international 20050801

• Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials.

  Journal of affective disorders 20050801

• Mirtazapine in drug-induced excessive sweating.

  European journal of clinical pharmacology 20050801

• Quinolinic acid toxicity on orexin neurons blocked by gamma aminobutyric acid type A receptor stimulation.

  Neuroreport 20050801

• Executive dysfunction and the course of geriatric depression.

  Biological psychiatry 20050801

• Genotype A1/A2 associated with neuroleptic malignant syndrome.

  Bipolar disorders 20050801

• Neuropsychological prediction of recovery in late-onset major depression.

  International journal of geriatric psychiatry 20050801

• Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D.

  The Journal of clinical psychiatry 20050801

• A bioequivalence study of citalopram based on quantification by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry.

  International journal of clinical pharmacology and therapeutics 20050801

• The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach.

  Journal of pharmacokinetics and pharmacodynamics 20050801

• Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.

  Biological psychiatry 20050715

• Serotonin modulates circadian entrainment in Drosophila.

  Neuron 20050707

• alpha(2)-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons.

  European journal of pharmacology 20050704

• Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050701

• The effect of escitalopram on sleep problems in depressed patients.

  Human psychopharmacology 20050701

• Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.

  Pharmacology, biochemistry, and behavior 20050701

• Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.

  Analytical and bioanalytical chemistry 20050701

• Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients.

  Progress in neuro-psychopharmacology & biological psychiatry 20050701

• Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): a case report.

  Pharmacopsychiatry 20050701

• Escitalopram in the treatment of generalized anxiety disorder.

  Expert review of neurotherapeutics 20050701

• Degradation of citalopram by simulated sunlight.

  Environmental toxicology and chemistry 20050701

• Citalopram-induced serotonin syndrome: a case report.

  The Kaohsiung journal of medical sciences 20050701

• Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.

  Journal of medicinal chemistry 20050630

• Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050605

• Treatment of Raynaud's phenomenon with escitalopram.

  The international journal of neuropsychopharmacology 20050601

• Evidence-based pharmacotherapy of Generalized Anxiety Disorder.

  The international journal of neuropsychopharmacology 20050601

• Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study.

  Psychopharmacology 20050601

• The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measured with 123I-5-I-R91150 SPECT.

  European journal of nuclear medicine and molecular imaging 20050601

• The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia.

  Journal of clinical psychopharmacology 20050601

• Activity of citalopram on adenosine and serotonin circulating levels in depressed patients.

  Journal of clinical psychopharmacology 20050601

• Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.

  Pharmacoepidemiology and drug safety 20050601

• Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.

  Journal of hepatology 20050601

• Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.

  European journal of clinical pharmacology 20050601

• Somatic symptoms in late-life anxiety: treatment issues.

  Journal of geriatric psychiatry and neurology 20050601

• Causal or casual?

  Pharmacoepidemiology and drug safety 20050601

• Toxicity with selective serotonin reuptake inhibitors.

  The American journal of psychiatry 20050601

• Differential actions of acute and chronic citalopram on the rodent hypothalamic-pituitary-adrenal axis response to acute restraint stress.

  The Journal of endocrinology 20050601

• A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder.

  The Journal of clinical psychiatry 20050601

• The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity.

  Progress in neuro-psychopharmacology & biological psychiatry 20050601

• Bioequivalence of two brands of citalopram 40 mg tablets after single oral administration to healthy volunteers.

  Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20050601

• Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations.

  Neuropsychiatric disease and treatment 20050601

• Atypical presentations of atypical antipsychotics.

  Psychiatry (Edgmont (Pa. : Township)) 20050601

• Quantitative analysis of immunolabeling for serotonin and for glutamate transporters after administration of imipramine and citalopram.

  Brain research 20050503

• Selective serotonin reuptake inhibitors induce spontaneous interneuronal activity in the leech nervous system.

  Journal of neurophysiology 20050501

• Specific in vitro binding of (S,S)-[3H]MeNER to norepinephrine transporters.

  Synapse (New York, N.Y.) 20050501

• Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.

  Pharmacological research 20050501

• Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050501

• Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.

  International clinical psychopharmacology 20050501

• Escitalopram and suicidality in adult depression and anxiety.

  International clinical psychopharmacology 20050501

• The emergence of tics during escitalopram and sertraline treatment.

  International clinical psychopharmacology 20050501

• Dopaminergic mechanism of antidepressant action in depressed patients.

  Journal of affective disorders 20050501

• The winner takes it all.

  Journal of medical ethics 20050501

• Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.

  Pharmacotherapy 20050501

• Delusional wife: a case of diagnostic ambiguity and treatment challenge.

  Journal of psychiatric practice 20050501

• Postmortem tissue distribution of olanzapine and citalopram in a drug intoxication.

  Journal of forensic sciences 20050501

• Enantiomeric determination, validation and robustness studies of racemic citalopram in pharmaceutical formulations by capillary electrophoresis.

  Journal of chromatography. A 20050429

• Alkaloids from Boophane disticha with affinity to the serotonin transporter in rat brain.

  Journal of ethnopharmacology 20050426

• Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine.

  European journal of pharmacology 20050404

• An open-label trial of escitalopram in pervasive developmental disorders.

  Journal of the American Academy of Child and Adolescent Psychiatry 20050401

• Child psychopharmacology, effect sizes, and the big bang.

  The American journal of psychiatry 20050401

• Child psychopharmacology, effect sizes, and the big bang.

  The American journal of psychiatry 20050401

• Child psychopharmacology, effect sizes, and the big bang.

  The American journal of psychiatry 20050401

• Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.

  The Journal of clinical psychiatry 20050401

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050401

• A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK.

  Current medical research and opinion 20050401

• An open trial of citalopram in children and adolescents with depression.

  Journal of child and adolescent psychopharmacology 20050401

• A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom.

  Clinical therapeutics 20050401

• Binding of S-citalopram and paroxetine discriminates between species.

  Synapse (New York, N.Y.) 20050315

• Serotonin modulation of cerebral blood flow measured with positron emission tomography (PET) in humans.

  Synapse (New York, N.Y.) 20050315

• The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment.

  Psychopharmacology 20050301

• Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences.

  Psychopharmacology 20050301

• The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050301

• Analysis of serotonin in brain microdialysates using capillary electrophoresis and native laser-induced fluorescence detection.

  Electrophoresis 20050301

• Simultaneous analysis of citalopram and desmethylcitalopram by liquid chromatography with fluorescence detection after solid-phase extraction.

  Clinical biochemistry 20050301

• Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram.

  Journal of psychopharmacology (Oxford, England) 20050301

• Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study.

  The British journal of psychiatry : the journal of mental science 20050301

• Obsessive-compulsive disorder (OCD) with psychotic symptoms and response to treatment with SSRI.

  Pharmacopsychiatry 20050301

• Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial.

  The Journal of clinical psychiatry 20050301

• [Citalopram in the etiology of inappropriate antidiuretic hormone secretion syndrome].

  Revista clinica espanola 20050301

• Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301

• Exacerbation of panic disorder with rifampin therapy in a patient receiving citalopram.

  Pharmacotherapy 20050301

• Efficacy of escitalopram in patients with severe depression: a pooled analysis.

  International journal of clinical practice 20050301

• Serum antioxidant enzymes and malondialdehyde levels in patients with premature ejaculation before and after pharmacotherapy.

  The journal of sexual medicine 20050301

• Involvement of spinal serotonin receptors in the regulation of intraspinal acetylcholine release.

  European journal of pharmacology 20050221

• Citalopram combined with WAY 100635 inhibits ejaculation and ejaculation-related Fos immunoreactivity.

  European journal of pharmacology 20050210

• Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression.

  Psychopharmacology 20050201

• Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats.

  Psychopharmacology 20050201

• Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.

  European journal of pain (London, England) 20050201

• Effects of the androgen antagonist flutamide and the serotonin reuptake inhibitor citalopram in bulimia nervosa: a placebo-controlled pilot study.

  Journal of clinical psychopharmacology 20050201

• Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain.

  Neuropharmacology 20050201

• Two types of aggression are differentially related to serotonergic activity and the A779C TPH polymorphism.

  Behavioral neuroscience 20050201

• Adolescents' response to antidepressant treatment in a community mental health center.

  Community mental health journal 20050201

• Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV.

  The Annals of pharmacotherapy 20050101

• Characterization of an allosteric citalopram-binding site at the serotonin transporter.

  Journal of neurochemistry 20050101

• Escitalopram/reboxetine combination in depressed patients with substance use disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20050101

• Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial.

  The American journal of psychiatry 20050101

• Quetiapine-induced weight gain and escitalopram.

  The American journal of psychiatry 20050101

• Catatonia in autism: a distinct subtype?

  Journal of intellectual disability research : JIDR 20050101

• Topiramate related obsessive-compulsive disorder.

  European psychiatry : the journal of the Association of European Psychiatrists 20050101

• Escitalopram intoxication.

  European psychiatry : the journal of the Association of European Psychiatrists 20050101

• Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram.

  BMC pharmacology 20050101

• Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study.

  Menopause (New York, N.Y.) 20050101

• Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.

  The Journal of clinical psychiatry 20050101

• Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment.

  Journal of psychopharmacology (Oxford, England) 20050101

• The safety of newer antidepressants in pregnancy and breastfeeding.

  Drug safety 20050101

• Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.

  Comprehensive psychiatry 20050101

• Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options.

  Drugs & aging 20050101

• Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopram.

  Neuropsychobiology 20050101

• Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder.

  PharmacoEconomics 20050101

• A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium.

  Clinical therapeutics 20050101

• Carcinoid tumor, selective serotonin reuptake inhibitors, and diarrhea.

  Psychosomatics 20050101

• Citalopram-induced diplopia.

  Psychosomatics 20050101

• Reversal of citalopram-induced junctional bradycardia with intravenous sodium bicarbonate.

  Pharmacotherapy 20050101

• Escitalopram in clinical practice: results of an open-label trial in a naturalistic setting.

  Depression and anxiety 20050101

• [A new quality of the therapy of anxiety and depression--escitalopram].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050101

• Possible serotonin syndrome with citalopram following cross-titration of clozapine to ziprasidone.

  General hospital psychiatry 20050101

• Are SSRIs really more effective for anxious depression?

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101

• Selective serotonin-reuptake inhibitors in the treatment of premature ejaculation.

  The Annals of pharmacotherapy 20050101

• Interpersonal psychotherapy for depression with panic spectrum symptoms: a pilot study.

  Depression and anxiety 20050101

• The use of selective serotonin reuptake inhibitors in children and adolescents with major depression.

  Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc 20050101

• Early-phase postmortem redistribution of the enantiomers of citalopram and its demethylated metabolites in rats.

  Journal of analytical toxicology 20050101

• Improvements in SSRI/SNRI-induced sexual dysfunction by switching to escitalopram.

  Journal of sex & marital therapy 20050101

• A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101

• Escitalopram for the treatment of GAD: efficacy across different subgroups and outcomes.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101

• Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20050101

• Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs.

  Journal of pharmacological and toxicological methods 20050101

• Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.

  Neuropsychobiology 20050101

• [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].

  L'Encephale 20050101

• Effects on serotonin of (-)nicotine and dimethylphenylpiperazinium in the dorsal raphe and nucleus accumbens of freely behaving rats.

  Neuroscience 20050101

• Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: a randomized, double-blind, placebo-controlled study.

  Digestion 20050101

• Persistence of antidepressant treatment effects in a pharmacotherapy plus psychotherapy trial for active injection drug users.

  The American journal on addictions 20050101

• Citalopram associated with acute angle-closure glaucoma: case report.

  BMC ophthalmology 20050101

• Escitalopram: a review of its use in the management of major depressive disorder.

  Drugs 20050101

• Linezolid-associated serotonin syndrome after concomitant treatment with citalopram and mirtazepine in a critically ill bone marrow transplant recipient.

  Journal of intensive care medicine 20050101

• Major depressive disorder in hepatitis C: an open-label trial of escitalopram.

  Primary care companion to the Journal of clinical psychiatry 20050101

• Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.

  Drug safety 20050101

• Dystonic rabbit syndrome from citalopram.

  Clinical neuropharmacology 20050101

• Escitalopram in adolescent major depression.

  MedGenMed : Medscape general medicine 20050101

• Zinc and depression. An update.

  Pharmacological reports : PR 20050101

• [Escitalopram for treatment of major depressive disorder in adults].

  L'Encephale 20050101

• [Depressive disorders in panic attack patients and their correction with escitalopram].

  Likars'ka sprava 20050101

• Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101

• [Anxiodepressive and neuromediatory disorders in hypertensive patients. Effects of cypramil therapy].

  Terapevticheskii arkhiv 20050101

• Bioavailability investigation of two different oral formulations of citalopram, a so-called 'second generation' antidepressant drug.

  Arzneimittel-Forschung 20050101

• Determination of citalopram in tablets by capillary zone electrophoresis and by direct and derivative UV-spectrophotometry.

  Acta poloniae pharmaceutica 20050101

• Aripiprazole augmentation of combination escitalopram and sertraline in the treatment of refractory obsessive-compulsive disorder.

  Psychiatry (Edgmont (Pa. : Township)) 20050101

• Synthesis of 8-thiabicyclo[3.2.1]oct-2-enes and their binding affinity for the dopamine and serotonin transporters.

  Bioorganic & medicinal chemistry letters 20041220

• Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers.

  Psychopharmacology 20041201

• Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20041201

• Gene expression profile analysis of the rat cortex following treatment with imipramine and citalopram.

  The international journal of neuropsychopharmacology 20041201

• Repetitive transcranial magnetic stimulation as an antidepressant monotherapy in a patient with major depression, leucocytopenia and rhabdomyolysis.

  The international journal of neuropsychopharmacology 20041201

• Executive dysfunction, heart disease burden, and remission of geriatric depression.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20041201

• Effects of serotonin transporter promoter polymorphisms on serotonin function.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20041201

• Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.

  International journal of geriatric psychiatry 20041201

• Utility of sparse concentration sampling for citalopram in elderly clinical trial subjects.

  Journal of clinical pharmacology 20041201

• Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures.

  Neuropharmacology 20041201

• Citalopram-induced jaw tremor.

  Clinical neurology and neurosurgery 20041201

• A case of hyponatremia associated with escitalopram.

  The Journal of clinical psychiatry 20041201

• Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.

  Antiviral therapy 20041201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20041201

• [Efficiency and safety of citalopram and venlafaxine in treatment of depressive disorders in elderly patients].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20041201

• Liquid chromatography--electrospray ionisation mass spectrometry method for the determination of escitalopram in human plasma and its application in bioequivalence study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041125

• Increased responsiveness of presumed 5-HT cells to citalopram in adult rats subjected to prolonged maternal separation relative to brief separation.

  Psychopharmacology 20041101

• Antidepressant-associated mania with escitalopram.

  European psychiatry : the journal of the Association of European Psychiatrists 20041101

• Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial.

  The American journal of psychiatry 20041101

• Cotard's syndrome and electroconvulsive therapy.

  Psychiatric services (Washington, D.C.) 20041101

• Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder.

  Psychopharmacology 20041101

• Can bilateral prefrontal repetitive transcranial magnetic stimulation (rTMS) induce mania? A case report.

  The Journal of clinical psychiatry 20041101

• Anger in depressive mixed states.

  The Journal of clinical psychiatry 20041101

• Spontaneous orgasm started with venlafaxine and continued with citalopram.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20041101

• Liquid chromatography-positive ion electrospray mass spectrometry method for the quantification of citalopram in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041025

• The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels.

  Brain research 20041022

• [Antidepressive agents can affect collection of urine and urination].

  Lakartidningen 20041007

• Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20041001

• Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.

  Consumer reports 20041001

• Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: an exploratory study.

  Journal of the American Academy of Child and Adolescent Psychiatry 20041001

• Neonatal administration of citalopram delays somatic maturation in rats.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20041001

• Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.

  The Journal of clinical psychiatry 20041001

• Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.

  The Journal of clinical psychiatry 20041001

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20041001

• Depression in general clinical practice.

  Journal of the Indian Medical Association 20041001

• The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression.

  Neuroscience letters 20040909

• Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040901

• Evidence based review of escitalopram in treating major depressive disorder in primary care.

  International clinical psychopharmacology 20040901

• Treating functional impairment of autism with selective serotonin-reuptake inhibitors.

  The Annals of pharmacotherapy 20040901

• DASB -in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as positron emission tomography (PET) tracer.

  Journal of neurochemistry 20040901

• Escitalopram dose-response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression.

  The international journal of neuropsychopharmacology 20040901

• [18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20040901

• Repetition of serotonin syndrome after reexposure to SSRI--a case report.

  Pharmacopsychiatry 20040901

• A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.

  The Journal of clinical psychiatry 20040901

• Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia.

  Environmental toxicology and chemistry 20040901

• Combined chronic treatment with citalopram and lithium does not modify the regional neurochemistry of nitric oxide in rat brain.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20040901

• A 5-HT(2C) receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat.

  Pharmacology, biochemistry, and behavior 20040901

• The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients.

  Pharmacopsychiatry 20040901

• Serotonin reuptake inhibitors in auditory processing disorders in elderly patients: preliminary results.

  The Laryngoscope 20040901

• Escitalopram: better treatment for depression is through the looking glass.

  Expert review of neurotherapeutics 20040901

• Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala.

  European journal of pharmacology 20040830

• [Motivational therapy can fail here. Sleep disorders in depressions].

  MMW Fortschritte der Medizin 20040819

• Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats.

  Behavioural brain research 20040812

• Panic attacks with spontaneous ejaculation successfully treated with citalopram and clonazepam.

  Journal of clinical psychopharmacology 20040801

• Changes in energy after switching from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine.

  Journal of clinical psychopharmacology 20040801

• The effect of citalopram on gene expression profile of Alzheimer lymphocytes.

  Neurochemical research 20040801

• Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment.

  European archives of psychiatry and clinical neuroscience 20040801

• 'Dopamine-dependent' side effects of selective serotonin reuptake inhibitors: a clinical review.

  The Journal of clinical psychiatry 20040801

• Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C.

  Neuroscience letters 20040722

• Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder.

  Biological psychiatry 20040715

• Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects.

  Psychopharmacology 20040701

• Cocaine-like discriminative stimulus effects of heroin: modulation by selective monoamine transport inhibitors.

  The Journal of pharmacology and experimental therapeutics 20040701

• A comparison of d, l-fenfluramine and citalopram challenges in healthy adults.

  Psychopharmacology 20040701

• Mechanisms for the inhibition of genital vascular responses by antidepressants in a female rabbit model.

  The Journal of pharmacology and experimental therapeutics 20040701

• Escitalopram versus citalopram: the surprising role of the R-enantiomer.

  Psychopharmacology 20040701

• Citalopram and mania.

  Journal of the American Academy of Child and Adolescent Psychiatry 20040701

• Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain.

  Nuclear medicine and biology 20040701

• Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans.

  NeuroImage 20040701

• Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.

  The American journal of psychiatry 20040701

• Mechanism of inhibitory effect of citalopram on isolated guinea-pig atria in relation to adenosine receptor.

  Human psychopharmacology 20040701

• Postmortem citalopram concentrations: alone or along with other compounds.

  Journal of forensic sciences 20040701

• The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.

  European journal of pharmacology 20040616

• Effects of citalopram on the excitability of the human motor cortex: a paired magnetic stimulation study.

  Journal of the neurological sciences 20040615

• The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine.

  Biological psychiatry 20040615

• [Oliguria and rise in creatine phosphokinase as a side-effect of citalopram].

  Atencion primaria 20040615

• Citalopram challenge in social anxiety disorder.

  The international journal of neuropsychopharmacology 20040601

• Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression.

  The Annals of pharmacotherapy 20040601

• Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response.

  Journal of clinical psychopharmacology 20040601

• Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.

  British journal of pharmacology 20040601

• A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents.

  The American journal of psychiatry 20040601

• Serotonin syndrome with tramadol and citalopram.

  The American journal of psychiatry 20040601

• Escitalopram in trichotillomania.

  European psychiatry : the journal of the Association of European Psychiatrists 20040601

• Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria.

  Current medical research and opinion 20040601

• [Content determination of S-citalopram by chiral high-performance liquid chromatography].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20040601

• Neonatal complications after intrauterine exposure to SSRI antidepressants.

  Prescrire international 20040601

• Effects of citalopram on worry and brain activation in patients with generalized anxiety disorder.

  Psychiatry research 20040530

• Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.

  Proceedings of the National Academy of Sciences of the United States of America 20040525

• Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression.

  European journal of pharmacology 20040525

• Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice.

  European journal of pharmacology 20040510

• Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension.

  Circulation 20040504

• R-citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter.

  British journal of pharmacology 20040501

• Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?

  European journal of clinical pharmacology 20040501

• Single photon emission computed tomography in posttraumatic stress disorder before and after treatment with a selective serotonin reuptake inhibitor.

  Journal of affective disorders 20040501

• Citalopram in the treatment of dysthymic disorder.

  International clinical psychopharmacology 20040501

• Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.

  International clinical psychopharmacology 20040501

• Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

  The American journal of psychiatry 20040501

• Hepatotoxicity related to citalopram.

  The American journal of psychiatry 20040501

• Adjunctive citalopram is effective on hallucinations and depersonalization symptoms: a case report.

  European psychiatry : the journal of the Association of European Psychiatrists 20040501

• Anger attacks in bipolar depression: predictors and response to citalopram added to mood stabilizers.

  The Journal of clinical psychiatry 20040501

• A case of kleptomania correlating with premenstrual dysphoria.

  The Journal of clinical psychiatry 20040501

• [Escitalopram: a chiral agent for treatment of depression].

  Medizinische Monatsschrift fur Pharmazeuten 20040501

• Differential effects of (R)-, (R, S)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on hippocampal serotonin release and induction of hypothermia in awake rats.

  Life sciences 20040423

• Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.

  Psychopharmacology 20040401

• [At what time is a reduction of medical under- or overtreatment sensible? Treatment of acute depression as an example].

  Psychiatrische Praxis 20040401

• A comparative solid-phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepin, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection.

  Journal of analytical toxicology 20040401

• Pseudoseizures and hysterical stridor.

  Epilepsy & behavior : E&B 20040401

• Improved potency of escitalopram on the human serotonin transporter: demonstration of an ex vivo assay technique.

  Journal of clinical psychopharmacology 20040401

• Olanzapine-induced neutropenia: mechanism and treatment.

  Journal of clinical psychopharmacology 20040401

• Clinical response augments NK cell activity independent of treatment modality: a randomized double-blind placebo controlled antidepressant trial.

  Psychological medicine 20040401

• Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.

  European journal of pharmacology 20040308

• Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial.

  JAMA 20040303

• Effects of long-term administration of the 5-hydroxytryptamine1B receptor antagonist AR-A000002 to guinea pigs.

  Psychopharmacology 20040301

• Acute augmentation of serotonin suppresses cardiovascular responses to emotional valence.

  The international journal of neuropsychopharmacology 20040301

• Pharmacology of a novel selective 5-hydroxytryptamine1B receptor antagonist, AR-A000002.

  Naunyn-Schmiedeberg's archives of pharmacology 20040301

• Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study.

  Acta psychiatrica Scandinavica 20040301

• Adherence to treatment of depression in active injection drug users: the minerva study.

  Journal of substance abuse treatment 20040301

• Amitriptyline and citalopram inhibit histamine-induced cardiovascular effects in rats.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20040301

• Enantioselective analysis of citalopram and its metabolites in postmortem blood and genotyping for CYD2D6 and CYP2C19.

  Journal of analytical toxicology 20040301

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040301

• Citalopram and bupropion-SR: combining versus switching in patients with treatment-resistant depression.

  The Journal of clinical psychiatry 20040301

• Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition.

  Pain 20040301

• [Cardiovascular effects of selective serotonin reuptake inhibitor antidepressants].

  Orvosi hetilap 20040222

• Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups.

  The Journal of pharmacology and experimental therapeutics 20040201

• Photo-distributed neutrophilic drug eruption and adult respiratory distress syndrome associated with antidepressant therapy.

  Journal of cutaneous pathology 20040201

• Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.

  Biological psychiatry 20040201

• Serotonin modulation of cerebral glucose metabolism in normal aging.

  Neurobiology of aging 20040201

• R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram.

  Pharmacology, biochemistry, and behavior 20040201

• Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor.

  The American journal of psychiatry 20040201

• Seizure secondary to citalopram overdose.

  The Journal of emergency medicine 20040201

• Escitalopram.

  Drugs of today (Barcelona, Spain : 1998) 20040201

• Metabolism of the newest antidepressants: comparisons with related predecessors.

  IDrugs : the investigational drugs journal 20040201

• Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

  Controlled clinical trials 20040201

• Therapeutic drug monitoring of trazodone: are there pharmacokinetic interactions involving citalopram and fluoxetine?

  International journal of clinical pharmacology and therapeutics 20040201

• Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys.

  The Journal of pharmacology and experimental therapeutics 20040101

• Reversal of fluoxetine-induced sexual dysfunction by switching to escitalopram.

  Journal of sex & marital therapy 20040101

• Escitalopram: superior to citalopram or a chiral chimera?

  Psychotherapy and psychosomatics 20040101

• The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex.

  Journal of neurochemistry 20040101

• Citalopram and dystonia.

  Journal of the American Academy of Child and Adolescent Psychiatry 20040101

• Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression.

  The American journal of psychiatry 20040101

• Plasma levels of citalopram in depressed patients with hepatitis C.

  Psychosomatics 20040101

• A case report of hyponatremia with citalopram use.

  Journal of the American Medical Directors Association 20040101

• Severe symptomatic hyponatremia during citalopram therapy--a case report.

  BMC nephrology 20040101

• Escitalopram continuation treatment prevents relapse of depressive episodes.

  The Journal of clinical psychiatry 20040101

• Frequency of infant adverse events that are associated with citalopram use during breast-feeding.

  American journal of obstetrics and gynecology 20040101

• Serotonin syndrome as a consequence of drug-resistant infections: an interaction between linezolid and citalopram.

  Journal of the American Medical Directors Association 20040101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040101

• A claims analysis comparing citalopram with sertraline as initial pharmacotherapy for a new episode of depression: impact on depression-related treatment charges.

  Clinical therapeutics 20040101

• Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.

  The Journal of clinical psychiatry 20040101

• Single-enantiomer drugs: elegant science, disappointing effects.

  Clinical pharmacokinetics 20040101

• Alexithymia in Noonan syndrome.

  Genetic counseling (Geneva, Switzerland) 20040101

• Comparative toxicity of citalopram and the newer antidepressants after overdose.

  Journal of toxicology. Clinical toxicology 20040101

• Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.

  Clinical pharmacokinetics 20040101

• Citalopram concentrations and response in obsessive-compulsive disorder. Preliminary results.

  CNS drugs 20040101

• [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

  L'Encephale 20040101

• Multivariate approaches for efficient detection of potential metabolites from liquid chromatography/mass spectrometry data.

  Rapid communications in mass spectrometry : RCM 20040101

• Citalopram treatment of major depressive disorder in Hispanic HIV and AIDS patients: a prospective study.

  Psychosomatics 20040101

• Citalopram and quality of life in lung transplant recipients.

  Psychosomatics 20040101

• Anxiety sensitivity and modulation of the serotonergic system in patients with PD.

  Journal of anxiety disorders 20040101

• Spotlight on the pharmacoeconomics of escitalopram in depression.

  CNS drugs 20040101

• A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder.

  Neuropsychobiology 20040101

• New formulations of existing antidepressants: advantages in the management of depression.

  CNS drugs 20040101

• Citalopram as treatment of depression in patients with epilepsy.

  Clinical neuropharmacology 20040101

• [Selective serotonin reuptake inhibitors--current knowledge].

  Psychiatria polska 20040101

• Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment.

  Journal of psychiatric research 20040101

• Antidepressants in the treatment of psychosis with comorbid depression in Parkinson disease.

  Clinical neuropharmacology 20040101

• Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.

  Depression and anxiety 20040101

• Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study.

  Depression and anxiety 20040101

• [The peculiarities of panic disorders determined by gender dimorphism].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20040101

• [Escitalopram--second generation of serotonin transporter inhibitors?].

  Psychiatria polska 20040101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20040101

• Citalopram treatment of depression in Parkinson's disease: the impact on anxiety, disability, and cognition.

  The Journal of neuropsychiatry and clinical neurosciences 20040101

• Reformulation of consumer health queries with professional terminology: a pilot study.

  Journal of medical Internet research 20040101

• [Clinical efficacy of citalopram in patients with hypertension and concomitant depression].

  Kardiologiia 20040101

• Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.

  BMC psychiatry 20040101

• [Use of cypramil in the treatment of depression in patients with gastrointestinal cancer].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20040101

• A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.

  CNS drugs 20040101

• Postmortem redistribution of the enantiomers of citalopram and its metabolites: an experimental study in rats.

  Journal of analytical toxicology 20040101

• Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache.

  Neuropsychobiology 20040101

• A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder.

  The Journal of clinical psychiatry 20040101

• Venous thromboembolism and escitalopram.

  General hospital psychiatry 20040101

• Kleptomania after head trauma: two case reports and combination treatment strategies.

  Clinical neuropharmacology 20040101

• Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions.

  Depression and anxiety 20040101

• Selective serotonin re-uptake inhibitors beyond psychiatry: are they useful in the treatment of severe, chronic, obstructive pulmonary disease?

  Depression and anxiety 20040101

• Chronic treatment with citalopram does not affect the expression of alpha1-adrenergic receptor (alpha1-AR) subtypes.

  Polish journal of pharmacology 20040101

• Poststroke depression: psychopharmacological considerations.

  Perspectives in psychiatric care 20040101

• Newer antidepressants in the primary care setting.

  Primary care companion to the Journal of clinical psychiatry 20040101

• Escitalopram Versus Citalopram and Sertraline: A Double-Blind Controlled, Multi-centric Trial in Indian Patients with Unipolar Major Depression.

  Indian journal of psychiatry 20040101

• Regional pattern of binding and c-Fos induction by (R)- and (S)-citalopram in rat brain.

  Neuroreport 20031219

• Potentiation of 5-hydroxytryptamine (5-HT) responses by a 5-HT uptake inhibitor in pulmonary and systemic vessels: effects of exposing rats to hypoxia.

  Naunyn-Schmiedeberg's archives of pharmacology 20031201

• 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.

  Journal of clinical psychopharmacology 20031201

• Premature ejaculation associated with citalopram withdrawal.

  The Annals of pharmacotherapy 20031201

• Citalopram-induced manic switch in an adolescent with epilepsy.

  The Australian and New Zealand journal of psychiatry 20031201

• Escitalopram (Lexapro) for depression.

  American family physician 20031201

• Putting theory into practice: a challenging case study in the treatment of depression.

  The Journal of family practice 20031201

• Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants.

  Epilepsy & behavior : E&B 20031201

• Therapeutic drug monitoring of 13 antidepressant and five neuroleptic drugs in serum with liquid chromatography-electrospray ionization mass spectrometry.

  Clinical chemistry and laboratory medicine 20031201

• Escitalopram-associated mania.

  Military medicine 20031201

• Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial.

  The Journal of clinical psychiatry 20031201

• 5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy.

  Experimental neurology 20031201

• [SSRI enantiomers already effective after 8 days. The proper twist against depression].

  MMW Fortschritte der Medizin 20031120

• Paradoxical effects of opioid antagonist naloxone on SSRI-induced analgesia and tolerance in mice.

  Pharmacology 20031101

• Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.

  British journal of pharmacology 20031101

• A preliminary study of left frontal region error negativity and symptom improvement in geriatric depression.

  The American journal of psychiatry 20031101

• Selective serotonin reuptake inhibitors in pilot fatalities of civil aviation accidents, 1990-2001.

  Aviation, space, and environmental medicine 20031101

• Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

  The Journal of clinical psychiatry 20031101

• The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression.

  Pharmacopsychiatry 20031101

• [Citalopram].

  Deutsche medizinische Wochenschrift (1946) 20031024

• Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.

  The Journal of pharmacology and experimental therapeutics 20031001

• Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes.

  British journal of clinical pharmacology 20031001

• Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19.

  Drug metabolism and disposition: the biological fate of chemicals 20031001

• Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopram.

  Therapeutic drug monitoring 20031001

• Somnambulism due to probable interaction of valproic acid and zolpidem.

  The Annals of pharmacotherapy 20031001

• Specific modulation of sigma binding sites by the anxiolytic drug opipramol.

  Journal of neural transmission (Vienna, Austria : 1996) 20031001

• Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan.

  Southern medical journal 20031001

• Stereospecific determination of citalopram and desmethylcitalopram by capillary electrophoresis and liquid-phase microextraction.

  Journal of pharmaceutical and biomedical analysis 20030919

• [11C]-NS 4194 versus [11C]-DASB for PET imaging of serotonin transporters in living porcine brain.

  Synapse (New York, N.Y.) 20030901

• Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.

  International clinical psychopharmacology 20030901

• R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model.

  Behavioural pharmacology 20030901

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20030901

• Treatment option for seasonal affective disorder.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030901

• Obsessive-compulsive spectrum disorders.

  Dialogues in clinical neuroscience 20030901

• Fatal overdose of the herbicide bentazone.

  Forensic science international 20030827

• Carbonic anhydrase activators. The selective serotonin reuptake inhibitors fluoxetine, sertraline and citalopram are strong activators of isozymes I and II.

  Bioorganic & medicinal chemistry letters 20030818

• Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension.

  American journal of respiratory and critical care medicine 20030815

• Antidepressant-like effects in various mice strains in the tail suspension test.

  Behavioural brain research 20030814

• Synthesis and biological evaluation of novel carbon-11-labelled analogues of citalopram as potential radioligands for the serotonin transporter.

  Bioorganic & medicinal chemistry 20030805

• Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.

  Psychopharmacology 20030801

• Citalopram treatment of children and adolescents with obsessive-compulsive disorder: a preliminary report.

  Psychiatry and clinical neurosciences 20030801

• Stereoselective single-dose kinetics of citalopram and its metabolites in rats.

  Chirality 20030801

• The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats.

  Neuropharmacology 20030801

• Functional coupling of serotonin and noradrenaline transporters.

  Journal of neurochemistry 20030801

• Enantiomeric separation of citalopram and its metabolites by capillary electrophoresis.

  Electrophoresis 20030801

• Cardiotoxicity and late onset seizures with citalopram overdose.

  The Journal of emergency medicine 20030801

• Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine.

  Journal of clinical psychopharmacology 20030801

• The effectiveness of citalopram for idiopathic chronic fatigue.

  The Journal of clinical psychiatry 20030801

• A 1-year naturalistic follow-up of patients with compulsive shopping disorder.

  The Journal of clinical psychiatry 20030801

• Serotonin transporters are preserved in the neocortex of anxious Alzheimer's disease patients.

  Neuroreport 20030718

• Antidepressants and emotional processing.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030701

• The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis.

  Seizure 20030701

• Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?

  Journal of neural transmission (Vienna, Austria : 1996) 20030701

• Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.

  International clinical psychopharmacology 20030701

• Citalopram for impulsive aggression.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030701

• Residual cognitive impairment in late-life depression after a 12-month period follow-up.

  International journal of geriatric psychiatry 20030701

• Differential neurochemical properties of central serotonergic transmission in Roman high- and low-avoidance rats.

  Journal of neurochemistry 20030701

• Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.

  British journal of pharmacology 20030701

• There is a new antidepressant escitalopram (Lexapro) that is a cousin of citalopram (Celexa). How are these two different and does the newer drug have any advantages?

  The Harvard mental health letter 20030701

• Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuation.

  The Journal of clinical psychiatry 20030701

• Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.

  The Journal of clinical psychiatry 20030701

• R-citalopram counteracts the effect of escitalopram in a rat conditioned fear stress model of anxiety.

  Pharmacology, biochemistry, and behavior 20030701

• Ectopic serotonin accumulation and efflux in rat mesencephalic slices after prior tissue 'radiolabelling'.

  Brain research bulletin 20030630

• Interference of anaesthetics with radioligand binding in neuroreceptor studies.

  European journal of nuclear medicine and molecular imaging 20030601

• Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.

  Psychopharmacology 20030601

• The effect of combined administration of ethanol and sertraline, fluoxetine and citalopram on rabbit EEG.

  Pharmacological research 20030601

• Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorder.

  Journal of affective disorders 20030601

• Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial.

  The Journal of clinical psychiatry 20030601

• An open-label study of citalopram in body dysmorphic disorder.

  The Journal of clinical psychiatry 20030601

• Serotonin syndrome: a brief review.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030527

• [Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].

  MMW Fortschritte der Medizin 20030526

• Lundbeck broke advertising rules.

  BMJ (Clinical research ed.) 20030510

• 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030501

• Age-related differences in the side effect profile of citalopram.

  Progress in neuro-psychopharmacology & biological psychiatry 20030501

• Citalopram--a risk factor for postoperative hyponatraemia.

  Anaesthesia 20030501

• Adaptive changes in the reactivity of 5-HT1A and 5-HT2 receptors induced in rat frontal cortex by repeated imipramine and citalopram.

  Naunyn-Schmiedeberg's archives of pharmacology 20030501

• Serotonin syndrome after concomitant treatment with linezolid and citalopram.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030501

• Placental passage of antidepressant medications.

  The American journal of psychiatry 20030501

• Citalopram treatment of fluoxetine-intolerant depressed patients.

  The Journal of clinical psychiatry 20030501

• [Therapy resistant major depression: improvement of symptomatology after combining antidepressants with Tianeptine (Stablon)].

  Psychiatrische Praxis 20030501

• Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells.

  Blood 20030415

• Contrasting effects of citalopram and reboxetine on waking salivary cortisol.

  Psychopharmacology 20030401

• Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.

  Therapeutic drug monitoring 20030401

• Olanzapine and serotonin toxicity.

  Psychiatry and clinical neurosciences 20030401

• Use of citalopram in pervasive developmental disorders.

  Journal of developmental and behavioral pediatrics : JDBP 20030401

• Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.

  The Journal of clinical psychiatry 20030401

• [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].

  Revue neurologique 20030401

• An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir.

  Clinical therapeutics 20030401

• R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model.

  European journal of pharmacology 20030319

• Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat.

  Psychopharmacology 20030301

• Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).

  Psychopharmacology 20030301

• Effect of citalopram on ouabain-induced arrhythmia in isolated guinea-pig atria.

  Human psychopharmacology 20030301

• Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques.

  Molecular psychiatry 20030301

• Polydrug fatality involving metaxalone.

  Journal of forensic sciences 20030301

• Burning mouth syndrome as a side effect of SSRIs.

  The Journal of clinical psychiatry 20030301

• An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients.

  Palliative & supportive care 20030301

• Chronic inhibition of the norepinephrine transporter in the brain participates in seizure sensitization to cocaine and local anesthetics.

  Brain research 20030221

• [Persistent fatigue despite sufficient sleep].

  Praxis 20030219

• Repeated citalopram treatment but not stress exposure attenuates hypothalamic-pituitary-adrenocortical axis response to acute citalopram injection.

  Life sciences 20030207

• [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.

  Synapse (New York, N.Y.) 20030201

• Positron emission tomography imaging of the serotonin transporter in the pig brain using [11C](+)-McN5652 and S-([18F]fluoromethyl)-(+)-McN5652.

  Synapse (New York, N.Y.) 20030201

• Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2).

  Gut 20030201

• SSRIs and ejaculation.

  Journal of clinical psychopharmacology 20030201

• Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center.

  Psychiatric services (Washington, D.C.) 20030201

• Depression, IV: STAR*D treatment trial for depression.

  The American journal of psychiatry 20030201

• Serum leptin levels in patients with premature ejaculation before and after citalopram treatment.

  BJU international 20030201

• Rat strain differences in peripheral and central serotonin transporter protein expression and function.

  The European journal of neuroscience 20030201

• Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum.

  The European journal of neuroscience 20030201

• Adult respiratory distress syndrome and renal failure associated with citalopram overdose.

  Human & experimental toxicology 20030201

• Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity.

  Brain research 20030103

• Chronic citalopram treatment induces time-dependent changes in the expression and DNA-binding activity of transcription factor AP-2 in rat brain.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20030101

• Acute SSRI administration affects the processing of social cues in healthy volunteers.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030101

• Dexamphetamine for obsessive-compulsive disorder.

  The American journal of psychiatry 20030101

• Impulsive aggressive behavior: open-label treatment with citalopram.

  The Journal of clinical psychiatry 20030101

• [Clinical significance of adrenoreactivity in patients with some paroxysmal disorders (panic attacks and migraine)].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101

• Serotonergic modulation of the balance system in panic disorder: an open study.

  Depression and anxiety 20030101

• Sexual addiction being studied.

  AIDS patient care and STDs 20030101

• Meniere's disease: some patients benefit significantly from SSRIs.

  Australian family physician 20030101

• abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice.

  Journal of psychiatric research 20030101

• Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment.

  Journal of psychiatric research 20030101

• Escitalopram : a review of its use in the management of major depressive and anxiety disorders.

  CNS drugs 20030101

• [Ability of cipramil to correct conditioned passive avoidance in ovariectomized female rats].

  Eksperimental'naia i klinicheskaia farmakologiia 20030101

• Soy and social stress affect serotonin neurotransmission in primates.

  The pharmacogenomics journal 20030101

• [Cipramil treatment of neurotic depression].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101

• Electrocardiographic dose-dependent changes in prophylactic doses of dosulepine, lithium and citalopram.

  Physiological research 20030101

• Citalopram treatment of social anxiety disorder with comorbid major depression.

  Depression and anxiety 20030101

• The development of new antidepressants: focus on duloxetine and escitalopram.

  Harvard review of psychiatry 20030101

• [Mechanisms of action of antidepressants: new data from Escitalopram].

  L'Encephale 20030101

• Decreased plasma prolactin release in euthymic lithium-treated women with bipolar disorder.

  Neuropsychobiology 20030101

• [Clinical effectiveness and safety of citalopram in patients with depression after myocardial infarction].

  Kardiologiia 20030101

• Repeated administration of antidepressants decreases field potentials in rat frontal cortex.

  Neuroscience 20030101

• 'My Father Did This to Me!' the psychodynamic treatment of an angry, sad, and violent young man.

  Harvard review of psychiatry 20030101

• Overview of the safety of citalopram.

  Psychopharmacology bulletin 20030101

• Escitalopram: a pharmacoeconomic review of its use in depression.

  PharmacoEconomics 20030101

• [Pharmacotherapy in heroin addiction: pharmacological approaches to remission stabilization and recurrence prevention].

  Vestnik Rossiiskoi akademii meditsinskikh nauk 20030101

• Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo.

  Psychopharmacology bulletin 20030101

• A pilot open-label trial of citalopram for restless activity and aberrant motor behaviors in Alzheimer disease.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20030101

• [Efficacy of citalopram in more than maximal dose in drug resistant depression. Case report].

  Psychiatria polska 20030101

• Obsessive-Compulsive disorder, Tourette's disorder, or pediatric autoimmune neuropsychiatric disorders associated with Streptococcus in an adolescent? Diagnostic and therapeutic challenges.

  Journal of child and adolescent psychopharmacology 20030101

• [Psychophysiologic disorders in patients with functional disorders of upper sections of the gastrointestinal tract and with gastroesophageal reflux disease].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• When is it worth introducing a quality improvement program? A mathematical model.

  Medical decision making : an international journal of the Society for Medical Decision Making 20030101

• Delusions of parasitiosis: a case with a review of its course and treatment.

  Skinmed 20030101

• Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.

  The Journal of clinical psychiatry 20030101

• Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study.

  Polish journal of pharmacology 20030101

• Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors.

  Redox report : communications in free radical research 20030101

• Pilot evaluation of citalopram for the relief of hot flashes.

  The journal of supportive oncology 20030101

• A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor. Comparison of cost-effectiveness between escitalopram, citalopram, fluoxetine, and venlafaxine for the treatment of depression in Norway.

  The European journal of health economics : HEPAC : health economics in prevention and care 20030101

• A renaissance for fluoxetine in the management of depression in the elderly?

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20030101

• MK-801- and ethanol-induced activity in inbred long-sleep and short-sleep mice: dopamine and serotonin systems.

  European journal of pharmacology 20021220

• Pentylenetetrazol-kindling of seizures selectively decreases [3H]-citalopram binding in the CA-3 area of rat hippocampus.

  Neuroscience letters 20021219

• Antidepressant effects on kinase gene expression patterns in rat brain.

  Neuroscience letters 20021213

• The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM.

  Pharmacology, biochemistry, and behavior 20021201

• Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings.

  Human psychopharmacology 20021201

• The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study.

  International journal of impotence research 20021201

• Simultaneous quantification of citalopram, clozapine, fluoxetine, norfluoxetine, maprotiline, desmethylmaprotiline and trazodone in human serum by HPLC analysis.

  International journal of clinical pharmacology and therapeutics 20021201

• Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.

  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20021201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20021201

• Effect of 5-HT1A receptor-mediated serotonin augmentation on Fos immunoreactivity in rat brain.

  European journal of pharmacology 20021129

• MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression.

  Journal of the neurological sciences 20021115

• Predosing with the unlabeled 'inactive' enantiomer as a tool for improvement of the PET signal.

  Synapse (New York, N.Y.) 20021101

• Citalopram in children and adolescents with depression or anxiety.

  The Annals of pharmacotherapy 20021101

• Frontal white matter microstructure and treatment response of late-life depression: a preliminary study.

  The American journal of psychiatry 20021101

• Hormone responses to citalopram in abstinent alcohol dependent subjects.

  Alcoholism, clinical and experimental research 20021101

• Escitalopram: efficacy and tolerability in the treatment of depression.

  Hospital medicine (London, England : 1998) 20021101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20021101

• Can olanzapine be implicated in causing serotonin syndrome?

  Psychiatry and clinical neurosciences 20021001

• Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20021001

• Efficacy of citalopram in anorexia nervosa: a pilot study.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20021001

• Citalopram-associated SIADH.

  The Annals of pharmacotherapy 20021001

• Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression.

  Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20021001

• Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [11C]5-bromo-2-[2-(dimethylaminomethylphenylsulfanyl)]phenylamine ([11C]DAPA).

  Nuclear medicine and biology 20021001

• Escitalopram.

  Expert opinion on investigational drugs 20021001

• Effect of YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT 2A receptor antagonistic activity, on a marble-burying behavior test as an obsessive-compulsive disorder model.

  Japanese journal of pharmacology 20021001

• Escitalopram (lexapro) for depression.

  The Medical letter on drugs and therapeutics 20020930

• Enhancement of stress-induced pituitary hormone release and cardiovascular activation by antidepressant treatment in healthy men.

  Journal of psychopharmacology (Oxford, England) 20020901

• Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta.

  BJOG : an international journal of obstetrics and gynaecology 20020901

• p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.

  Journal of neurochemistry 20020901

• Depression in multiple sclerosis associated with interferon beta-1a (Rebif).

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20020901

• Panic attacks associated with citalopram.

  Southern medical journal 20020901

• Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.

  The Journal of clinical psychiatry 20020901

• Addictive and nonaddictive smoking as related to responsivity to neurotransmitter systems.

  Behavioural pharmacology 20020901

• Potentiation of DOM-induced stimulus control by fluoxetine and citalopram: role of pharmacokinetics.

  Life sciences 20020802

• Serotonin agents in the treatment of acquired brain injury.

  The Journal of head trauma rehabilitation 20020801

• Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects.

  Synapse (New York, N.Y.) 20020801

• Block of volume-regulated anion channels by selective serotonin reuptake inhibitors.

  Naunyn-Schmiedeberg's archives of pharmacology 20020801

• Effect of citalopram treatment on relationship between platelet serotonin functions and the Karolinska scales of personality in panic patients.

  Journal of clinical psychopharmacology 20020801

• Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting.

  Journal of clinical psychopharmacology 20020801

• Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).

  American heart journal 20020801

• Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.

  Psychopharmacology 20020801

• Acute administration of citalopram facilitates memory consolidation in healthy volunteers.

  Psychopharmacology 20020801

• Acute citalopram administration produces correlated increases in plasma and salivary cortisol.

  Psychopharmacology 20020801

• Citalopram in pregnancy and lactation.

  Clinical pharmacology and therapeutics 20020801

• Citalopram treatment of compulsive shopping: an open-label study.

  The Journal of clinical psychiatry 20020801

• Escitalopram H Lundbeck.

  Current opinion in investigational drugs (London, England : 2000) 20020801

• [Misleading basis for marketing of Cipralex].

  Lakartidningen 20020711

• The selective serotonin reuptake inhibitor citalopram induces the storage of serotonin in catecholaminergic terminals.

  The Journal of pharmacology and experimental therapeutics 20020701

• Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy.

  The British journal of psychiatry : the journal of mental science 20020701

• Postmortem concentrations of citalopram.

  Journal of forensic sciences 20020701

• Perhexiline toxicity related to citalopram use.

  The Medical journal of Australia 20020603

• Prolonged coma caused by low sodium and hypo-osmolarity during treatment with citalopram.

  Journal of clinical psychopharmacology 20020601

• Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020601

• Management of treatment resistant obsessive-compulsive disorder. Algorithms for pharmacotherapy.

  Panminerva medica 20020601

• Early malnourished rats are not affected by anorexia induced by a selective serotonin reuptake inhibitor in adult life.

  Nutritional neuroscience 20020601

• Citalopram-Clonazepam combination for primary depersonalization disorder: a case report.

  The Australian and New Zealand journal of psychiatry 20020601

• Mental well-being in subjects with long-term excessive alcohol consumption: an experimental study.

  Alcohol (Fayetteville, N.Y.) 20020601

• Citalopram in PMS patients with prior SSRI treatment failure: a preliminary study.

  Journal of women's health & gender-based medicine 20020601

• Intravenous antidepressant treatment: focus on citalopram.

  European archives of psychiatry and clinical neuroscience 20020601

• Functional brain imaging and pharmacotherapy in trichotillomania. Single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram.

  Progress in neuro-psychopharmacology & biological psychiatry 20020601

• Effects of chronic citalopram treatment on central and peripheral spontaneous open-field behaviours in rats.

  Pharmacology & toxicology 20020601

• [Who does need Cipralex and why?].

  Lakartidningen 20020516

• Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model.

  Pharmacology, biochemistry, and behavior 20020501

• Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care.

  International clinical psychopharmacology 20020501

• Treatment of generalized anxiety disorder with citalopram.

  International clinical psychopharmacology 20020501

• Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy.

  Archives of general psychiatry 20020501

• A stroke patient with a non-convulsive status epilepticus during citalopram therapy.

  European journal of neurology 20020501

• Citalopram treatment for impulsive aggression in children and adolescents: an open pilot study.

  Journal of the American Academy of Child and Adolescent Psychiatry 20020501

• Serotonergic intervention affects both social dominance and affiliative behaviour.

  Psychopharmacology 20020501

• Impaired spatial learning in the Morris water maze induced by serotonin reuptake inhibitors in rats.

  Behavioural pharmacology 20020501

• Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.

  Pharmacology, biochemistry, and behavior 20020401

• 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors.

  Blood 20020401

• Modulation of the critical flicker fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes.

  Psychopharmacology 20020401

• Serotonin transporter distribution and density in the cerebral cortex of alcoholic and nonalcoholic comparison subjects: a whole-hemisphere autoradiography study.

  The American journal of psychiatry 20020401

• Citalopram-induced priapism.

  Pharmacotherapy 20020401

• Citalopram has an antagonistic action on cortical spreading depression in well-nourished and early-malnourished adult rats.

  Nutritional neuroscience 20020401

• Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.

  The Journal of clinical psychiatry 20020401

• Amitriptyline and citalopram, two different types of antidepressant drugs, relax histamine-contracted porcine coronary artery.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20020401

• 1-(1-naphthyl)-piperazine, a mixed 5-HT1A and 5-HT2A/2C receptor ligand, elicits an anxiolytic-like effect in the open-field test without changes in 5-HT metabolism.

  Methods and findings in experimental and clinical pharmacology 20020401

• Great expectations in stereochemistry: focus on antidepressants.

  CNS spectrums 20020401

• Escitalopram: a second-generation SSRI.

  CNS spectrums 20020401

• Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials.

  CNS spectrums 20020401

• New single-isomer compounds on the horizon.

  CNS spectrums 20020401

• Citalopram in fatal poisoning cases.

  Forensic science international 20020328

• Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 2: 4-substituted 6-nitroquipazines.

  Bioorganic & medicinal chemistry letters 20020311

• Reduced serotonin release and serotonin uptake sites in the rat nucleus accumbens and striatum after prenatal cocaine exposure.

  Brain research 20020301

• Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.

  The American journal of psychiatry 20020301

• Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice.

  The European journal of neuroscience 20020301

• An open-label trial of citalopram for major depression in patients with hepatitis C.

  The Journal of clinical psychiatry 20020301

• Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.

  The Journal of clinical psychiatry 20020301

• Exacerbation of idiopathic priapism with risperidone-citalopram combination.

  The Journal of clinical psychiatry 20020301

• Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests.

  The international journal of neuropsychopharmacology 20020301

• Overexpression of S100beta in transgenic mice does not protect from serotonergic denervation induced by 5,7-dihydroxytryptamine.

  Journal of neuroscience research 20020215

• Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents.

  FEBS letters 20020213

• Role of 5-HT1A receptors in the mediation of acute citalopram effects: a 8-OH-DPAT challenge study.

  Progress in neuro-psychopharmacology & biological psychiatry 20020201

• Tapping the potential of isomer science.

  Behavioral healthcare tomorrow 20020201

• Probable interaction between citalopram and acenocoumarol.

  The Annals of pharmacotherapy 20020201

• Organic hypomania secondary to sibutramine-citalopram interaction.

  The Journal of clinical psychiatry 20020201

• Interferon-induced depression treated with citalopram.

  The Journal of clinical psychiatry 20020201

• Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma by temperature-programmed packed capillary liquid chromatography with on-column focusing of large injection volumes.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020105

• State and trait abnormalities in serotonin function in major depression.

  The British journal of psychiatry : the journal of mental science 20020101

• Citalopram and psychotic symptoms.

  Journal of the American Academy of Child and Adolescent Psychiatry 20020101

• Dysthymic disorder: treatment with citalopram.

  Depression and anxiety 20020101

• An open-label study of citalopram in the treatment of pathological gambling.

  The Journal of clinical psychiatry 20020101

• In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations.

  Molecular psychiatry 20020101

• The SSRI, citalopram, improves bradykinesia in patients with Parkinson's disease treated with L-dopa.

  Clinical neuropharmacology 20020101

• Treatment of social anxiety disorder with citalopram.

  Progress in neuro-psychopharmacology & biological psychiatry 20020101

• Difference in serotonergic and noradrenergic regulation of human social behaviours.

  Psychopharmacology 20020101

• Adjunctive modafinil in ALS.

  The Journal of neuropsychiatry and clinical neurosciences 20020101

• Citalopram treatment of minor depression in elderly men: an open pilot study.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20020101

• The preclinical observation that escitalopram possesses a faster time to onset of efficacy than citalopram.

  Pharmacology & toxicology 20020101

• Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder.

  Journal of child and adolescent psychopharmacology 20020101

• Combined psychoeducation and treatment with selective serotonin reuptake inhibitors for youth with generalized social anxiety disorder.

  Journal of child and adolescent psychopharmacology 20020101

• Disposition of citalopram in biological specimens from postmortem cases.

  Journal of forensic sciences 20020101

• A case of SIADH and hyponatremia associated with citalopram.

  Psychosomatics 20020101

• [Post-stroke depression: an experience in using cipramil].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20020101

• [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].

  L'Encephale 20020101

• Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia.

  Molecular psychiatry 20020101

• Citalopram inhibits L-type calcium channel current in rat cardiomyocytes in culture.

  Physiological research 20020101

• [Effects of escitalopram on anxiety symptoms in depression].

  L'Encephale 20020101

• A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.

  Molecular psychiatry 20020101

• Naturalistic study of the early psychiatric use of citalopram in the United States.

  Depression and anxiety 20020101

• Citalopram treatment of paroxetine-intolerant depressed patients.

  Depression and anxiety 20020101

• Wolf-Hirschhorn (4p-)syndrome in a near adult with major depression; successful treatment with citalopram.

  Genetic counseling (Geneva, Switzerland) 20020101

• A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders.

  Journal of child and adolescent psychopharmacology 20020101

• Evaluating the consistency of pharmacotherapy exposure by use of state-of-the-art techniques.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20020101

• Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20020101

• Citalopram for the treatment of adolescent anxiety disorders: a pilot study.

  Psychopharmacology bulletin 20020101

• Tricyclic antidepressants prevent the differentiation of monocytes into macrophage-like cells in vitro.

  Cell biology and toxicology 20020101

• Citalopram-induced severe hyponatraemia with coma and seizure. Case report with literature and spontaneous reports review.

  Adverse drug reactions and toxicological reviews 20020101

• [Clinical efficacy of citalopram in patients with obsessive-compulsive disorder].

  Psychiatria polska 20020101

• Long-term treatment with citalopram in patients with highly recurrent forms of unipolar depression.

  Psychiatry research 20011215

• Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates?

  Synapse (New York, N.Y.) 20011201

• Citalopram augmentation of antipsychotic treatment in older schizophrenia patients.

  International journal of geriatric psychiatry 20011201

• SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram.

  Journal of clinical psychopharmacology 20011201

• Citalopram as adjunctive therapy in bipolar depression.

  The Journal of clinical psychiatry 20011201

• Citalopram in the maintenance treatment of major depressive disorder.

  The Journal of clinical psychiatry 20011201

• Citalopram-induced bradycardia and presyncope.

  The Annals of pharmacotherapy 20011201

• Enantioselective analysis of citalopram and metabolites in adolescents.

  Therapeutic drug monitoring 20011201

• Citalopram-induced photopigmentation.

  The Journal of dermatology 20011201

• Effects of acute citalopram treatment on the methamphetamine-induced locomotor activity.

  Progress in neuro-psychopharmacology & biological psychiatry 20011101

• Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study.

  The American journal of psychiatry 20011101

• Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue.

  British journal of pharmacology 20011101

• Structure, function and regulation of the 5-hydroxytryptamine (serotonin) transporter.

  Biochemical Society transactions 20011101

• Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder.

  International clinical psychopharmacology 20011101

• Treatment of pathological crying with citalopram.

  Pharmacopsychiatry 20011101

• Brief report: citalopram in child and adolescent depression with anxiety.

  MedGenMed : Medscape general medicine 20011031

• Citalopram for social phobia: a clinical case series.

  Progress in neuro-psychopharmacology & biological psychiatry 20011001

• Citalopram in social phobia.

  Journal of the American Academy of Child and Adolescent Psychiatry 20011001

• Clinical predictors of drug response in obsessive-compulsive disorder.

  Journal of clinical psychopharmacology 20011001

• Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects.

  Journal of clinical psychopharmacology 20011001

• Citalopram distribution in postmortem cases.

  Journal of analytical toxicology 20011001

• The clinical experience of citalopram in the treatment of post-traumatic stress disorder: a report of two Persian Gulf War veterans.

  Military medicine 20011001

• Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants.

  Journal of neurochemistry 20011001

• Chronic antidepressant treatments decrease pro-opiomelanocortin mRNA expression in the pituitary gland: effects of acute stress and 5-HT(1A) receptor activation.

  Journal of neuroendocrinology 20011001

• S-enantiomer of the selective serotonin reuptake inhibitor citalopram compared with racemate citalopram (S+R).

  Pharmacology & toxicology 20011001

• Membrane cholesterol modulates serotonin transporter activity.

  Biochemistry 20010904

• Rational design and synthesis of novel 2,5-disubstituted cis- and trans-piperidine derivatives exhibiting differential activity for the dopamine transporter.

  Bioorganic & medicinal chemistry letters 20010903

• Binding characteristics of selective serotonin reuptake inhibitors with relation to emission tomography studies.

  Synapse (New York, N.Y.) 20010901

• Distribution of serotonin, its metabolites and 5-HT transporters in the neostriatum of Lurcher and weaver mutant mice.

  Neurochemistry international 20010901

• Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.

  Biological psychiatry 20010901

• Treatment of abdominally obese men with a serotonin reuptake inhibitor: a pilot study.

  Journal of internal medicine 20010901

• Serotonergic involvement in the psychosocial dimension of personality.

  Journal of psychopharmacology (Oxford, England) 20010901

• Citalopram overdose, serotonin toxicity, or neuroleptic malignant syndrome?

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010901

• Case report: left bundle branch block--a rare complication of citalopram overdose.

  Journal of the South Carolina Medical Association (1975) 20010901

• Action of selective serotonin reuptake inhibitor on aggressive behavior in adult rat submitted to the neonatal malnutrition.

  Arquivos de neuro-psiquiatria 20010901

• [Citalopram and Torsades de Pointes. A case report].

  Archives des maladies du coeur et des vaisseaux 20010901

• Effects of corticosterone ingestion on hippocampal [(3)H]serotonin reuptake in inbred rat strains.

  Endocrine regulations 20010901

• A new alternative synthesis of 5-cyanophthalide, a versatile intermediate in the preparation of the antidepressant drug citalopram.

  Farmaco (Societa chimica italiana : 1989) 20010901

• Citalopram treatment of fluoxetine nonresponders.

  The Journal of clinical psychiatry 20010901

• [Serotonin uptake inhibitors provide rapid relief from premenstrual dysphoria. New findings shed light on how serotonin modulates sex hormone-related behavior].

  Lakartidningen 20010822

• Relationship between central serotonergic neurotransmission and reduction in alcohol intake by citalopram.

  Drug and alcohol dependence 20010801

• Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram.

  Drug metabolism and disposition: the biological fate of chemicals 20010801

• S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

  The Journal of pharmacology and experimental therapeutics 20010801

• S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

  The Journal of pharmacology and experimental therapeutics 20010801

• Low frequency rTMS as an add-on antidepressive strategy: heterogeneous impact on 99mTc-HMPAO and 18 F-FDG uptake as measured simultaneously with the double isotope SPECT technique. Pilot study.

  Nuclear medicine communications 20010801

• Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout.

  Journal of neurochemistry 20010801

• Long-term experience with citalopram in the treatment of adolescent OCD.

  Journal of the American Academy of Child and Adolescent Psychiatry 20010801

• Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010801

• Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor.

  Neuroreport 20010720

• Citalopram for OCD and Tourette's syndrome.

  Journal of the American Academy of Child and Adolescent Psychiatry 20010701

• Behavioral and neurochemical effects of anpirtoline and citalopram in isolated and group housed mice.

  Progress in neuro-psychopharmacology & biological psychiatry 20010701

• Citalopram in refractory obsessive-compulsive disorder: an open study.

  International clinical psychopharmacology 20010701

• Forced titration as a confound in an SSRI comparator study of sertaline versus citalopram in the treatment of major depressive disorder.

  Biological psychiatry 20010701

• Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle.

  Canadian journal of physiology and pharmacology 20010701

• Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010601

• The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after 1 week of treatment with citalopram: an open study.

  Journal of clinical psychopharmacology 20010601

• Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study.

  Acta psychiatrica Scandinavica 20010601

• Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.

  The Journal of clinical psychiatry 20010601

• Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database.

  The international journal of neuropsychopharmacology 20010601

• Rapid determination of citalopram in human plasma by high-performance liquid chromatography.

  Journal of chromatography. B, Biomedical sciences and applications 20010505

• Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model.

  Pharmacology & toxicology 20010501

• Does mirtazapine have a more rapid onset than SSRIs?

  The Journal of clinical psychiatry 20010501

• Low-dose citalopram as a 5-HT neuroendocrine probe.

  Psychopharmacology 20010501

• A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.

  Pharmacopsychiatry 20010501

• Further investigation of citalopram on alcohol consumption in heavy drinkers: responsiveness possibly linked to the DRD2 A2/A2 genotype.

  Alcohol (Fayetteville, N.Y.) 20010501

• On-line extraction using an alkyl-diol silica precolumn for racemic citalopram and its metabolites in plasma. Results compared with solid-phase extraction methodology.

  Journal of chromatography. B, Biomedical sciences and applications 20010405

• Local 5,7-dihydroxytryptamine lesions of rat amygdala: release of punished drinking, unaffected plus-maze behavior and ethanol consumption.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010401

• Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care.

  Journal of clinical psychopharmacology 20010401

• Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy.

  The British journal of psychiatry : the journal of mental science 20010401

• In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats.

  British journal of pharmacology 20010401

• Are newer antidepressants really 'better tolerated'?

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010401

• Citalopram: a comprehensive review.

  Expert opinion on pharmacotherapy 20010401

• The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers.

  Psychopharmacology 20010401

• Involvement of 5-HT1A and 5-HT1B receptors for citalopram-induced hypothermia in the rat.

  Psychopharmacology 20010401

• Quantitative radioluminography of serotonin uptake sites in the porcine brain.

  Synapse (New York, N.Y.) 20010315

• Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010301

• Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder.

  International clinical psychopharmacology 20010301

• Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala.

  Journal of neurochemistry 20010301

• Lack of citalopram effect on oral digoxin pharmacokinetics.

  Journal of clinical pharmacology 20010301

• A fatal case of serotonin syndrome after combined moclobemide-citalopram intoxication.

  Journal of analytical toxicology 20010301

• Citalopram in mentally retarded patients with depression: a long-term clinical investigation.

  European psychiatry : the journal of the Association of European Psychiatrists 20010301

• [Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate].

  [Hokkaido igaku zasshi] The Hokkaido journal of medical science 20010301

• Biophysical characterization of the cocaine binding pocket in the serotonin transporter using a fluorescent cocaine analogue as a molecular reporter.

  The Journal of biological chemistry 20010216

• Liquid-phase microextraction and capillary electrophoresis of citalopram, an antidepressant drug.

  Journal of chromatography. A 20010209

• Evidence for a serotonin transporter deficit in experimental acute liver failure.

  Neurochemistry international 20010201

• Female sexual dysfunction and antidepressant use.

  The American journal of psychiatry 20010201

• Citalopram-induced bruxism.

  The British journal of psychiatry : the journal of mental science 20010201

• The mood-lowering effect of tryptophan depletion: possible explanation for discrepant findings.

  Archives of general psychiatry 20010201

• Lack of effect of a single dose of ketoconazole on the pharmacokinetics of citalopram.

  Pharmacotherapy 20010201

• Severe symptomatic hyponatremia during citalopram therapy.

  The American journal of the medical sciences 20010201

• Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.

  Naunyn-Schmiedeberg's archives of pharmacology 20010201

• Disinhibition of libido: an adverse effect of SSRI?

  Journal of affective disorders 20010201

• In vitro metabolism of citalopram by monoamine oxidase B in human blood.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010201

• Effect of serotonin reuptake inhibitor on syndrome development in obese hyperglycemic mice (Umeå ob/ob).

  Metabolism: clinical and experimental 20010201

• Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.

  Psychopharmacology 20010201

• Mood and behavioural disorders following traumatic brain injury: clinical evaluation and pharmacological management.

  Brain injury 20010201

• Some behavioural effects of antidepressant drugs are time-dependent.

  Progress in neuro-psychopharmacology & biological psychiatry 20010201

• [The transfer of selective serotonin reuptake inhibitors to human milk].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20010120

• Catalepsy induced by the 5-HT(1A) receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram.

  European journal of pharmacology 20010112

• Differential sensitivities to the lethal, but not the neurotoxic, effects of p-chloroamphetamine in inbred rat strains.

  Neuroscience letters 20010105

• Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study.

  Neurochemistry international 20010101

• Reduction of intraspecific aggression in adult rats by neonatal treatment with a selective serotonin reuptake inhibitor.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20010101

• An open trial of citalopram in adolescents with post-traumatic stress disorder.

  International clinical psychopharmacology 20010101

• Serotonin syndrome. A common but often unrecognized psychiatric condition.

  Geriatrics 20010101

• Effect of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex.

  Journal of neurochemistry 20010101

• Evidence of early onset of antidepressant effect in randomized controlled trials.

  The Journal of clinical psychiatry 20010101

• Clinical significance of monitoring early symptom change to predict outcome.

  The Journal of clinical psychiatry 20010101

• An ideal trial to test differential onset of antidepressant effect.

  The Journal of clinical psychiatry 20010101

• Inositol in the treatment of trichotillomania and compulsive skin picking.

  The Journal of clinical psychiatry 20010101

• Following long-term training with citalopram, both mirtazapine and mianserin block its discriminative stimulus properties in rats.

  Psychopharmacology 20010101

• First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression.

  Neuropsychobiology 20010101

• QTc interval prolongation associated with citalopram overdose: a case report and literature review.

  Clinical neuropharmacology 20010101

• Trichotillomania associated with dementia: a case report.

  General hospital psychiatry 20010101

• Too much hypothalamic serotonin transporter is bad for your mood.

  Trends in molecular medicine 20010101

• A retrospective study of citalopram in adolescents with depression.

  Journal of child and adolescent psychopharmacology 20010101

• Rapid response to low dose citalopram in pathological crying.

  General hospital psychiatry 20010101

• [Cutaneous adverse effects during selective serotonin reuptake inhibitors therapy: 2 cases].

  Annales de dermatologie et de venereologie 20010101

• Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum.

  Journal of neural transmission (Vienna, Austria : 1996) 20010101

• SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

  Clinical neuropharmacology 20010101

• Methylphenidate augmentation of citalopram in elderly depressed patients.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20010101

• Lack of citalopram effect on the pharmacokinetics of cyclosporine.

  Psychosomatics 20010101

• The effects of hypothyroidism on 5-HT1A and 5-HT2A receptors and the serotonin transporter protein in the rat brain.

  Neuroscience and behavioral physiology 20010101

• Using treatment algorithms for the effective management of treatment-resistant depression.

  The Journal of clinical psychiatry 20010101

• The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.

  The Journal of clinical psychiatry 20010101

• New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study.

  European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20010101

• Palpebral twitching in a depressed adolescent on citalopram.

  Journal of child and adolescent psychopharmacology 20010101

• Effect of citalopram and buspirone on the antinociceptive action of analgesic drugs.

  Acta poloniae pharmaceutica 20010101

• [A clinical case of galactorrhoea after citalopram treatment].

  Actas espanolas de psiquiatria 20010101

• National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20010101

• A fatal case of moclobemide-citalopram intoxication.

  Journal of analytical toxicology 20010101

• Somatically expressed psychological distress and alexithymia in adolescence--reflecting unbearable emotions?

  Nordic journal of psychiatry 20010101

• [An episode of depression in a patient with coronary artery disease].

  Psychiatria polska 20010101

• De novo onset of Parkinson's disease after antidepressant treatment with citalopram.

  Pharmacopsychiatry 20000901

• Suicide attempt by pure citalopram overdose causing long-lasting severe sinus bradycardia, hypotension and syncopes: successful therapy with a temporary pacemaker.

  Pharmacopsychiatry 20000701

• Citalopram and clozapine: potential drug interaction.

  The Journal of clinical psychiatry 20000401

• Modulatory role of 5-HT3 receptors in mediation of apomorphine-induced aggressive behaviour in male rats.

  Behavioural brain research 19991201

• Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.

  The Journal of clinical psychiatry 19991201

• [Severe and recent hyponatremia and hypokalemia associated to the use of hydrochlorothiazide, enalapril and citalopram. Clinical case].

  Revista medica de Chile 19991001

• Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors.

  Journal of clinical psychopharmacology 19990601

• Citalopram and sexual side effects of selective serotonin reuptake inhibitors.

  The American journal of psychiatry 19990501

• Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges.

  Psychopharmacology 19990401

• Bradycardia during citalopram treatment: a case report.

  Pharmacological research 19990201

• The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation.

  Journal of biochemical and molecular toxicology 19990101

• Altropane, a SPECT or PET imaging probe for dopamine neurons: I. Dopamine transporter binding in primate brain.

  Synapse (New York, N.Y.) 19980601

• The effect of antidepressants on rat aggressive behavior in the electric footshock and apomorphine-induced aggressiveness paradigms.

  Methods and findings in experimental and clinical pharmacology 19980501

• Apomorphine-induced aggressiveness and [3H]citalopram binding after antidepressant treatment in rats.

  Pharmacology, biochemistry, and behavior 19980301

• Antidepressant drugs and heart electrical field.

  Physiological research 19980101

• Successful treatment of salbutamol-induced panic disorder with citalopram.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 19970801

• Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes.

  Pharmacogenetics 19970201

• An open pilot study of citalopram for behavioral disturbances of dementia. Plasma levels and real-time observations.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 19970101

• Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction.

  International clinical psychopharmacology 19970101

• Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.

  Polish journal of pharmacology 19970101

• Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation.

  Psychopharmacology 19961201

• Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group.

  International clinical psychopharmacology 19960901

• Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor.

  Psychopharmacology 19960801

• Pharmacology and pharmacokinetics of citalopram and other SSRIs.

  International clinical psychopharmacology 19960301

• Successful treatment of citalopram-induced anorgasmia by cyproheptadine.

  Acta psychiatrica Scandinavica 19960101

• Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia.

  Acta psychiatrica Scandinavica 19950501

• Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor.

  Journal of neural transmission. Parkinson's disease and dementia section 19950101

• Mania induced by citalopram.

  Archives of general psychiatry 19940801

• Citalopram for post-stroke pathological crying.

  Lancet (London, England) 19931002

• The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy.

  Clinical pharmacology and therapeutics 19921101

• The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer.

  Journal of neural transmission. General section 19920101

• Some central effects of repeated treatment with fluvoxamine.

  Polish journal of pharmacology and pharmacy 19890101

• Serotonin-uptake inhibitors in obsessive-compulsive disorder: a case report.

  Comprehensive psychiatry 19860101

• Effects of serotonergic and anticholinergic drugs in haloperidol-induced dystonia in Cebus monkeys.

  Clinical neuropharmacology 19860101

• Orthostatic side effects of clomipramine and citalopram during treatment for depression.

  Psychopharmacology 19850101

• Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice.

  Journal of neural transmission 19820101